U.S. patent application number 13/201101 was filed with the patent office on 2012-03-01 for pyrimidine derivatives and their use as herbicides.
This patent application is currently assigned to SYNGENTA CROP PROTECTION, LLC. Invention is credited to Mary Bernadette Aspinall, Mohamed Abdelouahab Boussemghoune, Harry Glithro, William Guy Whittingham, Caroline Louise Winn.
Application Number | 20120053053 13/201101 |
Document ID | / |
Family ID | 40548196 |
Filed Date | 2012-03-01 |
United States Patent
Application |
20120053053 |
Kind Code |
A1 |
Boussemghoune; Mohamed Abdelouahab
; et al. |
March 1, 2012 |
PYRIMIDINE DERIVATIVES AND THEIR USE AS HERBICIDES
Abstract
The present invention relates to substituted pyrimidine
derivatives, as well as N-oxides thereof and agriculturally
acceptable salts thereof, and their use to control undesired plant
growth, in particular in crops of useful plants. The invention
extends to herbicidal compositions comprising such compounds,
N-oxides and/or salts as well as mixtures of the same with one or
more further active ingredient (such as, for example, an herbicide,
fungicide, insecticide and/or plant growth regulator) and/or a
safener. The invention further relates to intermediates useful in
the preparation of such compounds, and to processes for their
preparation.
Inventors: |
Boussemghoune; Mohamed
Abdelouahab; (Berkshire, GB) ; Whittingham; William
Guy; (Berkshire, GB) ; Winn; Caroline Louise;
(Berkshire, GB) ; Glithro; Harry; (Berkshire,
GB) ; Aspinall; Mary Bernadette; (Berkshire,
GB) |
Assignee: |
SYNGENTA CROP PROTECTION,
LLC
Greensboro
NC
|
Family ID: |
40548196 |
Appl. No.: |
13/201101 |
Filed: |
February 11, 2010 |
PCT Filed: |
February 11, 2010 |
PCT NO: |
PCT/GB2010/000242 |
371 Date: |
November 11, 2011 |
Current U.S.
Class: |
504/103 ;
504/239; 504/242; 504/243; 544/312; 544/319; 544/328; 544/329;
544/334; 544/335; 564/244; 564/246; 564/247 |
Current CPC
Class: |
C07D 239/36 20130101;
C07D 239/32 20130101; C07D 239/42 20130101; C07D 239/34 20130101;
A01N 43/54 20130101 |
Class at
Publication: |
504/103 ;
544/334; 544/329; 544/319; 544/312; 504/242; 504/239; 504/243;
564/244; 564/246; 564/247; 544/335; 544/328 |
International
Class: |
A01N 43/54 20060101
A01N043/54; C07D 239/42 20060101 C07D239/42; C07D 239/38 20060101
C07D239/38; C07D 239/34 20060101 C07D239/34; C07D 239/52 20060101
C07D239/52; A01P 13/00 20060101 A01P013/00; C07C 257/18 20060101
C07C257/18; A01N 25/32 20060101 A01N025/32; C07D 239/28 20060101
C07D239/28; C07D 405/10 20060101 C07D405/10; C07D 239/30 20060101
C07D239/30; C07D 239/56 20060101 C07D239/56 |
Foreign Application Data
Date |
Code |
Application Number |
Feb 13, 2009 |
GB |
0902474.6 |
Claims
1. A compound of formula (I) ##STR00227## or salt or N-oxide
thereof, wherein: A is halogen, optionally substituted alkylthio,
optionally substituted alkyl, optionally substituted alkenyl or an
optionally substituted 3-8 membered carbocyclic ring; X is azido,
halogen, optionally substituted alkoxy, optionally substituted
alkylthio, optionally substituted alkylsulphinyl, optionally
substituted alkylsulphonyl or NR.sup.5R.sup.6; R.sup.5 is hydrogen,
C.sub.2-4 alkenyl, SO.sub.2R.sup.ss, C(O)R.sup.uu or optionally
substituted C.sub.1-4 alkyl; R.sup.6 is hydrogen, C.sub.2-4 alkenyl
or optionally substituted C.sub.1-4; each R.sup.ss is independently
C.sub.1-4 alkyl or phenyl optionally substituted by 1-3 groups
R.sup.zz; each R.sup.uu is independently C.sub.1-4 alkyl, phenyl
optionally substituted by 1-3 groups R.sup.zz, C.sub.1-4 alkoxy, or
NR.sup.acR.sup.ad; each R.sup.zz is independently halogen,
C.sub.1-4 alkyl, C.sub.1-4 alkoxy, or C.sub.1-4 alkylsulphonyl;
R.sup.ac and R.sup.ad are each independently hydrogen or C.sub.1-4
alkyl; or R.sup.5 and R.sup.6 together form a group
.dbd.C(R.sup.i)OR.sup.j, .dbd.C(R.sup.k)SR.sup.l,
.dbd.C(R.sup.m)NR.sup.nR.sup.o wherein R.sup.i is hydrogen,
C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl, phenyl, C.sub.1-4 alkoxy,
C.sub.1-4 alkylthio, or NR.sup.acR.sup.ad wherein R.sup.ac and
R.sup.ad are as defined above, R.sup.j and R.sup.l are each
independently C.sub.1-4 alkyl, R.sup.k is hydrogen, C.sub.1-4
alkyl, C.sub.3-6 cycloalkyl, phenyl, C.sub.1-4 alkylthio, or
NR.sup.acR.sup.ad wherein R.sup.ac and R.sup.ad are as defined
above, R.sup.m is hydrogen, C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl,
phenyl, or NR.sup.acR.sup.ad wherein R.sup.ac and R.sup.ad are as
defined above, and R.sup.n and R.sup.o are each independently
hydrogen or C.sub.1-4alkyl; Y is optionally substituted alkyl,
optionally substituted cycloalkyl, optionally substituted alkenyl,
or optionally substituted alkynyl; and, Z is
O.sub.m--(CHR.sup.w).sub.n--C(O)R.sup.cb, wherein m is an integer
of 0 or 1, n is an integer of 0 or 1 and n.gtoreq.m, R.sup.w is
hydrogen or C.sub.1-4 alkyl R.sup.cb is hydroxy, optionally
substituted alkylthio, NH.sub.2, or OR.sup.co, R.sup.co is
C.sub.1-20 alkyl optionally substituted by 1-3 groups R.sup.cq, or
C.sub.1-20 haloalkyl optionally substituted by 1-3 groups R.sup.cq;
each R.sup.cq is independently C.sub.1-6 alkoxy, phenyl optionally
substituted by 1-3 groups R.sup.cr, or heteroaryl optionally
substituted by 1-2 groups R.sup.cs; each R.sup.cr and each R.sup.cs
are independently halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4
haloalkyl, C.sub.2-6 alkoxyalkyl, C.sub.1-4 alkoxy, C.sub.1-4
haloalkoxy, C.sub.1-4alkylsulphonyl, or C.sub.1-4 alkoxycarbonyl;
provided that: i) when Y is C.sub.1-4 alkyl, C.sub.1-4 haloalkyl,
C.sub.2-4 alkoxyalkyl, C.sub.2-4 alkylthioalkyl, C.sub.2-4 alkenyl,
C.sub.2-4 haloalkenyl, C.sub.2-4 alkoxyalkenyl, C.sub.2-4
thioalkylalkenyl, C.sub.2-4 alkynyl, C.sub.2-4 haloalkynyl,
C.sub.2-4 alkylcarbonyl or C.sub.2-4 haloalkylcarbonyl; X is
NR.sup.5R.sup.6; R.sup.5 is H, C.sub.1-4 alkyl, C.sub.3-4 alkenyl,
C.sub.1-4 alkylsulfonyl or C.sub.1-4 acyl; R.sup.6 is H, C.sub.1-4
alkyl or C.sub.3-4 alkenyl; A is C1-C6 alkyl, cyclopropyl, C1-C6
haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl or a group of the
formula ##STR00228## W.sub.1 represents H or halogen; X.sub.1
represents H, halogen, nitro, cyano, formyl, C.sub.1-6 alkyl,
C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkoxy, C.sub.2-4
alkoxyalkyl, C.sub.1-6 alkylcarbonyl, C.sub.1-6 alkylthio,
C.sub.1-6 alkylsulfinyl, C.sub.1-6 alkylsulfonyl, C.sub.2-4
alkenyloxy, C.sub.2-4 alkynyloxy, C.sub.2-4 alkenylthio, C.sub.2-4
alkynylthio, C.sub.1-6 haloalkyl, C.sub.2-6 halo-alkenyl, C.sub.2-6
haloalkynyl, C.sub.1-6 haloalkoxy, C.sub.2-4 haloalkoxyalkyl,
C.sub.2-6 haloalkylcarbonyl, C.sub.1-6 haloalkylthio, C.sub.1-6
haloalkylsulfinyl, C.sub.1-6 halo-alkylsulfonyl, C.sub.3-6
trialkylsilyl, C.sub.2-4 haloalkenyloxy, C.sub.2-4 haloalkynyloxy,
C.sub.2-4 haloalkenylthio, C.sub.2-4 haloalkynylthio,
--C(O)OR.sup.7', --C(O)NR.sup.6'R.sup.7', --CR.sup.6'NOR.sup.7',
--NR.sup.6'R.sup.7', --NR.sup.6'OR.sup.7', --NR.sup.6'SO2R.sup.7',
--NR.sup.6'C(O)R.sup.7', --NR.sup.6'C(O)OR.sup.7',
--NR.sup.6'C(O)NR.sup.6'R.sup.7' or --NCR.sup.6'NR.sup.6'R.sup.7';
R.sup.6' represents H, C.sub.1-4 alkyl or C.sub.1-4 haloalkyl;
R.sup.7' represents C.sub.1-4 alkyl or C.sub.1-4 haloalkyl; Y.sub.1
represents H, halogen, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl,
C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, C.sub.2-6 alkenyl or
C.sub.2-6 haloalkenyl, or, X.sub.1 and Y.sub.1 taken together,
represents --O(CH.sub.2).sub.nnCH.sub.2--, or
--O(CH.sub.2).sub.nnO-- wherein nn=1 or 2; and Z.sub.1 represents H
or halogen, then Z is other than CO.sub.2H, CO.sub.2Me, CO.sub.2Et,
CO.sub.2.sup.nBu or CO.sub.2.sup.-NHEt.sub.3.sup.+.
2. The compound according to claim 1, wherein A is halogen,
C.sub.1-4 alkylthio, phenyl optionally substituted by 1-3 groups
R.sup.1, or C.sub.3-6 cycloalkyl optionally substituted by 1-4
groups R.sup.2; R.sup.1 is halogen, cyano, C.sub.1-4 alkyl,
C.sub.1-4 haloalkyl, C.sub.1-4 alkoxy, C.sub.1-4 haloalkoxy,
C.sub.1-4 alkylthio, C.sub.1-4 haloalkylthio, amino, C.sub.1-4
alkylamino, di(C.sub.1-4)alkylamino or two adjacent groups R.sup.1
together with the atoms to which they are joined form a 6-membered
aromatic ring, said ring being optionally substituted by 1-2 groups
selected from: halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4
haloalkyl, C.sub.1-4 alkoxy, C.sub.1-4 haloalkoxy, C.sub.1-4
alkylthio, C.sub.1-4 haloalkylthio; R.sup.2 is halogen, cyano,
C.sub.1-4 alkyl, C.sub.1-4 haloalkyl, C.sub.3-6 cycloalkyl,
C.sub.1-4 alkoxy, C.sub.1-4haloalkoxy, C.sub.1-4 alkoxycarbonyl, or
C.sub.1-4 alkylaminocarbonyl; or any two geminal R.sup.2 groups
together form a group selected from oxo, .dbd.CR.sup.mmR.sup.nn, or
.dbd.NOR.sup.oo; or two groups R.sup.2 together with the atoms to
which they are joined form a 3-6-membered ring system, said ring
system being optionally substituted by 1-2 groups selected from:
halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4 haloalkyl, C.sub.1-4
alkoxy, or C.sub.1-4 haloalkoxy; R.sup.mm and R.sup.nn are each
independently hydrogen, halogen, cyano, nitro, C.sub.1-4 alkyl, or
C.sub.1-4 alkoxycarbonyl; R.sup.oo is hydrogen, C.sub.1-4 alkyl,
C.sub.3-6cycloalkyl (C.sub.1-2)alkyl or C.sub.3-6cycloalkyl; X is
azido, halogen, C.sub.1-3 alkoxy, C.sub.1-4
alkoxycarbonylC.sub.1-3alkoxy, C.sub.1-4 alkylthio, C.sub.1-4
alkylsulphinyl, C.sub.1-4 alkylsulphonyl or NR.sup.5R.sup.6 wherein
R.sup.5 is hydrogen, C.sub.1-4 alkyl optionally substituted with 1
or 2 C.sub.1-4 alkoxy groups, C.sub.1-4 haloalkyl optionally
substituted with 1 or 2 C.sub.1-4 alkoxy groups, C.sub.2-4 alkenyl,
SO.sub.2R.sup.ss, or C(O)R.sup.uu; R.sup.6 is hydrogen, C.sub.1-4
alkyl optionally substituted with 1 or 2 C.sub.1-4 alkoxy groups,
or C.sub.1-4 haloalkyl optionally substituted with 1 or 2 C.sub.1-4
alkoxy groups, C.sub.2-4 alkenyl; R.sup.ss and R.sup.uu are
C.sub.1-3 alkyl, Y is C.sub.1-6 alkyl optionally substituted by 1-3
groups R.sup.ba, C.sub.1-6haloalkyl optionally substituted by 1-3
groups R.sup.ba, C.sub.3-6cycloalkyl optionally substituted by 1-3
groups R.sup.bc, C.sub.2-6alkenyl optionally substituted by 1-3
groups R.sup.bd, C.sub.2-6 alkynyl optionally substituted by 1-3
groups R.sup.be, wherein each R.sup.ba is independently cyano,
nitro, hydroxyl, C.sub.3-6cycloalkyl, C.sub.1-4 alkoxy,
C.sub.1-4alkylthio, C.sub.1-4alkylcarbonyl or
C.sub.1-4alkoxycarbonyl, or two geminal R.sup.ba together form an
oxo or oximino group; R.sup.bc is halogen, cyano, C.sub.1-4alkyl,
C.sub.1-4alkoxy, or C.sub.1-4alkoxycarbonyl; R.sup.bd is halogen,
cyano, C.sub.3-6cycloalkyl, C.sub.1-4alkylcarbonyl, or C.sub.1-4
alkoxycarbonyl; R.sup.be is halogen, cyano, hydroxyl,
C.sub.1-4alkoxycarbonyl, or C.sub.3-12 trialkylsilyl; and, Z is
O.sub.m--(CH.sub.2).sub.n--C(O)R.sup.cb, wherein n is an integer of
0 or 1, m is an integer of 0 or 1, and n=m R.sup.cb is hydroxyl,
C.sub.1-10 alkoxy, phenyl C.sub.1-2 alkoxy or NH.sub.2.
3. The compound according to claim 1 or claim 2, wherein A is Cl,
phenyl optionally substituted by 1-3 groups R.sup.1, cyclopropyl
optionally substituted by 1-2 groups R.sup.2; each R.sup.1 is
independently halogen, cyano, C.sub.1-2 alkyl, C.sub.1-2 haloalkyl,
C.sub.1-2 alkoxy, C.sub.1-2 haloalkoxy, amino, C.sub.1-4
alkylamino, or di(C.sub.1-4)alkylamino; each R.sup.2 is
independently halogen, cyano, C.sub.1-2alkyl, C.sub.1-2 haloalkyl,
C.sub.1-2 alkoxy, C.sub.1-2 haloalkoxy or C.sub.2-4 alkoxycarbonyl;
X is N.sub.3, Cl, OCH.sub.3, OCH.sub.2CO.sub.2CH.sub.3, NH.sub.2,
NHCH.sub.3, N(CH.sub.3).sub.2, NH-i-propyl, SMe, SOMe, SO.sub.2Me,
NHCOCH.sub.3, NHC(O)OCH.sub.3, NHSO.sub.2CH.sub.3,
NCH.sub.3COCH.sub.3, NCH.sub.3C(O)OCH.sub.3, or
NCH.sub.3SO.sub.2CH.sub.3; Y is C.sub.1-3 alkyl, C.sub.1-3
haloalkyl, C.sub.2-5alkoxyalkyl, cyclopropyl optionally substituted
by 1 or 2 groups R.sup.bc, C.sub.2-4 alkenyl, C.sub.2-4
haloalkenyl, or C.sub.2-4 alkynyl optionally substituted by 1 or 2
groups R.sup.be, wherein each R.sup.bc is independently halogen or
C.sub.1-2 alkyl, and each R.sup.be is independently halogen or
C.sub.3-9 trialkylsilyl; and Z is selected from the group
consisting of CO.sub.2H, CO.sub.2CH.sub.3,
CO.sub.2CH.sub.2CH.sub.3, CO.sub.2-i-propyl, CO.sub.2-n-propyl,
CO.sub.2CH.sub.2-i-propyl, CO.sub.2CH.sub.2-Phenyl, CONH.sub.2,
OCH.sub.2CO.sub.2H, OCH.sub.2CO.sub.2CH.sub.3.
4. The compound according to any one of the preceding claims
wherein A is selected from the group consisting of: Cl, methylthio,
isopropyl, cyclopropyl, 2-methylcyclopropyl, 4-methylphenyl,
4-methoxyphenyl, 4-chlorophenyl, 4-bromophenyl, 4-iodophenyl,
4-fluorophenyl, 4-trifluoromethylphenyl, 4-trifluoromethoxyphenyl,
2,4-dimethoxyphenyl, 2,4-dichlorophenyl, 2-chloro-4-methylphenyl,
2-chloro-4-trifluoromethylphenyl, 2-fluoro-4-methylphenyl,
2-fluoro-3-methoxyphenyl, 2-fluoro-4-methoxyphenyl,
2,4-bis(trifluoromethyl)phenyl, 3,4-dimethylphenyl,
3,4-dimethoxyphenyl, 3-chloro-4-methylphenyl,
3-chloro-4-methoxyphenyl, 3,4-dichlorophenyl,
3-chloro-4-fluorophenyl, 3-chloro-4-trifluoromethylphenyl,
3-fluoro-4-methylphenyl, 3-fluoro-4-methoxyphenyl,
4-methyl-3-nitrophenyl, 4-methoxy-2-methylphenyl,
4-chloro-2-methylphenyl, 4-chloro-3-methylphenyl,
4-chloro-2-methoxyphenyl, 4-chloro-3-methoxyphenyl,
4-chloro-3-nitrophenyl, 4-chloro-3-cyanophenyl,
4-chloro-2-fluorophenyl, 4-chloro-3-fluorophenyl,
4-chloro-2-trifluoromethylphenyl, 4-chloro-3-trifluoromethylphenyl,
4-fluoro-3-methylphenyl, 4-fluoro-3-methoxyphenyl,
4-fluoro-3-trifluoromethylphenyl, 2,4,5-trimethylphenyl,
2,3,4-trimethoxyphenyl, 2,3,4-trichlorophenyl,
2,4,5-trichlorophenyl, 2,4,6-trichlorophenyl,
2,3,4-trifluorophenyl, 2,4-dichloro-3-fluorophenyl,
3,4-dichloro-2-fluorophenyl, 4-chloro-2,3-difluorophenyl,
4-chloro-2,6-difluorophenyl, 4-chloro-3,5-difluorophenyl,
2,4-dichloro-6-fluorophenyl, 4-chloro-2-fluoro-3-methoxyphenyl,
4-chloro-2-fluoro-3-trifluoromethylphenyl,
4-chloro-3-dimethylamino-2-fluorophenyl, and
2-fluoro-3-methoxy-4-methylphenyl; Y is selected from the group
consisting of: methyl, ethyl, isopropyl, n-propyl, prop-1-en-2-yl,
prop-1-enyl, prop-2-enyl, but-1-enyl, pent-1-enyl, difluoromethyl,
trifluoromethyl, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl,
1-methylprop-1-enyl, 2-methylprop-1-enyl, 1,2-dimethylprop-1-enyl,
3-methylbut-1-ynyl, 3-methylbut-2-enyl, 3,3-dimethylbut-1-ynyl,
acetyl, formyl, methoxymethyl, 2-methoxyethyl, hydroxyiminomethyl,
methoxyiminomethyl, 1-(hydroxyimino)ethyl, 1-(methoxyimino)ethyl,
cyclopropyl, 1-methylcyclopropyl, 2,2-dichlorocyclopropyl, vinyl,
2-cyclopropylvinyl, 1-ethoxyvinyl, 2,2-dichlorovinyl, ethynyl,
prop-1-ynyl, 2-bromoethynyl, 2-chloroethynyl, and
2-trimethylsilylethynyl.
5. A compound according to any one of claim 1, 2 or 4 wherein A is
optionally substituted alkylthio.
6. A compound according to any preceding claim wherein X is azido,
halogen, optionally substituted alkoxy, optionally substituted
alkylthio, optionally substituted alkylsulphinyl or optionally
substituted alkylsulphonyl.
7. A compound according to any preceding claim wherein n is 1.
8. A herbicidal composition comprising a compound as defined in any
one of the preceding claims and at least one agriculturally
acceptable formulation adjuvant or diluent.
9. The herbicidal composition according to claim 8, further
comprising a crop safener.
10. A compound as defined in any one of claims 1 to 7, or a
herbicidal composition according to claim 8 or claim 9, in
admixture with at least one active ingredient selected from the
group consisting of: an insecticide, an acaricide, a nematocide, a
molluscicide, an herbicide, a fungicide, and a plant growth
regulator.
11. Use of a compound according to any one of claims 1 to 7 as a
herbicide.
12. A method of controlling weeds in crops of useful plants which
comprises applying to said weeds or to the locus of said weeds, or
to said crop of useful plants, a compound as defined in any one of
claims 1 to 7, or a herbicidal composition according to claim 8 or
claim 9, or a mixture according to claim 10.
13. A compound of formula (II) ##STR00229## wherein R.sup.7 is
methyl, Br, or Cl; R.sup.8 is H, F, Cl, OR.sup.10, or
N(R.sup.10).sub.2; R.sup.9 is H, F, or Cl; and each R.sup.10 is
independently H or C.sub.1-4alkyl, provided that (i) R.sup.8 and
R.sup.9 are not both hydrogen, (ii) when R.sup.7 is methyl and
R.sup.9 is hydrogen, then R.sup.8 is not F, Cl, or NH.sub.2, (iii)
when R.sup.7 is Cl and R.sup.8 is hydrogen, R.sup.9 is not Cl, (iv)
when R.sup.7 is Cl and R.sup.8 is Cl, R.sup.9 is not hydrogen, and
(v) when R.sup.7 is Br and R.sup.9 is hydrogen, R.sup.8 is not
F.
14. A process for the preparation of a compound of formula (T)
##STR00230## or salt or N-oxide thereof, wherein: A is halogen,
optionally substituted alkylthio, optionally substituted alkyl,
optionally substituted alkenyl or an optionally substituted 3-8
membered carbocyclic ring; Y' is hydrogen, optionally substituted
alkyl, optionally substituted cycloalkyl, optionally substituted
alkenyl, or optionally substituted alkynyl; and, Z' is hydroxyl or
CHR.sup.w).sub.n--C(O)R.sup.cb, wherein n is an integer of 0 or 1
R.sup.w is hydrogen or C.sub.1-4 alkyl R.sup.cb is hydroxy,
optionally substituted alkylthio, NH.sub.2, or OR.sup.co, R.sup.co
is C.sub.1-20 alkyl optionally substituted by 1-3 groups R.sup.cq,
or C.sub.1-20 haloalkyl optionally substituted by 1-3 groups
R.sup.cq; each R.sup.cq is independently C.sub.1-6 alkoxy, phenyl
optionally substituted by 1-3 groups R.sup.cr, or heteroaryl
optionally substituted by 1-2 groups R.sup.cs; each R.sup.cr and
each R.sup.cs are independently halogen, cyano, C.sub.1-4 alkyl,
C.sub.1-4 haloalkyl, C.sub.2-6 alkoxyalkyl, C.sub.1-4 alkoxy,
C.sub.1-4 haloalkoxy, C.sub.1-4 alkylsulphonyl, or C.sub.1-4
alkoxycarbonyl comprising reacting an amidine of formula (N)
##STR00231## wherein A is as defined above, or a salt form thereof,
with a keto ester of the formula (U) ##STR00232## or a salt form
thereof, wherein Y' and Z' are as defined above, or Z' is OR, and R
is selected from hydrogen or alkyl.
15. A process according to claim 14 comprising the further step or
steps of converting the compound of formula (T) to a compound of
formula (I) ##STR00233## wherein A, Z and Y are as defined in claim
14, and X is azido, halogen, optionally substituted alkoxy,
optionally substituted alkylthio, optionally substituted
alkylsulphyl, optionally substituted alkylsulphonyl or
NR.sup.5R.sup.6; R.sup.5 is hydrogen, C.sub.2-4 alkenyl,
SO.sub.2R.sup.ss, C(O)R.sup.uu or optionally substituted C.sub.1-4
alkyl; R.sup.6 is hydrogen, C.sub.2-4 alkenyl or optionally
substituted C.sub.1-4 alkyl; each R.sup.ss is independently
C.sub.1-4 alkyl or phenyl optionally substituted by 1-3 groups
R.sup.zz; each R.sup.uu is independently C.sub.1-4 alkyl, phenyl
optionally substituted by 1-3 groups R.sup.zz, C.sub.1-4 alkoxy, or
NR.sup.acR.sup.ad; each R.sup.zz is independently halogen,
C.sub.1-4 alkyl, C.sub.1-4 alkoxy, or C.sub.1-4 alkylsulphonyl;
R.sup.ac and R.sup.ad are each independently hydrogen or C.sub.1-4
alkyl; or R.sup.5 and R.sup.6 together form a group
.dbd.C(R.sup.i)OR.sup.j, .dbd.C(R.sup.k)SR.sup.l,
.dbd.C(R.sup.m)NR.sup.nR.sup.o wherein R.sup.i is hydrogen,
C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl, phenyl, C.sub.1-4 alkoxy,
C.sub.1-4 alkylthio, or NR.sup.acR.sup.ad wherein R.sup.ac and
R.sup.ad are as defined above, R.sup.j and R.sup.l are each
independently C.sub.1-4 alkyl, R.sup.k is hydrogen, C.sub.1-4
alkyl, C.sub.3-6 cycloalkyl, phenyl, C.sub.1-4 alkylthio, or
NR.sup.acR.sup.ad wherein R.sup.ac and R.sup.ad are as defined
above, R.sup.m is hydrogen, C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl,
phenyl, or NR.sup.acR.sup.ad wherein R.sup.ac and R.sup.ad are as
defined above, and R.sup.n and R.sup.o are each independently
hydrogen or C.sub.1-4 alkyl, or a salt form thereof.
Description
[0001] The present invention relates to substituted pyrimidine
derivatives, as well as N-oxides thereof and agriculturally
acceptable salts thereof, their use to control undesired plant
growth, in particular in crops of useful plants, to processes for
their preparation, and intermediates useful in such processes. The
invention extends to herbicidal compositions comprising such
compounds, N-oxides and/or salts as well as mixtures of the same
with one or more further active ingredient (such as, for example,
an herbicide, fungicide, insecticide and/or plant growth regulator)
and/or a safener.
[0002] Substituted pyrimidine derivatives and their use as
herbicides are disclosed in International Patent Publication No. WO
2005/063721. International Patent Publication No. WO 2007/082076
discloses a number of 2-(poly-substituted
aryl)-6-amino-5-halo-4-pyrimidine carboxylic acids and their use as
herbicides, whilst International Patent Publication No. WO
2007/092184 discloses certain substituted pyrimidine and pyridine
carboxylic acid derivatives as compounds capable of improving the
harvestability of crops. Further picolinic and pyrimidine acid
derivatives are disclosed in WO2009/046090 and WO2009/029735.
[0003] In part, due to the evolution of herbicide-resistant weed
populations, and herbicide-resistant crops becoming volunteer
weeds, there is a continuing need to control such undesired plant
growth in particular in crops of useful plants. Other factors, for
example, the demand for cheaper, more effective herbicides, and for
herbicides with an improved environmental profile (e.g. safer, less
toxic etc.) also drive the need to identify novel herbicidal
compounds.
[0004] The present invention seeks to address this need, and is
based on the finding that substituted pyrimidine derivatives, in
particular where the 5 position of the pyrimidine ring is
substituted with an optionally substituted alkyl, optionally
substituted cycloalkyl, optionally substituted alkenyl, or
optionally substituted alkynyl group, are particularly effective
herbicidal compounds.
[0005] Thus in a first aspect of the invention there is provided a
compound of formula (I)
##STR00001##
[0006] or salt or N-oxide thereof,
[0007] wherein: [0008] A is halogen, optionally substituted
alkylthio, optionally substituted alkyl, optionally substituted
alkenyl or an optionally substituted 3-8 membered carbocyclic ring;
[0009] X is azido, halogen, optionally substituted alkoxy,
optionally substituted alkylthio, optionally substituted
alkylsulphinyl, optionally substituted alkylsulphonyl or
NR.sup.5R.sup.6; [0010] R.sup.5 is hydrogen, C.sub.2-4 alkenyl,
SO.sub.2R.sup.ss, C(O)R.sup.uu or optionally substituted C.sub.1-4
alkyl; [0011] R.sup.6 is hydrogen, C.sub.2-4 alkenyl or optionally
substituted C.sub.1-4 alkyl; [0012] each R.sup.ss is independently
C.sub.1-4 alkyl or phenyl optionally substituted by 1-3 groups
R.sup.zz; [0013] each R.sup.uu is independently C.sub.1-4 alkyl,
phenyl optionally substituted by 1-3 groups R.sup.zz, C.sub.1-4
alkoxy, or NR.sup.acR.sup.ad; [0014] each R.sup.zz is independently
halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, or C.sub.1-4
alkylsulphonyl; [0015] R.sup.ac and R.sup.ad are each independently
hydrogen or C.sub.1-4 alkyl; [0016] or R.sup.5 and R.sup.6 together
form a group .dbd.C(R.sup.i)OR.sup.j, .dbd.C(R.sup.k)SR.sup.l,
.dbd.C(R.sup.m)NR.sup.nR.sup.o wherein [0017] R.sup.i is hydrogen,
C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl, phenyl, C.sub.1-4 alkoxy,
C.sub.1-4 alkylthio, or NR.sup.acR.sup.ad wherein R.sup.ac and
R.sup.ad are as defined above, [0018] R.sup.j and R.sup.l are each
independently C.sub.1-4 alkyl, [0019] R.sup.k is hydrogen,
C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl, phenyl, C.sub.1-4 alkylthio,
or NR.sup.acR.sup.ad wherein R.sup.ac and R.sup.ad are as defined
above, [0020] R.sup.m is hydrogen, C.sub.1-4 alkyl, C.sub.3-6
cycloalkyl, phenyl, or NR.sup.acR.sup.ad wherein R.sup.ac and
R.sup.ad are as defined above, and [0021] R.sup.n and R.sup.o are
each independently hydrogen or C.sub.1-4 alkyl; [0022] Y is
optionally substituted alkyl, optionally substituted cycloalkyl,
optionally substituted alkenyl, or optionally substituted alkynyl;
[0023] and, [0024] Z is O.sub.m--(CHR.sup.w).sub.n--C(O)R.sup.cb,
wherein [0025] m is an integer of 0 or 1, [0026] n is an integer of
0 or 1 and n.gtoreq.m, [0027] R.sup.w is hydrogen or C.sub.1-4
alkyl [0028] R.sup.cb is hydroxy, optionally substituted alkylthio,
NH.sub.2, or OR.sup.co, [0029] R.sup.co is C.sub.1-20 alkyl
optionally substituted by 1-3 groups R.sup.cq, or C.sub.1-20
haloalkyl optionally substituted by 1-3 groups R.sup.cq; [0030]
each R.sup.cq is independently C.sub.1-6 alkoxy, phenyl optionally
substituted by 1-3 groups R.sup.cr, or heteroaryl optionally
substituted by 1-2 groups R.sup.cs; [0031] each R.sup.cr and each
R.sup.cs are independently halogen, cyano, C.sub.1-4 alkyl,
C.sub.1-4 haloalkyl, C.sub.2-6 alkoxyalkyl, C.sub.1-4 alkoxy,
C.sub.1-4 haloalkoxy, C.sub.1-4 alkylsulphonyl, or C.sub.1-4
alkoxycarbonyl; [0032] provided that: [0033] i) when Y is C.sub.1-4
alkyl, C.sub.1-4 haloalkyl, C.sub.2-4 alkoxyalkyl, C.sub.2-4
alkylthioalkyl, C.sub.2-4 alkenyl, C.sub.2-4 haloalkenyl, C.sub.2-4
alkoxyalkenyl, C.sub.2-4 thioalkylalkenyl, C.sub.2-4 alkynyl,
C.sub.2-4 haloalkynyl, C.sub.2-4 alkylcarbonyl or C.sub.2-4
haloalkylcarbonyl; [0034] X is NR.sup.5R.sup.6; [0035] R.sup.5 is
H, C.sub.1-4 alkyl, C.sub.3-4 alkenyl, C.sub.1-4 alkylsulfonyl or
C.sub.1-4 acyl; [0036] R.sup.6 is H, C.sub.1-4 alkyl or C.sub.3-4
alkenyl; [0037] A is C1-C6 alkyl, cyclopropyl, C1-C6 haloalkyl,
C2-C6 alkenyl, C2-C6 haloalkenyl or a group of the formula
[0037] ##STR00002## [0038] W.sub.1 represents H or halogen; [0039]
X.sub.1 represents H, halogen, nitro, cyano, formyl, C.sub.1-6
alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkoxy,
C.sub.2-4 alkoxyalkyl, C.sub.1-6 alkylcarbonyl, C.sub.1-6
alkylthio, C.sub.1-6 alkylsulfinyl, C.sub.1-6 alkylsulfonyl,
C.sub.2-4 alkenyloxy, C.sub.2-4 alkynyloxy, C.sub.2-4 alkenylthio,
C.sub.2-4 alkynylthio, C.sub.1-6 haloalkyl, C.sub.2-6 halo-alkenyl,
C.sub.2-6 haloalkynyl, C.sub.1-6 haloalkoxy, C.sub.2-4
haloalkoxyalkyl, C.sub.2-6 haloalkylcarbonyl, C.sub.1-6
haloalkylthio, C.sub.1-6 haloalkylsulfinyl, C.sub.1-6
halo-.alkylsulfonyl, C.sub.3-6 trialkylsilyl, C.sub.2-4
haloalkenyloxy, C.sub.2-4 haloalkynyloxy, C.sub.2-4
haloalkenylthio, C.sub.2-4 haloalkynylthio, --C(O)OR.sup.7',
--C(O)NR.sup.6'R.sup.7', --CR.sup.6'NOR.sup.7',
--NR.sup.6'R.sup.7', --NR.sup.6'OR.sup.7', --NR.sup.6'SO2R.sup.7',
--NR.sup.6'C(O)R.sup.7', --NR.sup.6'(O)OR.sup.7',
--NR.sup.6'C(O)NR.sup.6'R.sup.7' or --NCR.sup.6'NR.sup.6'R.sup.7';
[0040] R.sup.6' represents H, C.sub.1-4 alkyl or C.sub.1-4
haloalkyl; [0041] R.sup.7' represents C.sub.1-4 alkyl or C.sub.1-4
haloalkyl; [0042] Y.sub.1 represents H, halogen, C.sub.1-6 alkyl,
C.sub.1-6 haloalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy,
C.sub.2-6 alkenyl or C.sub.2-6 haloalkenyl, or, X.sub.1 and Y.sub.1
taken together, represents --O(CH.sub.2).sub.nnCH.sub.2--, or
--O(CH.sub.2).sub.nnO-- wherein nn=1 or 2; and [0043] Z.sub.1
represents H or halogen, then Z is other than CO.sub.2H,
CO.sub.2Me, CO.sub.2Et, CO.sub.2.sup.nBu or
CO.sub.2.sup.-NHEt.sub.3.sup.+. In a second aspect of the invention
there is provided a herbicidal composition comprising a compound as
defined above and at least one agriculturally acceptable
formulation adjuvant or diluent.
[0044] In a second aspect of the invention there is provided a
compound as defined above, or a herbicidal composition as defined
above in admixture with at least one active ingredient selected
from the group consisting of: an insecticide, an acaricide, a
nematocide, a molluscicide, an herbicide, a fungicide, and a plant
growth regulator.
[0045] In a third aspect of the invention there is provided a use
of a compound according to the invention as a herbicide.
[0046] In a fourth aspect of the invention, there is provided a
method of controlling weeds in crops of useful plants which
comprises applying to said weeds or to the locus of said weeds, or
to said crop of useful plants, a compound, composition or a mixture
according to the invention.
[0047] In a fifth aspect of the invention, there is provided a
compound of formula (II)
##STR00003##
wherein R.sup.7 is methyl, Br, or Cl;
R.sup.8 is H, F, Cl, OR.sup.10, or N(R.sup.10).sub.2;
R.sup.9 is H, F, or Cl; and
[0048] each R.sup.10 is independently H or C.sub.1-4alkyl, provided
that (i) R.sup.8 and R.sup.9 are not both hydrogen, (ii) when
R.sup.7 is methyl and R.sup.9 is hydrogen, then R.sup.8 is not F,
Cl, or NH.sub.2, (iii) when R.sup.7 is Cl and R.sup.8 is hydrogen,
R.sup.9 is not Cl, (iv) when R.sup.7 is Cl and R.sup.8 is Cl,
R.sup.9 is not hydrogen, and (v) when R.sup.7 is Br and R.sup.9 is
hydrogen, R.sup.8 is not F.
[0049] In a sixth aspect of the invention, there is provided a
process for the preparation of a compound of formula (T)
##STR00004##
[0050] or salt or N-oxide thereof,
[0051] wherein: [0052] A is halogen, optionally substituted
alkylthio, optionally substituted alkyl, optionally substituted
alkenyl or an optionally substituted 3-8 membered carbocyclic ring;
[0053] Y' is hydrogen, optionally substituted alkyl, optionally
substituted cycloalkyl, optionally substituted alkenyl, or
optionally substituted alkynyl; [0054] and, [0055] Z' is hydroxyl
or (CHR.sup.w).sub.n--C(O)R.sup.cb, wherein [0056] n is an integer
of 0 or 1, [0057] R.sup.w is hydrogen or C.sub.1-4 alkyl [0058]
R.sup.cb is hydroxy, optionally substituted alkylthio, optionally
substituted alkyl, NH.sub.2, or OR.sup.co, [0059] R.sup.co is
C.sub.1-20 alkyl optionally substituted by 1-3 groups R.sup.cq, or
C.sub.1-20 haloalkyl optionally substituted by 1-3 groups R.sup.cq;
[0060] each R.sup.cq is independently C1-6 alkoxy, phenyl
optionally substituted by 1-3 groups R.sup.cr, or heteroaryl
optionally substituted by 1-2 groups R.sup.cs; each R.sup.cr and
each R.sup.cs are independently halogen, cyano, C.sub.1-4 alkyl,
C.sub.1-4 haloalkyl, C.sub.2-6 alkoxyalkyl, C.sub.1-4 alkoxy,
C.sub.1-4 haloalkoxy, C.sub.1-4 alkylsulphonyl, or C.sub.1-4
alkoxycarbonyl comprising reacting an amidine of formula (N)
##STR00005##
[0060] wherein A is as defined above, or a salt form thereof, with
a keto ester of the formula (U)
##STR00006##
or a salt form thereof, wherein Y' and Z' are as defined above, or
Z' is OR, and R is selected from hydrogen or alkyl.
[0061] In an seventh aspect, there is provided a compound of
formula (I)
##STR00007##
[0062] or salt or N-oxide thereof,
[0063] wherein: [0064] A is halogen, optionally substituted
alkylthio, optionally substituted alkyl, optionally substituted
alkenyl or an optionally substituted 3-8 membered carbocyclic ring;
[0065] X is azido, halogen, optionally substituted alkoxy, or
NR.sup.5R.sup.6; [0066] R.sup.5 is hydrogen, optionally substituted
C.sub.1-4 alkyl provided said substitution does not comprise a ring
system or a hydroxyl group, C.sub.2-4 alkenyl, SO.sub.2R.sup.ss, or
C(O)R.sup.uu; [0067] R.sup.6 is hydrogen, optionally substituted
C.sub.1-4 alkyl provided said substitution does not comprise a ring
system or a hydroxyl group, C.sub.2-4 alkenyl; [0068] each R.sup.ss
is independently C.sub.1-4 alkyl or phenyl optionally substituted
by 1-3 groups R.sup.zz; [0069] each R.sup.uu is independently
C.sub.1-4 alkyl, phenyl optionally substituted by 1-3 groups
R.sup.zz, C.sub.1-4 alkoxy, or NR.sup.acR.sup.ad; [0070] each
R.sup.zz is independently halogen, C.sub.1-4 alkyl, C.sub.1-4
alkoxy, or C.sub.1-4 alkylsulphonyl; [0071] R.sup.ac and R.sup.ad
are each independently hydrogen or C.sub.1-4 alkyl; [0072] or
R.sup.5 and R.sup.6 together form a group .dbd.C(R.sup.i)OR.sup.j,
.dbd.C(R.sup.k)SR.sup.l, .dbd.C(R.sup.m)NR.sup.nR.sup.o wherein
[0073] R.sup.i is hydrogen, C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl,
phenyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, or NR.sup.acR.sup.ad
wherein R.sup.ac and R.sup.ad are as defined above, [0074] R.sup.j
and R.sup.l are each independently C.sub.1-4 alkyl, [0075] R.sup.k
is hydrogen, C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl, phenyl,
C.sub.1-4 alkylthio, or NR.sup.acR.sup.ad wherein R.sup.ac and
R.sup.ad are as defined above, [0076] R.sup.m is hydrogen,
C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl, phenyl, or NR.sup.acR.sup.ad
wherein R.sup.ac and R.sup.ad are as defined above, and [0077]
R.sup.n and R.sup.o are each independently hydrogen or C.sub.1-4
alkyl; [0078] Y is optionally substituted alkyl, optionally
substituted cycloalkyl, optionally substituted alkenyl, or
optionally substituted alkynyl; [0079] and, [0080] Z is
O.sub.m--(CHR.sup.w).sub.n--C(O)R.sup.cb, wherein [0081] m is an
integer of 0 or 1, [0082] n is an integer of 0 or 1 and n.gtoreq.m,
[0083] R.sup.w is hydrogen or C.sub.1-4 alkyl [0084] R.sup.cb is
hydroxy, optionally substituted alkylthio, optionally substituted
alkyl, NH.sub.2, or OR.sup.co, [0085] R.sup.co is C.sub.1-20 alkyl
optionally substituted by 1-3 groups R.sup.cq, or C.sub.1-20
haloalkyl optionally substituted by 1-3 groups R.sup.cq; [0086]
each R.sup.cq is independently phenyl optionally substituted by 1-3
groups R.sup.cr, or heteroaryl optionally substituted by 1-2 groups
R.sup.cs; each R.sup.cr and each R.sup.cs are independently
halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4 haloalkyl, C.sub.2-6
alkoxyalkyl, C.sub.1-4 alkoxy, C.sub.1-4 haloalkoxy, C.sub.1-4
alkylsulphonyl, or C.sub.1-4 alkoxycarbonyl.
[0087] For the avoidance of doubt, the term "compound" as used
herein includes all salts and N-oxides of said compound.
[0088] The compounds of formula (I) may exist in different
geometric or optical isomers or different tautomeric forms. One or
more centres of chirality may be present, in which case compounds
of the formula (I) may be present as pure enantiomers, mixtures of
enantiomers, pure diastereomers or mixtures of diastereomers. There
may be double bonds present in the molecule, such as C.dbd.C or
C.dbd.N bonds, in which case compounds of formula (I) may exist as
single isomers or mixtures of isomers. Centres of tautomerisation
may be present. This invention covers all such isomers and
tautomers and mixtures thereof in all proportions as well as
isotopic forms such as deuterated compounds.
[0089] Suitable acid addition salts include those with an inorganic
acid such as hydrochloric, hydrobromic, sulfuric, nitric and
phosphoric acids, or an organic carboxylic acid such as oxalic,
tartaric, lactic, butyric, toluic, hexanoic and phthalic acids, or
sulphonic acids such as methane, benzene and toluene sulphonic
acids. Other examples of organic carboxylic acids include haloacids
such as trifluoroacetic acid.
[0090] Suitable salts also include those formed by strong bases
(e.g. metal hydroxides--in particular sodium, potassium or
lithium--or quaternary ammonium hydroxide) as well as those formed
with amines.
[0091] N-oxides are oxidised forms of tertiary amines or oxidised
forms of nitrogen containing heteroaromatic compounds. They are
described in many books for example in "Heterocyclic N-oxides" by
Angelo Albini and Silvio Pietra, CRC Press, Boca Raton, Fla.,
1991.
[0092] Each alkyl moiety either alone or as part of a larger group
(such as alkoxy, alkoxyalkyl, alkylcarbonyl, alkoxycarbony,
alkylaminocarbonyl, alkylsulphonyl, alkylthio, hakoalkylthio,
haloalkyl, haloalkoxy, trialklylsilyl, etc.) is a straight or
branched chain and is, for example, methyl, ethyl, n-propyl,
n-butyl, n-pentyl, n-hexyl, iso-propyl, sec-butyl, iso-butyl,
tert-butyl or neo-pentyl. As defined herein alkyl groups may be
C.sub.1 to C.sub.20 alkyl groups, but are typically C.sub.1-10,
preferably C.sub.1-C.sub.6, more preferably C.sub.1-C.sub.4, even
more preferably C.sub.1-3, and most preferably C.sub.1-C.sub.2
alkyl groups.
[0093] Ring or chain forming alkylene, alkenylene and alkynylene
groups can optionally be further substituted by one or more
halogen, C.sub.1-3 alkyl and/or C.sub.1-3 alkoxy groups.
[0094] When present, the optional substituents on an alkyl moiety
(alone or as part of a larger group) include one or more of
halogen, nitro, cyano, C.sub.3-7 cycloalkyl (itself optionally
substituted with C.sub.1-6 alkyl or halogen), C.sub.5-7
cycloalkenyl (itself optionally substituted with C.sub.1-6 alkyl or
halogen), hydroxy, C.sub.1-10 alkoxy, C.sub.1-10
alkoxy(C.sub.1-10)alkoxy, C.sub.1-6
alkoxycarbonyl(C.sub.1-10)alkoxy, C.sub.1-10 haloalkoxy,
aryl(C.sub.1-4-alkoxy (where the aryl group is optionally
substituted), C.sub.3-7 cycloalkyloxy (where the cycloalkyl group
is optionally substituted with C.sub.1-6 alkyl or halogen),
C.sub.2-10 alkenyloxy, C.sub.2-10 alkynyloxy, mercapto, C.sub.1-10
alkylthio, C.sub.1-10 haloalkylthio, aryl(C.sub.1-4alkylthio (where
the aryl group is optionally substituted), C.sub.3-7 cycloalkylthio
(where the cycloalkyl group is optionally substituted with
C.sub.1-6 alkyl or halogen), arylthio (where the aryl group is
optionally substituted), C.sub.1-6 alkylsulfonyl, C.sub.1-6
haloalkylsulfonyl, C.sub.1-6 alkylsulfinyl, C.sub.1-6
haloalkylsulfinyl, arylsulfonyl (where the aryl group may be
optionally substituted), tri(C.sub.1-4)alkylsilyl,
aryl(C.sub.1-4)alkylthio(C.sub.1-4)alkyl, aryloxy(C.sub.1-4)alkyl,
formyl, C.sub.1-10 alkylcarbonyl, HO.sub.2C, C.sub.1-10
alkoxycarbonyl, aminocarbonyl, C.sub.1-6 alkylaminocarbonyl,
di(C.sub.1-6 alkyl)aminocarbonyl, N--(C.sub.1-3
alkyl)-N--(C.sub.1-3 alkoxy)aminocarbonyl, C.sub.1-6
alkylcarbonyloxy, arylcarbonyloxy (where the aryl group is
optionally substituted), di(C.sub.1-6)alkylaminocarbonyloxy, oximes
and oxime-ethers such as .dbd.NOalkyl, .dbd.NOhaloalkyl and
.dbd.NOaryl (itself optionally substituted), aryl (itself
optionally substituted), heteroaryl (itself optionally
substituted), heterocyclyl (itself optionally substituted with
C.sub.1-6 alkyl or halogen), aryloxy (where the aryl group is
optionally substituted), heteroaryloxy, (where the heteroaryl group
is optionally substituted), heterocyclyloxy (where the heterocyclyl
group is optionally substituted with C.sub.1-6 alkyl or halogen),
amino, C.sub.1-6 alkylamino, di(C.sub.1-6)alkylamino, C.sub.1-6
alkylcarbonylamino,
N--(C.sub.1-6)alkylcarbonyl-N--(C.sub.1-6)alkylamino, C.sub.2-6
alkenylcarbonyl, C.sub.2-6 alkynylcarbonyl, C.sub.3-6
alkenyloxycarbonyl, C.sub.3-6 alkynyloxycarbonyl, aryloxycarbonyl
(where the aryl group is optionally substituted) and arylcarbonyl
(where the aryl group is optionally substituted).
[0095] Alkenyl and alkynyl moieties can be in the form of straight
or branched chains, and the alkenyl moieties, where appropriate,
can be of either the (E)- or (Z)-configuration. Preferably alkenyl
moieties are C.sub.2-6 alkenyl groups, more preferably C.sub.2-4
alkenyl groups, and most preferably vinyl or allyl. Alkynyl
moieties are preferably C.sub.2-6 alkynyl groups, more preferably
C.sub.2-4 alkynyl groups and most prefereably ethynyl and
propargyl. Alkenyl and alkynyl moieties can contain one or more
double and/or triple bonds in any combination. It is understood,
that allenyl and alkynylalkenyl are included in these terms.
[0096] When present, the optional substituents on alkenyl or
alkynyl include those optional substituents given above for an
alkyl moiety.
[0097] In the context of this specification acyl is optionally
substituted C.sub.1-6 alkylcarbonyl (for example acetyl),
optionally substituted C.sub.2-6 alkenylcarbonyl, optionally
substituted C.sub.3-6 cycloalkylcarbonyl (for example
cyclopropylcarbonyl), optionally substituted C.sub.2-6
alkynylcarbonyl, optionally substituted arylcarbonyl (for example
benzoyl) or optionally substituted heteroarylcarbonyl.
[0098] Halogen is fluorine, chlorine, bromine or iodine.
[0099] Haloalkyl groups are alkyl groups which are substituted with
one or more of the same or different halogen atoms and are, for
example, CF.sub.3, CF.sub.2Cl, CF.sub.2H, CCl.sub.2H, FCH.sub.2,
ClCH.sub.2, BrCH.sub.2, CH.sub.3CHF, (CH.sub.3).sub.2CF,
CF.sub.3CH.sub.2 or CHF.sub.2CH.sub.2.
[0100] In the context of the present specification ring systems may
be saturated, unsaturated, or aromatic, and may also be fused,
spiro or bridging ring systems. The terms "aryl", "aromatic ring"
and "aromatic ring system" as used herein refer to ring systems
which may be mono-, bi- or tricyclic. Examples of such rings
include phenyl, naphthalenyl, anthracenyl, indenyl or
phenanthrenyl. A preferred aryl group is phenyl. In addition, the
terms "heteroaryl", "heteroaromatic ring" or "heteroaromatic ring
system" refer to an aromatic ring system containing at least one
heteroatom and consisting either of a single ring or of two or more
fused rings. Preferably, single rings will contain up to three and
bicyclic systems up to four heteroatoms which will preferably be
chosen from nitrogen, oxygen and sulphur. Examples of such groups
include furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl,
1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl,
isothiazolyl, 1,2,3-oxadiazolyl, 1,2,4-oxadiazolyl,
1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,3-thiadiazolyl,
1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl,
pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl,
1,2,4-triazinyl, 1,3,5-triazinyl, benzofuryl, benzisofuryl,
benzothienyl, benzisothienyl, indolyl, isoindolyl, indazolyl,
benzothiazolyl, benzisothiazolyl, benzoxazolyl, benzisoxazolyl,
benzimidazolyl, 2,1,3-benzoxadiazole, quinolinyl, isoquinolinyl,
cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl,
naphthyridinyl, benzotriazinyl, purinyl, pteridinyl and
indolizinyl. Preferred examples of heteroaromatic radicals include
pyridyl, pyrimidyl, triazinyl, thienyl, furyl, oxazolyl, isoxazolyl
and thiazolyl.
[0101] The terms heterocycle and heterocyclyl refer to a
non-aromatic preferably monocyclic or bicyclic ring systems
containing up to 10 atoms including one or more (preferably one or
two) heteroatoms selected from O, S and N. Examples of such rings
include 1,3-dioxolane, oxetane, tetrahydrofuran, morpholine,
thiomorpholine and piperazine.
[0102] In the case of heteroaromatic or heterocyclic rings
containing S as a heteroatom, the S atom may also be in the form of
a mono- or di-oxide.
[0103] When present, the optional substituents on heterocyclyl
include C.sub.1-6 alkyl and C.sub.1-6 haloalkyl, an oxo-group
(allowing one of the carbon atoms in the ring to be in the form of
a keto group), as well as those optional substituents given above
for an alkyl moiety.
[0104] Cycloalkyl includes cyclopropyl, cyclobutyl, cyclopentyl and
cyclohexyl. Cycloalkylalkyl is preferentially cyclopropylmethyl.
Cycloalkenyl includes cyclopentenyl and cyclohexenyl.
[0105] When present, the optional substituents on cycloalkyl or
cycloalkenyl include C.sub.1-3 alkyl as well as those optional
substituents given above for an alkyl moiety.
[0106] Carbocyclic rings include aryl, cycloalkyl and cycloalkenyl
groups.
[0107] When present, the optional substituents on aryl or
heteroaryl are selected independently, from halogen, nitro, cyano,
C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6
alkoxy-(C.sub.1-6)alkyl, C.sub.2-6 alkenyl, C.sub.2-6 haloalkenyl,
C.sub.2-6 alkynyl, C.sub.3-7 cycloalkyl (itself optionally
substituted with C.sub.1-6 alkyl or halogen), C.sub.5-7
cycloalkenyl (itself optionally substituted with C.sub.1-6 alkyl or
halogen), hydroxy, C.sub.1-10 alkoxy, C.sub.1-10
alkoxy(C.sub.1-10)alkoxy,
tri(C.sub.1-4)alkyl-silyl(C.sub.1-6)alkoxy, C.sub.1-6
alkoxycarbonyl(C.sub.1-10)alkoxy, C.sub.1-10 haloalkoxy,
aryl(C.sub.1-4)alkoxy (where the aryl group is optionally
substituted with halogen or C.sub.1-6 alkyl), C.sub.3-7
cycloalkyloxy (where the cycloalkyl group is optionally substituted
with C.sub.1-6 alkyl or halogen), C.sub.2-10 alkenyloxy, C.sub.2-10
alkynyloxy, mercapto, C.sub.1-10 alkylthio, C.sub.1-10
haloalkylthio, aryl(C.sub.1-4)alkylthio, C.sub.3-7 cycloalkylthio
(where the cycloalkyl group is optionally substituted with
C.sub.1-6 alkyl or halogen),
tri(C.sub.1-4-alkylsilyl(C.sub.1-6)alkylthio, arylthio, C.sub.1-6
alkylsulfonyl, C.sub.1-6 haloalkylsulfonyl, C.sub.1-6
alkylsulfinyl, C.sub.1-6 haloalkylsulfinyl, arylsulfonyl,
tri(C.sub.1-4)alkylsilyl, aryldi(C.sub.1-4-alkylsilyl,
(C.sub.1-4)alkyldiarylsilyl, triarylsilyl, C.sub.1-10
alkylcarbonyl, HO.sub.2C, C.sub.1-10 alkoxycarbonyl, aminocarbonyl,
C.sub.1-6 alkylaminocarbonyl, di(C.sub.1-6 alkyl)-aminocarbonyl,
N--(C.sub.1-3 alkyl)-N--(C.sub.1-3 alkoxy)aminocarbonyl, C.sub.1-6
alkylcarbonyloxy, arylcarbonyloxy,
di(C.sub.1-6)alkylamino-carbonyloxy, aryl (itself optionally
substituted with C.sub.1-6 alkyl or halogen), heteroaryl (itself
optionally substituted with C.sub.1-6 alkyl or halogen),
heterocyclyl (itself optionally substituted with C.sub.1-6 alkyl or
halogen), aryloxy (where the aryl group is optionally substituted
with C.sub.1-6 alkyl or halogen), heteroaryloxy (where the
heteroaryl group is optionally substituted with C.sub.1-6 alkyl or
halogen), heterocyclyloxy (where the heterocyclyl group is
optionally substituted with C.sub.1-6 alkyl or halogen), amino,
C.sub.1-6 alkylamino, di(C.sub.1-6)alkylamino, C.sub.1-6
alkylcarbonylamino,
N--(C.sub.1-6)alkylcarbonyl-N--(C.sub.1-6)alkylamino, arylcarbonyl,
(where the aryl group is itself optionally substituted with halogen
or C.sub.1-6 alkyl) or two adjacent positions on an aryl or
heteroaryl system may be cyclised to form a 5, 6 or 7 membered
carbocyclic or heterocyclic ring, itself optionally substituted
with halogen or C.sub.1-6 alkyl. Further substituents for aryl or
heteroaryl include arylcarbonylamino (where the aryl group is
substituted by C.sub.1-6 alkyl or halogen),
C.sub.1-6alkoxycarbonylamino,
C.sub.1-6alkoxycarbonyl-N--(C.sub.1-6)alkylamino,
aryloxycarbonylamino (where the aryl group is substituted by
C.sub.1-6 alkyl or halogen),
aryloxycarbonyl-N--(C.sub.1-6)alkylamino (where the aryl group is
substituted by C.sub.1-6 alkyl or halogen), arylsulphonylamino
(where the aryl group is substituted by C.sub.1-6 alkyl or
halogen), arylsulphonyl-N--(C.sub.1-6)alkylamino (where the aryl
group is substituted by C.sub.1-6 alkyl or halogen),
aryl-N--(C.sub.1-6)alkylamino (where the aryl group is substituted
by C.sub.1-6 alkyl or halogen), arylamino (where the aryl group is
substituted by C.sub.1-6 alkyl or halogen), heteroarylamino (where
the heteroaryl group is substituted by C.sub.1-6 alkyl or halogen),
heterocyclylamino (where the heterocyclyl group is substituted by
C.sub.1-6 alkyl or halogen), aminocarbonylamino, C.sub.1-6
alkylaminocarbonylamino, di(C.sub.1-6)alkylaminocarbonylamino,
arylaminocarbonylamino where the aryl group is substituted by
C.sub.1-6 alkyl or halogen),
aryl-N--(C.sub.1-6)alkylaminocarbonylamino (where the aryl group is
substituted by C.sub.1-6 alkyl or halogen), C.sub.1-6
alkylaminocarbonyl-N--(C.sub.1-6)alkylamino,
di(C.sub.1-6)alkylaminocarbonyl-N--(C.sub.1-6)alkylamino,
arylaminocarbonyl-N--(C.sub.1-6)alkylamino (where the aryl group is
substituted by C.sub.1-6 alkyl or halogen) and
aryl-N--(C.sub.1-6)alkylaminocarbonyl-N--(C.sub.1-6)alkylamino
(where the aryl group is substituted by C.sub.1-6 alkyl or
halogen).
[0108] For substituted phenyl moieties, heterocyclyl and heteroaryl
groups it is preferred that one or more substituents are
independently selected from halogen, C.sub.1-6 alkyl, C.sub.1-6
haloalkyl, C.sub.1-6 alkoxy(C.sub.1-6)alkyl, C.sub.1-6 alkoxy,
C.sub.1-6 haloalkoxy, C.sub.1-6 alkylthio, C.sub.1-6 haloalkylthio,
C.sub.1-6 alkylsulfinyl, C.sub.1-6 haloalkylsulfinyl, C.sub.1-6
alkylsulfonyl, C.sub.1-6 haloalkylsulfonyl, C.sub.2-6 alkenyl,
C.sub.2-6 haloalkenyl, C.sub.2-6 alkynyl, C.sub.3-7 cycloalkyl,
nitro, cyano, CO.sub.2H, C.sub.1-6 alkylcarbonyl, C.sub.1-6
alkoxycarbonyl, aryl, heteroaryl, C.sub.1-6 alkylamino,
di(C.sub.1-6 alkyl)amino, C.sub.1-6 alkylaminocarbonyl, or
di(C.sub.1-6 alkyl)aminocarbonyl.
[0109] Haloalkenyl groups are alkenyl groups which are substituted
with one or more of the same or different halogen atoms.
[0110] It is to be understood that dialkylamino substituents
include those where the dialkyl groups together with the N atom to
which they are attached form a five, six or seven-membered
heterocyclic ring which may contain one or two further heteroatoms
selected from O, N or S and which is optionally substituted by one
or two independently selected (C.sub.1-6)alkyl groups. When
heterocyclic rings are formed by joining two groups on an N atom,
the resulting rings are suitably pyrrolidine, piperidine,
thiomorpholine and morpholine each of which may be substituted by
one or two independently selected (C.sub.1-6) alkyl groups.
[0111] In preferred embodiments of the invention, the preferred
groups for A, X, Y, and Z, in any combination thereof, are as set
out below.
[0112] According to the invention A is selected from halogen,
optionally substituted alkylthio, optionally substituted alkyl,
optionally substituted alkenyl and an optionally substituted 3-8
membered carbocyclic ring. Preferably, A is optionally substituted
alkylthio.
[0113] In preferred embodiments A is selected from: halogen,
C.sub.1-4 alkylthio, phenyl optionally substituted by 1-3 groups
R.sup.1, and C.sub.3-6 cycloalkyl optionally substituted by 1-4
groups R.sup.2.
[0114] More preferably A is Cl, phenyl optionally substituted by
1-3 groups R.sup.1, or cyclopropyl optionally substituted by 1-2
groups R.sup.2.
[0115] Most preferably A is selected from the group consisting of:
Cl, methylthio, isopropyl, cyclopropyl, 2-methylcyclopropyl,
4-methylphenyl, 4-methoxyphenyl, 4-chlorophenyl, 4-bromophenyl,
4-iodophenyl, 4-fluorophenyl, 4-trifluoromethylphenyl,
4-trifluoromethoxyphenyl, 2,4-dimethoxyphenyl, 2,4-dichlorophenyl,
2-chloro-4-methylphenyl, 2-chloro-4-trifluoromethylphenyl,
2-fluoro-4-methylphenyl, 2-fluoro-3-methoxyphenyl,
2-fluoro-4-methoxyphenyl, 2,4-bis(trifluoromethyl)phenyl,
3,4-dimethylphenyl, 3,4-dimethoxyphenyl, 3-chloro-4-methylphenyl,
3-chloro-4-methoxyphenyl, 3,4-dichlorophenyl,
3-chloro-4-fluorophenyl, 3-chloro-4-trifluoromethylphenyl,
3-fluoro-4-methylphenyl, 3-fluoro-4-methoxyphenyl,
4-methyl-3-nitrophenyl, 4-methoxy-2-methylphenyl,
4-chloro-2-methylphenyl, 4-chloro-3-methylphenyl,
4-chloro-2-methoxyphenyl, 4-chloro-3-methoxyphenyl,
4-chloro-3-nitrophenyl, 4-chloro-3-cyanophenyl,
4-chloro-2-fluorophenyl, 4-chloro-3-fluorophenyl,
4-chloro-2-trifluoromethylphenyl, 4-chloro-3-trifluoromethylphenyl,
4-fluoro-3-methylphenyl, 4-fluoro-3-methoxyphenyl,
4-fluoro-3-trifluoromethylphenyl, 2,4,5-trimethylphenyl,
2,3,4-trimethoxyphenyl, 2,3,4-trichlorophenyl,
2,4,5-trichlorophenyl, 2,4,6-trichlorophenyl,
2,3,4-trifluorophenyl, 2,4-dichloro-3-fluorophenyl,
3,4-dichloro-2-fluorophenyl, 4-chloro-2,3-difluorophenyl,
4-chloro-2,6-difluorophenyl, 4-chloro-3,5-difluorophenyl,
2,4-dichloro-6-fluorophenyl, 4-chloro-2-fluoro-3-methoxyphenyl,
4-chloro-2-fluoro-3-trifluoromethylphenyl,
4-chloro-3-dimethylamino-2-fluorophenyl, and
2-fluoro-3-methoxy-4-methylphenyl.
[0116] Each R.sup.1 is independently halogen, cyano, C.sub.1-4
alkyl, C.sub.1-4 haloalkyl, C.sub.1-4 alkoxy, C.sub.1-4 haloalkoxy,
C.sub.1-4 alkylthio, C.sub.1-4 haloalkylthio, amino, C.sub.1-4
alkylamino, di(C.sub.1-4)alkylamino, or two adjacent groups R.sup.1
together with the atoms to which they are joined form a 6-membered
aromatic ring, said ring being optionally substituted by 1-2 groups
selected from: halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4
haloalkyl, C.sub.1-4 alkoxy, C.sub.1-4 haloalkoxy, C.sub.1-4
alkylthio, C.sub.1-4 haloalkylthio. Preferably each R.sup.1 is
independently halogen, cyano, C.sub.1-2 alkyl, C.sub.1-2 haloalkyl,
C.sub.1-2 alkoxy, C.sub.1-2 haloalkoxy, amino, C.sub.1-4
alkylamino, or di(C.sub.1-4)alkylamino.
[0117] Each R.sup.2 is independently halogen, cyano, C.sub.1-4
alkyl, C.sub.1-4 haloalkyl, C.sub.3-6 cycloalkyl, C.sub.1-4 alkoxy,
C.sub.1-4 haloalkoxy, C.sub.1-4 alkoxycarbonyl, or C.sub.1-4
alkylaminocarbonyl; or any two geminal R.sup.2 groups together form
a group selected from oxo, .dbd.CR.sup.mmR.sup.nn, or
.dbd.NOR.sup.oo; or two groups R.sup.2 together with the atoms to
which they are joined form a 3-6-membered ring system, said ring
system being optionally substituted by 1-2 groups selected from:
halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4 haloalkyl, C.sub.1-4
alkoxy, or C.sub.1-4 haloalkoxy. Preferably R.sup.2 is halogen,
cyano, C.sub.1-2 alkyl, C.sub.1-2 haloalkyl, C.sub.1-2 alkoxy,
C.sub.1-2 haloalkoxy or C.sub.2-4 alkoxycarbonyl. R.sup.mm and
R.sup.nn are each independently hydrogen, halogen, cyano, nitro,
C.sub.1-4 alkyl, or C.sub.1-4 alkoxycarbonyl. R.sup.oo is hydrogen,
C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl(C.sub.1-2)alkyl or C.sub.3-6
cycloalkyl.
[0118] According to the invention X is selected from: azido,
halogen, optionally substituted alkoxy, optionally substituted
alkylthio, optionally substituted alkylsulphinyl, optionally
substituted alkylsulphonyl and NR.sup.5R.sup.6, where R.sup.5 and
R.sup.6 are as defined hereinbefore.
[0119] In preferred embodiments X is selected from: azido, halogen,
C.sub.1-3 alkoxy, C.sub.1-4 alkoxycarbonylC.sub.1-3alkoxy, and
NR.sup.5R.sup.6. Most preferably X is N.sub.3, Cl, OCH.sub.3,
OCH.sub.2CO.sub.2CH.sub.3, NH.sub.2, NHCH.sub.3, N(CH.sub.3).sub.2,
NH-isopropyl, NHCOCH.sub.3, NHC(O)OCH.sub.3, NHSO.sub.2CH.sub.3,
NCH.sub.3COCH.sub.3, NCH.sub.3C(O)OCH.sub.3, or
NCH.sub.3SO.sub.2CH.sub.3.
[0120] In alternative preferred embodiments, X is selected from:
azido, halogen, optionally substituted alkoxy, optionally
substituted alkylthio, optionally substituted alkylsulphinyl and
optionally substituted alkylsulphonyl. More preferably, X is
selected from: optionally substituted alkylthio, optionally
substituted alkylsulphinyl and optionally substituted
alkylsulphonyl.
[0121] Preferably R.sup.5 is hydrogen, C.sub.1-4 alkyl optionally
substituted with 1 or 2 hydroxy or C.sub.1-4 alkoxy groups,
C.sub.1-4 haloalkyl optionally substituted with 1 or 2 hydroxy or
C.sub.1-4 alkoxy groups, C.sub.2-4 alkenyl, SO.sub.2R.sup.ss, or
C(O)R.sup.uu, wherein R.sup.ss and R.sup.uu are as defined
hereinbefore. In more preferred embodiments, R.sup.ss and R.sup.uu
are each independently C.sub.1-3 alkyl.
[0122] Preferably R.sup.6 is hydrogen, C.sub.1-4 alkyl optionally
substituted with 1 or 2 hydroxy or C.sub.1-4 alkoxy groups,
C.sub.1-4 haloalkyl optionally substituted with 1 or 2 hydroxy or
C.sub.1-4 alkoxy groups, or C.sub.2-4 alkenyl.
[0123] Alternatively, and preferably, R.sup.5 is hydrogen,
C.sub.2-4 alkenyl, SO.sub.2R.sup.ss, C(O)R.sup.uu or optionally
substituted C.sub.1-4 alkyl provided said substitution does not
comprise a ring system or a hydroxyl group;
[0124] Alternatively, and preferably, R.sup.6 is hydrogen,
C.sub.2-4 alkenyl or optionally substituted C.sub.1-4 alkyl
provided said substitution does not comprise a ring system or a
hydroxyl group;
[0125] In preferred embodiments of the present invention Y is
C.sub.1-6 alkyl optionally substituted by 1-3 groups R.sup.ba,
C.sub.1-6 haloalkyl optionally substituted by 1-3 groups R.sup.ba,
C.sub.3-6 cycloalkyl optionally substituted by 1-3 groups R.sup.bc,
C.sub.2-6alkenyl optionally substituted by 1-3 groups R.sup.bd, or
C.sub.2-6 alkynyl optionally substituted by 1-3 groups
R.sup.be.
[0126] In more preferred embodiments Y is C.sub.1-3 alkyl,
C.sub.1-3 haloalkyl, C.sub.2-5alkoxyalkyl, cyclopropyl optionally
substituted by 1 or 2 groups R.sup.bc, C.sub.2-4 alkenyl, C.sub.2-4
haloalkenyl, or C.sub.2-4 alkynyl optionally substituted by 1 or 2
groups R.sup.be.
[0127] More preferably still, Y is selected from the group
consisting of: methyl, ethyl, isopropyl, n-propyl, prop-1-en-2-yl,
prop-1-enyl, prop-2-enyl, but-1-enyl, pent-1-enyl, difluoromethyl,
trifluoromethyl, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl,
1-methylprop-1-enyl, 2-methylprop-1-enyl, 1,2-dimethylprop-1-enyl,
3-methylbut-1-ynyl, 3-methylbut-2-enyl, 3,3-dimethylbut-1-ynyl,
acetyl, formyl, methoxymethyl, 2-methoxyethyl, hydroxyiminomethyl,
methoxyiminomethyl, 1-(hydroxyimino)ethyl, 1-(methoxyimino)ethyl,
cyclopropyl, 1-methylcyclopropyl, 2,2-dichlorocyclopropyl, vinyl,
2-cyclopropylvinyl, 1-ethoxyvinyl, 2,2-dichlorovinyl, ethynyl,
prop-1-ynyl, 2-bromoethynyl, 2-chloroethynyl, and
2-trimethylsilylethynyl.
[0128] Each R.sup.ba is independently cyano, nitro, hydroxyl,
C.sub.3-6 cycloalkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio,
C.sub.1-4 alkylcarbonyl or C.sub.1-4 alkoxycarbonyl, or two geminal
R.sup.ba together form an oxo or oximino group.
[0129] Each R.sup.bc is independently halogen, cyano,
C.sub.1-4alkoxy, or C.sub.1-4 alkoxycarbonyl. Preferably each
R.sup.bc is independently halogen or C.sub.1-2 alkyl.
[0130] Each R.sup.bd is independently halogen, cyano,
C.sub.3-6cycloalkyl, C.sub.1-4alkylcarbonyl, or C.sub.1-4
alkoxycarbonyl.
[0131] Each R.sup.be is independently halogen, cyano, hydroxyl,
C.sub.1-4alkoxycarbonyl, or C.sub.3-12 trialkylsilyl. Preferably
each R.sup.be is independently halogen or C.sub.3-9
trialkylsilyl.
[0132] In preferred embodiments of the invention Z is
O.sub.m--(CH.sub.2).sub.n--C(O)R.sup.cb, wherein n is an integer of
0 or 1, m is an integer of 0 or 1, and both .sub.n and .sub.m have
the same value, and wherein R.sup.cb is hydroxyl, C.sub.1-10
alkoxy, phenyl C.sub.1-2 alkoxy or NH.sub.2. More preferably still
Z is selected from the group consisting of CO.sub.2H,
CO.sub.2CH.sub.3, CO.sub.2CH.sub.2CH.sub.3, CO.sub.2-i-propyl,
CO.sub.2-n-propyl, CO.sub.2CH.sub.2-i-propyl,
CO.sub.2CH.sub.2-Phenyl, CONH.sub.2, OCH.sub.2CO.sub.2H,
OCH.sub.2CO.sub.2CH.sub.3.
[0133] In alternative, preferred embodiments, Z is
O.sub.m--(CHR.sup.w).sub.n--C(O)R.sup.cb, wherein [0134] m is an
integer of 0 or 1, [0135] n is an integer of 0 or 1 and n.gtoreq.m,
[0136] R.sup.w is hydrogen or C.sub.1-4 alkyl [0137] R.sup.cb is
optionally substituted alkylthio, optionally substituted alkoxy or
NH.sub.2.
[0138] The compounds described below are illustrative of novel
compounds of the invention. Table 1 below provides 402 compounds
designated compound numbers 1-1 to 1-402 respectively, of formula
(I) wherein A is chloro, and wherein the values of X, Y and Z are
as given in Table 1.
TABLE-US-00001 TABLE 1 Cmpd. No. X Y Z 1-1 NH.sub.2 methyl
CO.sub.2H 1-2 NH.sub.2 ethyl CO.sub.2H 1-3 NH.sub.2 n-propyl
CO.sub.2H 1-4 NH.sub.2 isopropyl CO.sub.2H 1-5 NH.sub.2
difluoromethyl CO.sub.2H 1-6 NH.sub.2 trifluoromethyl CO.sub.2H 1-7
NH.sub.2 hydroxymethyl CO.sub.2H 1-8 NH.sub.2 methoxymethyl
CO.sub.2H 1-9 NH.sub.2 1-hydroxyethyl CO.sub.2H 1-10 NH.sub.2
2-hydroxyethyl CO.sub.2H 1-11 NH.sub.2 2-methoxyethyl CO.sub.2H
1-12 NH.sub.2 formyl CO.sub.2H 1-13 NH.sub.2 acetyl CO.sub.2H 1-14
NH.sub.2 hydroxyiminomethyl CO.sub.2H 1-15 NH.sub.2
methoxyiminomethyl CO.sub.2H 1-16 NH.sub.2 1-(hydroxyimino)ethyl
CO.sub.2H 1-17 NH.sub.2 1-(methoxyimino)ethyl CO.sub.2H 1-18
NH.sub.2 cyclopropyl CO.sub.2H 1-19 NH.sub.2 1-methylcyclopropyl
CO.sub.2H 1-20 NH.sub.2 2,2-dichlorocyclopropyl CO.sub.2H 1-21
NH.sub.2 vinyl CO.sub.2H 1-22 NH.sub.2 prop-1-enyl CO.sub.2H 1-23
NH.sub.2 prop-2-enyl CO.sub.2H 1-24 NH.sub.2 prop-1-en-2-yl
CO.sub.2H 1-25 NH.sub.2 pent-1-enyl CO.sub.2H 1-26 NH.sub.2
2-cyclopropylvinyl CO.sub.2H 1-27 NH.sub.2 1-ethoxyvinyl CO.sub.2H
1-28 NH.sub.2 1-methylprop-1-enyl CO.sub.2H 1-29 NH.sub.2
2-methylprop-1-enyl CO.sub.2H 1-30 NH.sub.2 1,2-dimethylprop-1-enyl
CO.sub.2H 1-31 NH.sub.2 2,2-dichlorovinyl CO.sub.2H 1-32 NH.sub.2
3-methylbut-2-enyl CO.sub.2H 1-33 NH.sub.2 ethynyl CO.sub.2H 1-34
NH.sub.2 prop-1-ynyl CO.sub.2H 1-35 NH.sub.2 but-1-ynyl CO.sub.2H
1-36 NH.sub.2 3-methylbut-1-ynyl CO.sub.2H 1-37 NH.sub.2
3,3-dimethylbut-1-ynyl CO.sub.2H 1-38 NH.sub.2
2-trimethylsilylethynyl CO.sub.2H 1-39 NH.sub.2 2-chloroethynyl
CO.sub.2H 1-40 NH.sub.2 2-bromoethynyl CO.sub.2H 1-41 NH.sub.2
methyl CO.sub.2Me 1-42 NH.sub.2 ethyl CO.sub.2Me 1-43 NH.sub.2
n-propyl CO.sub.2Me 1-44 NH.sub.2 isopropyl CO.sub.2Me 1-45
NH.sub.2 difluoromethyl CO.sub.2Me 1-46 NH.sub.2 trifluoromethyl
CO.sub.2Me 1-47 NH.sub.2 hydroxymethyl CO.sub.2Me 1-48 NH.sub.2
methoxymethyl CO.sub.2Me 1-49 NH.sub.2 1-hydroxyethyl CO.sub.2Me
1-50 NH.sub.2 2-hydroxyethyl CO.sub.2Me 1-51 NH.sub.2
2-methoxyethyl CO.sub.2Me 1-52 NH.sub.2 formyl CO.sub.2Me 1-53
NH.sub.2 acetyl CO.sub.2Me 1-54 NH.sub.2 hydroxyiminomethyl
CO.sub.2Me 1-55 NH.sub.2 methoxyiminomethyl CO.sub.2Me 1-56
NH.sub.2 1-(hydroxyimino)ethyl CO.sub.2Me 1-57 NH.sub.2
1-(methoxyimino)ethyl CO.sub.2Me 1-58 NH.sub.2 cyclopropyl
CO.sub.2Me 1-59 NH.sub.2 1-methylcyclopropyl CO.sub.2Me 1-60
NH.sub.2 2,2-dichlorocyclopropyl CO.sub.2Me 1-61 NH.sub.2 vinyl
CO.sub.2Me 1-62 NH.sub.2 prop-1-enyl CO.sub.2Me 1-63 NH.sub.2
prop-2-enyl CO.sub.2Me 1-64 NH.sub.2 prop-1-en-2-yl CO.sub.2Me 1-65
NH.sub.2 pent-1-enyl CO.sub.2Me 1-66 NH.sub.2 2-cyclopropylvinyl
CO.sub.2Me 1-67 NH.sub.2 1-ethoxyvinyl CO.sub.2Me 1-68 NH.sub.2
1-methylprop-1-enyl CO.sub.2Me 1-69 NH.sub.2 2-methylprop-1-enyl
CO.sub.2Me 1-70 NH.sub.2 1,2-dimethylprop-1-enyl CO.sub.2Me 1-71
NH.sub.2 2,2-dichlorovinyl CO.sub.2Me 1-72 NH.sub.2
3-methylbut-2-enyl CO.sub.2Me 1-73 NH.sub.2 ethynyl CO.sub.2Me 1-74
NH.sub.2 prop-1-ynyl CO.sub.2Me 1-75 NH.sub.2 but-1-ynyl CO.sub.2Me
1-76 NH.sub.2 3-methylbut-1-ynyl CO.sub.2Me 1-77 NH.sub.2
3,3-dimethylbut-1-ynyl CO.sub.2Me 1-78 NH.sub.2
2-trimethylsilylethynyl CO.sub.2Me 1-79 NH.sub.2 2-chloroethynyl
CO.sub.2Me 1-80 NH.sub.2 2-bromoethynyl CO.sub.2Me 1-81 NH.sub.2
methyl CO.sub.2Et 1-82 NH.sub.2 ethyl CO.sub.2Et 1-83 NH.sub.2
n-propyl CO.sub.2Et 1-84 NH.sub.2 isopropyl CO.sub.2Et 1-85
NH.sub.2 difluoromethyl CO.sub.2Et 1-86 NH.sub.2 trifluoromethyl
CO.sub.2Et 1-87 NH.sub.2 hydroxymethyl CO.sub.2Et 1-88 NH.sub.2
methoxymethyl CO.sub.2Et 1-89 NH.sub.2 1-hydroxyethyl CO.sub.2Et
1-90 NH.sub.2 2-hydroxyethyl CO.sub.2Et 1-91 NH.sub.2
2-methoxyethyl CO.sub.2Et 1-92 NH.sub.2 formyl CO.sub.2Et 1-93
NH.sub.2 acetyl CO.sub.2Et 1-94 NH.sub.2 hydroxyiminomethyl
CO.sub.2Et 1-95 NH.sub.2 methoxyiminomethyl CO.sub.2Et 1-96
NH.sub.2 1-(hydroxyimino)ethyl CO.sub.2Et 1-97 NH.sub.2
1-(methoxyimino)ethyl CO.sub.2Et 1-98 NH.sub.2 cyclopropyl
CO.sub.2Et 1-99 NH.sub.2 1-methylcyclopropyl CO.sub.2Et 1-100
NH.sub.2 2,2-dichlorocyclopropyl CO.sub.2Et 1-101 NH.sub.2 vinyl
CO.sub.2Et 1-102 NH.sub.2 prop-1-enyl CO.sub.2Et 1-103 NH.sub.2
prop-2-enyl CO.sub.2Et 1-104 NH.sub.2 prop-1-en-2-yl CO.sub.2Et
1-105 NH.sub.2 pent-1-enyl CO.sub.2Et 1-106 NH.sub.2
2-cyclopropylvinyl CO.sub.2Et 1-107 NH.sub.2 1-ethoxyvinyl
CO.sub.2Et 1-108 NH.sub.2 1-methylprop-1-enyl CO.sub.2Et 1-109
NH.sub.2 2-methylprop-1-enyl CO.sub.2Et 1-110 NH.sub.2
1,2-dimethylprop-1-enyl CO.sub.2Et 1-111 NH.sub.2 2,2-dichlorovinyl
CO.sub.2Et 1-112 NH.sub.2 3-methylbut-2-enyl CO.sub.2Et 1-113
NH.sub.2 ethynyl CO.sub.2Et 1-114 NH.sub.2 prop-1-ynyl CO.sub.2Et
1-115 NH.sub.2 but-1-ynyl CO.sub.2Et 1-116 NH.sub.2
3-methylbut-1-ynyl CO.sub.2Et 1-117 NH.sub.2 3,3-dimethylbut-1-ynyl
CO.sub.2Et 1-118 NH.sub.2 2-trimethylsilylethynyl CO.sub.2Et 1-119
NH.sub.2 2-chloroethynyl CO.sub.2Et 1-120 NH.sub.2 2-bromoethynyl
CO.sub.2Et 1-121 NHMe methyl CO.sub.2H 1-122 NHMe trifluoromethyl
CO.sub.2H 1-123 NHMe acetyl CO.sub.2H 1-124 NHMe cyclopropyl
CO.sub.2H 1-125 NHMe vinyl CO.sub.2H 1-126 NHMe prop-1-enyl
CO.sub.2H 1-127 NHMe prop-2-enyl CO.sub.2H 1-128 NHMe ethynyl
CO.sub.2H 1-129 NHMe prop-1-ynyl CO.sub.2H 1-130 NHMe
2-trimethylsilylethynyl CO.sub.2H 1-131 NMe.sub.2 methyl CO.sub.2H
1-132 NMe.sub.2 trifluoromethyl CO.sub.2H 1-133 NMe.sub.2 acetyl
CO.sub.2H 1-134 NMe.sub.2 cyclopropyl CO.sub.2H 1-135 NMe.sub.2
vinyl CO.sub.2H 1-136 NMe.sub.2 prop-1-enyl CO.sub.2H 1-137
NMe.sub.2 prop-2-enyl CO.sub.2H 1-138 NMe.sub.2 ethynyl CO.sub.2H
1-139 NMe.sub.2 prop-1-ynyl CO.sub.2H 1-140 NMe.sub.2
2-trimethylsilylethynyl CO.sub.2H 1-141 NHCOMe methyl CO.sub.2H
1-142 NHCOMe trifluoromethyl CO.sub.2H 1-143 NHCOMe acetyl
CO.sub.2H 1-144 NHCOMe cyclopropyl CO.sub.2H 1-145 NHCOMe vinyl
CO.sub.2H 1-146 NHCOMe prop-1-enyl CO.sub.2H 1-147 NHCOMe
prop-2-enyl CO.sub.2H 1-148 NHCOMe ethynyl CO.sub.2H 1-149 NHCOMe
prop-1-ynyl CO.sub.2H 1-150 NHCOMe 2-trimethylsilylethynyl
CO.sub.2H 1-151 NHCO.sub.2Me methyl CO.sub.2H 1-152 NHCO.sub.2Me
trifluoromethyl CO.sub.2H 1-153 NHCO.sub.2Me acetyl CO.sub.2H 1-154
NHCO.sub.2Me cyclopropyl CO.sub.2H 1-155 NHCO.sub.2Me vinyl
CO.sub.2H 1-156 NHCO.sub.2Me prop-1-enyl CO.sub.2H 1-157
NHCO.sub.2Me prop-2-enyl CO.sub.2H 1-158 NHCO.sub.2Me ethynyl
CO.sub.2H 1-159 NHCO.sub.2Me prop-1-ynyl CO.sub.2H 1-160
NHCO.sub.2Me 2-trimethylsilylethynyl CO.sub.2H 1-161 NHSO.sub.2Me
methyl CO.sub.2H 1-162 NHSO.sub.2Me trifluoromethyl CO.sub.2H 1-163
NHSO.sub.2Me acetyl CO.sub.2H 1-164 NHSO.sub.2Me cyclopropyl
CO.sub.2H 1-165 NHSO.sub.2Me vinyl CO.sub.2H 1-166 NHSO.sub.2Me
prop-1-enyl CO.sub.2H 1-167 NHSO.sub.2Me prop-2-enyl CO.sub.2H
1-168 NHSO.sub.2Me ethynyl CO.sub.2H 1-169 NHSO.sub.2Me prop-1-ynyl
CO.sub.2H 1-170 NHSO.sub.2Me 2-trimethylsilylethynyl CO.sub.2H
1-171 NMeCOMe methyl CO.sub.2H 1-172 NMeCOMe trifluoromethyl
CO.sub.2H 1-173 NMeCOMe acetyl CO.sub.2H 1-174 NMeCOMe cyclopropyl
CO.sub.2H 1-175 NMeCOMe vinyl CO.sub.2H 1-176 NMeCOMe prop-1-enyl
CO.sub.2H 1-177 NMeCOMe prop-2-enyl CO.sub.2H 1-178 NMeCOMe ethynyl
CO.sub.2H 1-179 NMeCOMe prop-1-ynyl CO.sub.2H 1-180 NMeCOMe
2-trimethylsilylethynyl CO.sub.2H 1-181 NMeCO.sub.2Me methyl
CO.sub.2H 1-182 NMeCO.sub.2Me trifluoromethyl CO.sub.2H 1-183
NMeCO.sub.2Me acetyl CO.sub.2H 1-184 NMeCO.sub.2Me cyclopropyl
CO.sub.2H 1-185 NMeCO.sub.2Me vinyl CO.sub.2H 1-186 NMeCO.sub.2Me
prop-1-enyl CO.sub.2H 1-187 NMeCO.sub.2Me prop-2-enyl CO.sub.2H
1-188 NMeCO.sub.2Me ethynyl CO.sub.2H 1-189 NMeCO.sub.2Me
prop-1-ynyl CO.sub.2H 1-190 NMeCO.sub.2Me 2-trimethylsilylethynyl
CO.sub.2H 1-191 NMeSO.sub.2Me methyl CO.sub.2H 1-192 NMeSO.sub.2Me
trifluoromethyl CO.sub.2H 1-193 NMeSO.sub.2Me acetyl CO.sub.2H
1-194 NMeSO.sub.2Me cyclopropyl CO.sub.2H 1-195 NMeSO.sub.2Me vinyl
CO.sub.2H 1-196 NMeSO.sub.2Me prop-1-enyl CO.sub.2H 1-197
NMeSO.sub.2Me prop-2-enyl CO.sub.2H 1-198 NMeSO.sub.2Me ethynyl
CO.sub.2H 1-199 NMeSO.sub.2Me prop-1-ynyl CO.sub.2H 1-200
NMeSO.sub.2Me 2-trimethylsilylethynyl CO.sub.2H 1-201 NH.sup.iPr
methyl CO.sub.2H 1-202 NH.sup.iPr trifluoromethyl CO.sub.2H 1-203
NH.sup.iPr acetyl CO.sub.2H 1-204 NH.sup.iPr cyclopropyl CO.sub.2H
1-205 NH.sup.iPr vinyl CO.sub.2H 1-206 NH.sup.iPr prop-1-enyl
CO.sub.2H 1-207 NH.sup.iPr prop-2-enyl CO.sub.2H 1-208 NH.sup.iPr
ethynyl CO.sub.2H 1-209 NH.sup.iPr prop-1-ynyl CO.sub.2H 1-210
NH.sup.iPr 2-trimethylsilylethynyl CO.sub.2H 1-211 NHMe methyl
CO.sub.2Me 1-212 NHMe trifluoromethyl CO.sub.2Me 1-213 NHMe acetyl
CO.sub.2Me 1-214 NHMe cyclopropyl CO.sub.2Me 1-215 NHMe vinyl
CO.sub.2Me 1-216 NHMe prop-1-enyl CO.sub.2Me 1-217 NHMe prop-2-enyl
CO.sub.2Me 1-218 NHMe ethynyl CO.sub.2Me 1-219 NHMe prop-1-ynyl
CO.sub.2Me 1-220 NHMe 2-trimethylsilylethynyl CO.sub.2Me 1-221
NMe.sub.2 methyl CO.sub.2Me 1-222 NMe.sub.2 trifluoromethyl
CO.sub.2Me 1-223 NMe.sub.2 acetyl CO.sub.2Me 1-224 NMe.sub.2
cyclopropyl CO.sub.2Me 1-225 NMe.sub.2 vinyl CO.sub.2Me 1-226
NMe.sub.2 prop-1-enyl CO.sub.2Me 1-227 NMe.sub.2 prop-2-enyl
CO.sub.2Me 1-228 NMe.sub.2 ethynyl CO.sub.2Me 1-229 NMe.sub.2
prop-1-ynyl CO.sub.2Me 1-230 NMe.sub.2 2-trimethylsilylethynyl
CO.sub.2Me 1-231 NHCOMe methyl CO.sub.2Me 1-232 NHCOMe
trifluoromethyl CO.sub.2Me 1-233 NHCOMe acetyl CO.sub.2Me 1-234
NHCOMe cyclopropyl CO.sub.2Me 1-235 NHCOMe vinyl CO.sub.2Me 1-236
NHCOMe prop-1-enyl CO.sub.2Me 1-237 NHCOMe prop-2-enyl CO.sub.2Me
1-238 NHCOMe ethynyl CO.sub.2Me 1-239 NHCOMe prop-1-ynyl CO.sub.2Me
1-240 NHCOMe 2-trimethylsilylethynyl CO.sub.2Me 1-241 NHCO.sub.2Me
methyl CO.sub.2Me 1-242 NHCO.sub.2Me trifluoromethyl CO.sub.2Me
1-243 NHCO.sub.2Me acetyl CO.sub.2Me 1-244 NHCO.sub.2Me cyclopropyl
CO.sub.2Me 1-245 NHCO.sub.2Me vinyl CO.sub.2Me
1-246 NHCO.sub.2Me prop-1-enyl CO.sub.2Me 1-247 NHCO.sub.2Me
prop-2-enyl CO.sub.2Me 1-248 NHCO.sub.2Me ethynyl CO.sub.2Me 1-249
NHCO.sub.2Me prop-1-ynyl CO.sub.2Me 1-250 NHCO.sub.2Me
2-trimethylsilylethynyl CO.sub.2Me 1-251 NHSO.sub.2Me methyl
CO.sub.2Me 1-252 NHSO.sub.2Me trifluoromethyl CO.sub.2Me 1-253
NHSO.sub.2Me acetyl CO.sub.2Me 1-254 NHSO.sub.2Me cyclopropyl
CO.sub.2Me 1-255 NHSO.sub.2Me vinyl CO.sub.2Me 1-256 NHSO.sub.2Me
prop-1-enyl CO.sub.2Me 1-257 NHSO.sub.2Me prop-2-enyl CO.sub.2Me
1-258 NHSO.sub.2Me ethynyl CO.sub.2Me 1-259 NHSO.sub.2Me
prop-1-ynyl CO.sub.2Me 1-260 NHSO.sub.2Me 2-trimethylsilylethynyl
CO.sub.2Me 1-261 NMeCOMe methyl CO.sub.2Me 1-262 NMeCOMe
trifluoromethyl CO.sub.2Me 1-263 NMeCOMe acetyl CO.sub.2Me 1-264
NMeCOMe cyclopropyl CO.sub.2Me 1-265 NMeCOMe vinyl CO.sub.2Me 1-266
NMeCOMe prop-1-enyl CO.sub.2Me 1-267 NMeCOMe prop-2-enyl CO.sub.2Me
1-268 NMeCOMe ethynyl CO.sub.2Me 1-269 NMeCOMe prop-1-ynyl
CO.sub.2Me 1-270 NMeCOMe 2-trimethylsilylethynyl CO.sub.2Me 1-271
NMeCO.sub.2Me methyl CO.sub.2Me 1-272 NMeCO.sub.2Me trifluoromethyl
CO.sub.2Me 1-273 NMeCO.sub.2Me acetyl CO.sub.2Me 1-274
NMeCO.sub.2Me cyclopropyl CO.sub.2Me 1-275 NMeCO.sub.2Me vinyl
CO.sub.2Me 1-276 NMeCO.sub.2Me prop-1-enyl CO.sub.2Me 1-277
NMeCO.sub.2Me prop-2-enyl CO.sub.2Me 1-278 NMeCO.sub.2Me ethynyl
CO.sub.2Me 1-279 NMeCO.sub.2Me prop-1-ynyl CO.sub.2Me 1-280
NMeCO.sub.2Me 2-trimethylsilylethynyl CO.sub.2Me 1-281
NMeSO.sub.2Me methyl CO.sub.2Me 1-282 NMeSO.sub.2Me trifluoromethyl
CO.sub.2Me 1-283 NMeSO.sub.2Me acetyl CO.sub.2Me 1-284
NMeSO.sub.2Me cyclopropyl CO.sub.2Me 1-285 NMeSO.sub.2Me vinyl
CO.sub.2Me 1-286 NMeSO.sub.2Me prop-1-enyl CO.sub.2Me 1-287
NMeSO.sub.2Me prop-2-enyl CO.sub.2Me 1-288 NMeSO.sub.2Me ethynyl
CO.sub.2Me 1-289 NMeSO.sub.2Me prop-1-ynyl CO.sub.2Me 1-290
NMeSO.sub.2Me 2-trimethylsilylethynyl CO.sub.2Me 1-291 NH.sup.iPr
methyl CO.sub.2Me 1-292 NH.sup.iPr trifluoromethyl CO.sub.2Me 1-293
NH.sup.iPr acetyl CO.sub.2Me 1-294 NH.sup.iPr cyclopropyl
CO.sub.2Me 1-295 NH.sup.iPr vinyl CO.sub.2Me 1-296 NH.sup.iPr
prop-1-enyl CO.sub.2Me 1-297 NH.sup.iPr prop-2-enyl CO.sub.2Me
1-298 NH.sup.iPr ethynyl CO.sub.2Me 1-299 NH.sup.iPr prop-1-ynyl
CO.sub.2Me 1-300 NH.sup.iPr 2-trimethylsilylethynyl CO.sub.2Me
1-301 NMe.sub.2 methyl CO.sub.2Et 1-302 NH.sub.2 methyl
CO.sub.2.sup.iPr 1-303 NH.sub.2 trifluoromethyl CO.sub.2.sup.iPr
1-304 NH.sub.2 acetyl CO.sub.2.sup.iPr 1-305 NH.sub.2 cyclopropyl
CO.sub.2.sup.iPr 1-306 NH.sub.2 vinyl CO.sub.2.sup.iPr 1-307
NH.sub.2 prop-1-enyl CO.sub.2.sup.iPr 1-308 NH.sub.2 prop-2-enyl
CO.sub.2.sup.iPr 1-309 NH.sub.2 ethynyl CO.sub.2.sup.iPr 1-310
NH.sub.2 prop-1-ynyl CO.sub.2.sup.iPr 1-311 NH.sub.2
2-trimethylsilylethynyl CO.sub.2.sup.iPr 1-312 NH.sub.2 methyl
CO.sub.2.sup.nPr 1-313 NH.sub.2 trifluoromethyl CO.sub.2.sup.nPr
1-314 NH.sub.2 acetyl CO.sub.2.sup.nPr 1-315 NH.sub.2 cyclopropyl
CO.sub.2.sup.nPr 1-316 NH.sub.2 vinyl CO.sub.2.sup.nPr 1-317
NH.sub.2 prop-1-enyl CO.sub.2.sup.nPr 1-318 NH.sub.2 prop-2-enyl
CO.sub.2.sup.nPr 1-319 NH.sub.2 ethynyl CO.sub.2.sup.nPr 1-320
NH.sub.2 prop-1-ynyl CO.sub.2.sup.nPr 1-321 NH.sub.2
2-trimethylsilylethynyl CO.sub.2.sup.nPr 1-322 NH.sub.2 methyl
CO.sub.2CH.sub.2.sup.iPr 1-323 NH.sub.2 trifluoromethyl
CO.sub.2CH.sub.2.sup.iPr 1-324 NH.sub.2 acetyl
CO.sub.2CH.sub.2.sup.iPr 1-325 NH.sub.2 cyclopropyl
CO.sub.2CH.sub.2.sup.iPr 1-326 NH.sub.2 vinyl
CO.sub.2CH.sub.2.sup.iPr 1-327 NH.sub.2 prop-1-enyl
CO.sub.2CH.sub.2.sup.iPr 1-328 NH.sub.2 prop-2-enyl
CO.sub.2CH.sub.2.sup.iPr 1-329 NH.sub.2 ethynyl
CO.sub.2CH.sub.2.sup.iPr 1-330 NH.sub.2 prop-1-ynyl
CO.sub.2CH.sub.2.sup.iPr 1-331 NH.sub.2 2-trimethylsilylethynyl
CO.sub.2CH.sub.2.sup.iPr 1-332 NH.sub.2 methyl CO.sub.2CH.sub.2Ph
1-333 NH.sub.2 trifluoromethyl CO.sub.2CH.sub.2Ph 1-334 NH.sub.2
acetyl CO.sub.2CH.sub.2Ph 1-335 NH.sub.2 cyclopropyl
CO.sub.2CH.sub.2Ph 1-336 NH.sub.2 vinyl CO.sub.2CH.sub.2Ph 1-337
NH.sub.2 prop-1-enyl CO.sub.2CH.sub.2Ph 1-338 NH.sub.2 prop-2-enyl
CO.sub.2CH.sub.2Ph 1-339 NH.sub.2 ethynyl CO.sub.2CH.sub.2Ph 1-340
NH.sub.2 prop-1-ynyl CO.sub.2CH.sub.2Ph 1-341 NH.sub.2
2-trimethylsilylethynyl CO.sub.2CH.sub.2Ph 1-342 NH.sub.2 methyl
CONH.sub.2 1-343 NH.sub.2 trifluoromethyl CONH.sub.2 1-344 NH.sub.2
acetyl CONH.sub.2 1-345 NH.sub.2 cyclopropyl CONH.sub.2 1-346
NH.sub.2 vinyl CONH.sub.2 1-347 NH.sub.2 prop-1-enyl CONH.sub.2
1-348 NH.sub.2 prop-2-enyl CONH.sub.2 1-349 NH.sub.2 ethynyl
CONH.sub.2 1-350 NH.sub.2 prop-1-ynyl CONH.sub.2 1-351 NH.sub.2
2-trimethylsilylethynyl CONH.sub.2 1-352 NH.sub.2 methyl
OCH.sub.2CO.sub.2H 1-353 NH.sub.2 trifluoromethyl
OCH.sub.2CO.sub.2H 1-354 NH.sub.2 acetyl OCH.sub.2CO.sub.2H 1-355
NH.sub.2 cyclopropyl OCH.sub.2CO.sub.2H 1-356 NH.sub.2 vinyl
OCH.sub.2CO.sub.2H 1-357 NH.sub.2 prop-1-enyl OCH.sub.2CO.sub.2H
1-358 NH.sub.2 prop-2-enyl OCH.sub.2CO.sub.2H 1-359 NH.sub.2
ethynyl OCH.sub.2CO.sub.2H 1-360 NH.sub.2 prop-1-ynyl
OCH.sub.2CO.sub.2H 1-361 NH.sub.2 2-trimethylsilylethynyl
OCH.sub.2CO.sub.2H 1-362 NH.sub.2 methyl OCH.sub.2CO.sub.2Me 1-363
NH.sub.2 trifluoromethyl OCH.sub.2CO.sub.2Me 1-364 NH.sub.2 acetyl
OCH.sub.2CO.sub.2Me 1-365 NH.sub.2 cyclopropyl OCH.sub.2CO.sub.2Me
1-366 NH.sub.2 vinyl OCH.sub.2CO.sub.2Me 1-367 NH.sub.2 prop-1-enyl
OCH.sub.2CO.sub.2Me 1-368 NH.sub.2 prop-2-enyl OCH.sub.2CO.sub.2Me
1-369 NH.sub.2 ethynyl OCH.sub.2CO.sub.2Me 1-370 NH.sub.2
prop-1-ynyl OCH.sub.2CO.sub.2Me 1-371 NH.sub.2
2-trimethylsilylethynyl OCH.sub.2CO.sub.2Me 1-372 NH.sub.2
1-hydroxyethyl CH.sub.2OH 1-373 Cl methyl CO.sub.2H 1-374 Cl methyl
CO.sub.2Me 1-375 Cl methyl OCH.sub.2CO.sub.2H 1-376 Cl methyl
OCH.sub.2CO.sub.2Me 1-377 OMe methyl CO.sub.2H 1-378 OMe methyl
CO.sub.2Me 1-379 OMe methyl OCH.sub.2CO.sub.2H 1-380 OMe methyl
OCH.sub.2CO.sub.2Me 1-381 OCH.sub.2CO.sub.2Me methyl CO.sub.2H
1-382 OCH.sub.2CO.sub.2Me methyl CO.sub.2Me 1-383
OCH.sub.2CO.sub.2Me methyl OCH.sub.2CO.sub.2H 1-384
OCH.sub.2CO.sub.2Me methyl OCH.sub.2CO.sub.2Me 1-385 N.sub.3 methyl
CO.sub.2H 1-386 N.sub.3 methyl CO.sub.2Me 1-387 N.sub.3 methyl
OCH.sub.2CO.sub.2H 1-388 N.sub.3 methyl OCH.sub.2CO.sub.2Me 1-389
OCH.sub.2CO.sub.2.sup.tBu methyl OCH.sub.2CO.sub.2.sup.tBu 1-390 Cl
methyl CO.sub.2Et 1-391 NH.sub.2 vinyl CO.sub.2.sup.nBu 1-392
NH.sub.2 vinyl CO.sub.2.sup.noctyl 1-393 NH.sub.2 vinyl
CO.sub.2(2-ethylhexyl) 1-394 NH.sub.2 vinyl CO.sub.2CH(Me)Ph 1-395
NH.sub.2 vinyl CO.sub.2prop-2-enyl 1-396 NH.sub.2 vinyl
CO.sub.2(CH.sub.2).sub.2OEt 1-397 NH.sub.2 vinyl
CO.sub.2(CH.sub.2).sub.2O.sup.nBu 1-398 OMe vinyl CO.sub.2Me 1-399
N.sub.3 vinyl CO.sub.2Me 1-400 SMe vinyl CO.sub.2Me 1-401 SOMe
vinyl CO.sub.2Me 1-402 SO.sub.2Me vinyl CO.sub.2Me
[0139] 402 compounds of formula (I), wherein A is cyclopropyl, and
the values of X, Y and Z are as given in Table 1 for compounds 1-1
to 1-402, are designated as compound Nos. 2-1 to 2-402,
respectively.
[0140] 402 compounds of formula (I), wherein A is
2-methylcyclopropyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
3-1 to 3-402, respectively.
[0141] 402 compounds of formula (I), wherein A is isopropyl, and
the values of X, Y and Z are as given in Table 1 for compounds 1-1
to 1-402, are designated as compound Nos. 4-1 to 4-402,
respectively.
[0142] 402 compounds of formula (I), wherein A is 4-chlorophenyl,
and the values of X, Y and Z are as given in Table 1 for compounds
1-1 to 1-402, are designated as compound Nos. 5-1 to 5-402,
respectively.
[0143] 402 compounds of formula (I), wherein A is 4-bromophenyl,
and the values of X, Y and Z are as given in Table 1 for compounds
1-1 to 1-402, are designated as compound Nos. 6-1 to 6-402,
respectively.
[0144] 402 compounds of formula (I), wherein A is 4-iodophenyl, and
the values of X, Y and Z are as given in Table 1 for compounds 1-1
to 1-402, are designated as compound Nos. 7-1 to 7-402,
respectively.
[0145] 402 compounds of formula (I), wherein A is
2,4-dichlorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
8-1 to 8-402, respectively.
[0146] 402 compounds of formula (I), wherein A is
3,4-dichlorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
9-1 to 9-402, respectively.
[0147] 402 compounds of formula (I), wherein A is
4-chloro-2-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 10-1 to 10-402, respectively.
[0148] 402 compounds of formula (I), wherein A is
4-chloro-2-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 11-1 to 11-402, respectively.
[0149] 402 compounds of formula (I), wherein A is
4-chloro-2,6-difluorophenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 12-1 to 12-402, respectively.
[0150] 402 compounds of formula (I), wherein A is
4-chloro-3-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 13-1 to 13-402, respectively.
[0151] 402 compounds of formula (I), wherein A is
4-chloro-3-trifluoromethylphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 14-1 to 14-402, respectively.
[0152] 402 compounds of formula (I), wherein A is
4-chloro-2-fluorophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 15-1 to 15-402, respectively.
[0153] 402 compounds of formula (I), wherein A is
4-chloro-3-nitrophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 16-1 to 16-402, respectively.
[0154] 402 compounds of formula (I), wherein A is
4-chloro-2-trifluoromethylphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 17-1 to 17-402, respectively.
[0155] 402 compounds of formula (I), wherein A is
4-chloro-3-cyanophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 18-1 to 18-402, respectively.
[0156] 402 compounds of formula (I), wherein A is
4-chloro-3-fluorophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 19-1 to 19-402, respectively.
[0157] 402 compounds of formula (I), wherein A is
2,4,6-trichlorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
20-1 to 20-402, respectively.
[0158] 402 compounds of formula (I), wherein A is
2,4-dichloro-3-fluorophenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 21-1 to 21-402, respectively.
[0159] 402 compounds of formula (I), wherein A is
4-chloro-2,3-difluorophenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 22-1 to 22-402, respectively.
[0160] 402 compounds of formula (I), wherein A is
3,4-dichloro-2-fluorophenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 23-1 to 23-402, respectively.
[0161] 402 compounds of formula (I), wherein A is
2,4-dichloro-6-fluorophenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 24-1 to 24-402, respectively.
[0162] 402 compounds of formula (I), wherein A is
2,4,5-trichlorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
25-1 to 25-402, respectively.
[0163] 402 compounds of formula (I), wherein A is
4-chloro-3-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 26-1 to 26-402, respectively.
[0164] 402 compounds of formula (I), wherein A is
4-chloro-2-fluoro-3-methoxyphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 27-1 to 27-402, respectively.
[0165] 402 compounds of formula (I), wherein A is
4-chloro-2-fluoro-3-trifluoromethylphenyl, and the values of X, Y
and Z are as given in Table 1 for compounds 1-1 to 1-402, are
designated as compound Nos. 28-1 to 28-402, respectively.
[0166] 402 compounds of formula (I), wherein A is
2,3,4-trichlorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
29-1 to 29-402, respectively.
[0167] 402 compounds of formula (I), wherein A is
4-chloro-3,5-difluorophenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 30-1 to 30-402, respectively.
[0168] 402 compounds of formula (I), wherein A is
4-trifluoromethylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 31-1 to 31-402, respectively.
[0169] 402 compounds of formula (I), wherein A is
2,4-bis(trifluoromethyl)phenyl, and the values of X, Y and Z are as
given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 32-1 to 32-402, respectively.
[0170] 402 compounds of formula (I), wherein A is
4-chloro-3-dimethylamino-2-fluorophenyl, and the values of X, Y and
Z are as given in Table 1 for compounds 1-1 to 1-402, are
designated as compound Nos. 33-1 to 33-402, respectively.
[0171] 402 compounds of formula (I), wherein A is
3-chloro-4-trifluoromethylphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 34-1 to 34-402, respectively.
[0172] 402 compounds of formula (I), wherein A is
2-chloro-4-trifluoromethylphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 35-1 to 35-402, respectively.
[0173] 402 compounds of formula (I), wherein A is 4-methylphenyl,
and the values of X, Y and Z are as given in Table 1 for compounds
1-1 to 1-402, are designated as compound Nos. 36-1 to 36-402,
respectively.
[0174] 402 compounds of formula (I), wherein A is
2-chloro-4-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 37-1 to 37-402, respectively.
[0175] 402 compounds of formula (I), wherein A is
3-chloro-4-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 38-1 to 38-402, respectively.
[0176] 402 compounds of formula (I), wherein A is
3-fluoro-4-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 39-1 to 39-402, respectively.
[0177] 402 compounds of formula (I), wherein A is
2,4,5-trimethylphenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
40-1 to 40-402, respectively.
[0178] 402 compounds of formula (I), wherein A is 4-fluorophenyl,
and the values of X, Y and Z are as given in Table 1 for compounds
1-1 to 1-402, are designated as compound Nos. 41-1 to 41-402,
respectively.
[0179] 402 compounds of formula (I), wherein A is
4-fluoro-3-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 42-1 to 42-402, respectively.
[0180] 402 compounds of formula (I), wherein A is
4-fluoro-3-trifluoromethylphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 43-1 to 43-402, respectively.
[0181] 402 compounds of formula (I), wherein A is
3-chloro-4-fluorophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 44-1 to 44-402, respectively.
[0182] 402 compounds of formula (I), wherein A is
4-fluoro-3-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 45-1 to 45-402, respectively.
[0183] 402 compounds of formula (I), wherein A is
2,3,4-trifluorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
46-1 to 46-402, respectively.
[0184] 402 compounds of formula (I), wherein A is
4-trifluoromethoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 47-1 to 47-402, respectively.
[0185] 402 compounds of formula (I), wherein A is
2-fluoro-3-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 48-1 to 48-402, respectively.
[0186] 402 compounds of formula (I), wherein A is 4-methoxyphenyl,
and the values of X, Y and Z are as given in Table 1 for compounds
1-1 to 1-402, are designated as compound Nos. 49-1 to 49-402,
respectively.
[0187] 402 compounds of formula (I), wherein A is
4-methoxy-2-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 50-1 to 50-402, respectively.
[0188] 402 compounds of formula (I), wherein A is
2,4-dimethoxyphenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
51-1 to 51-402, respectively.
[0189] 402 compounds of formula (I), wherein A is
3-fluoro-4-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 52-1 to 52-402, respectively.
[0190] 402 compounds of formula (I), wherein A is
3-chloro-4-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 53-1 to 53-402, respectively.
[0191] 402 compounds of formula (I), wherein A is
3,4-dimethylphenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
54-1 to 54-402, respectively.
[0192] 402 compounds of formula (I), wherein A is
4-methyl-3-nitrophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 55-1 to 55-402, respectively.
[0193] 402 compounds of formula (I), wherein A is
2-fluoro-4-methylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 56-1 to 56-402, respectively.
[0194] 402 compounds of formula (I), wherein A is
2-fluoro-4-methoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 57-1 to 57-402, respectively.
[0195] 402 compounds of formula (I), wherein A is
2,3,4-trimethoxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 58-1 to 58-402, respectively.
[0196] 402 compounds of formula (I), wherein A is
3,4-dimethoxyphenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
59-1 to 59-402, respectively.
[0197] 402 compounds of formula (I), wherein A is
2-fluoro-3-methoxy-4-methylphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 60-1 to 60-402, respectively.
[0198] 402 compounds of formula (I), wherein A is
3-chloro-5-fluorophenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 61-1 to 61-402, respectively.
[0199] 402 compounds of formula (I), wherein A is methylthio, and
the values of X, Y and Z are as given in Table 1 for compounds 1-1
to 1-402, are designated as compound Nos. 62-1 to 62-402,
respectively.
[0200] 402 compounds of formula (I), wherein A is
3,4,5-trifluorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
63-1 to 63-402, respectively.
[0201] 402 compounds of formula (I), wherein A is
3-dimethylamino-4-ethenyl-2-fluorophenyl, and the values of X, Y
and Z are as given in Table 1 for compounds 1-1 to 1-402, are
designated as compound Nos. 64-1 to 64-402, respectively.
[0202] 402 compounds of formula (I), wherein A is
4-acetyl-2-fluoro-3-methoxyphenyl, and the values of X, Y and Z are
as given in Table 1 for compounds 1-1 to 1-402, are designated as
compound Nos. 65-1 to 65-402, respectively.
[0203] 402 compounds of formula (I), wherein A is
4-(1-ethoxyethenyl)-2-fluoro-3-methoxyphenyl, and the values of X,
Y and Z are as given in Table 1 for compounds 1-1 to 1-402, are
designated as compound Nos. 66-1 to 66-402, respectively.
[0204] 402 compounds of formula (I), wherein A is
3,4-difluorophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
67-1 to 67-402, respectively.
[0205] 402 compounds of formula (I), wherein A is 4-cyanophenyl,
and the values of X, Y and Z are as given in Table 1 for compounds
1-1 to 1-402, are designated as compound Nos. 68-1 to 68-402,
respectively.
[0206] 402 compounds of formula (I), wherein A is
4-methoxycarbonylphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 69-1 to 69-402, respectively.
[0207] 402 compounds of formula (I), wherein A is
3,4-methylenedioxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 70-1 to 70-402, respectively.
[0208] 402 compounds of formula (I), wherein A is
3,4-ethylenedioxyphenyl, and the values of X, Y and Z are as given
in Table 1 for compounds 1-1 to 1-402, are designated as compound
Nos. 71-1 to 71-402, respectively.
[0209] 402 compounds of formula (I), wherein A is
4-methylthiophenyl, and the values of X, Y and Z are as given in
Table 1 for compounds 1-1 to 1-402, are designated as compound Nos.
72-1 to 72-402, respectively.
[0210] 402 compounds of formula (I), wherein A is 4-naphthyl, and
the values of X, Y and Z are as given in Table 1 for compounds 1-1
to 1-402, are designated as compound Nos. 73-1 to 73-402,
respectively.
[0211] General methods for the production of compounds of formula
(I) are described below. Unless otherwise stated in the text, the
substitutents A, X, Y and Z are as defined hereinbefore. The
abbreviation LG as used herein refers to any suitable leaving
group, and includes halogen, sulphonate, and sulphone groups. The
groups R as used herein are, independently of each other, alkyl or
substituted alkyl groups, preferably C1-C12 alkyl groups. The
groups R' may, independently of each other, take a range of values
depending on the particular structure of the molecule in which they
are present; the skilled man will recognise what values are
applicable in each case, particularly in view of the definition of
compounds of formula (I) as described hereinbefore.
[0212] Compounds of formula (I) may be prepared from compounds of
formula (A), where LG represents a suitable leaving group (reaction
scheme 1).
##STR00008##
[0213] For example, a compound of formula (I) may be prepared by
reacting a suitable metal or metalloid derivative A-M (for example,
a boronic acid or ester, a trialkyltin derivative, a zinc
derivative or a Grignard reagent) with a compound of formula (A) in
the presence of a suitable base (for example an inorganic base,
such as potassium phosphate or caesium fluoride, or an organic
base, such as triethylamine), a metal source (for example, a
palladium source such as Pd.sub.2(dba).sub.3) and, optionally, a
ligand for the metal (for example a phosphine ligand, such as
X-Phos) in a suitable solvent (for example a single solvent, such
as acetonitrile, or a mixed solvent system, such as a mixture of
dimethoxyethane and water)--see reaction scheme 2. The metal
catalyst and ligands may also be added as a single, pre-formed,
complex (for example a palladium/phosphine complex, such as
palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
##STR00009##
[0214] As an additional example (see reaction scheme 3) a compound
of formula (I) in which A is an alkenyl group may be prepared using
a Heck reaction in which the group A component containing the
double bond may be reacted with a compound of formula (A) in the
presence of a suitable metal catalyst (for example a palladium
derivative, such as palladium acetate), optionally with a suitable
ligand for the metal, and a suitable base (for example an inorganic
base, such as potassium phosphate) in a suitable solvent (for
example N-methylpyrrolidone).
##STR00010##
[0215] Alternatively, compounds of formula (I) may be prepared from
compounds of formula (B), where M represents a suitable metal or
metalloid derivative (for example a boronic acid or ester, a
trialkyltin group, a suitably substituted silyl group, a zinc
derivative or a magnesium halide) by reaction with a compound A-LG
in which LG represents a leaving group such as a halogen atom or
sulphonate (reaction scheme 4, below).
##STR00011##
[0216] For example, a compound of formula (I) may be prepared from
a compound of formula B in which M is a boronic acid group by
reaction with a compound A-LG in the presence of a metal catalyst
(for example a palladium derivative such as Pd.sub.2(dba).sub.3),
optionally with a suitable ligand (for example a phosphine such as
X-Phos) and a base (for example potassium phosphate or caesium
fluoride) in a suitable solvent.
[0217] Compounds of formula (B) may be prepared from other
compounds of formula (B) using a transmetallation reaction. For
example, a compound of formula (B) where M is a boronic acid may be
prepared from a compound of formula (B) where M is a magnesium
halide by reaction with a trialkylboronate, followed by hydrolysis
(for example under acidic conditions).
[0218] Alternatively compounds of formula (B) may be prepared from
compounds of formula (A), shown schematically below (reaction
scheme 5).
##STR00012##
[0219] For example, a compound of formula (B) where M is a boronate
ester or a trialkylstannane may be prepared from a compound of
formula (A) by treating it with a suitable M-containing reagent
(for example pinacolborane, bispinacolatodiboron, hexa-alkyldi-tin)
in the presence of a metal catalyst (for example a palladium
species, such as bis(diphenylphosphine)palladium dichloride) in a
suitable solvent (for example dioxane).
[0220] Alternatively, a compound of formula (B) where M is a
magnesium halide may be prepared from a compound of formula (A) by
treatment with a suitable Grignard reagent (for example an
isopropylmagnesium halide such as isopropylmagnesium chloride) in a
suitable solvent.
[0221] Compounds of formula (A) may be prepared from compounds of
formula (C) (reaction scheme 6), where LG' is a second leaving
group, which may be the same as or different to LG.
##STR00013##
[0222] For example, a compound of formula (A) may be prepared from
a compound of formula (C) by reaction with a reagent X--H or
X.sup.- in a suitable solvent (for example an ether solvent, such
as tetrahydrofuran, or a polar aprotic solvent, such as
dimethylsulphoxide). The reagent X.sup.- may be generated in situ
by addition of a suitable base to X--H, or it may be prepared
separately and added as a suitable salt.
[0223] As an additional example a compound of formula (A) may be
prepared from a compound of formula (C) by treatment with a reagent
X--H in the presence of a suitable catalyst (for example a metal
catalyst, such as a palladium source) and optionally a suitable
ligand (for example a phosphine ligand, such as Josiphos) in a
suitable solvent.
[0224] Compounds of formula (C1), which are compounds of formula
(C) in which LG and LG' are the same and are, for example, a
halogen atom or a sulphonate) may be prepared from compounds of
formula (D) (see reaction scheme 7 below).
##STR00014##
[0225] For example, a compound of formula (C1) in which LG is a
halogen atom may be prepared from a compound of formula (D) by
treatment with a suitable reagent (for example a phosphoryl halide
such as phosphorous oxychloride) and optionally a suitable base
(for example an organic base, such as N,N-diethylaniline).
[0226] Compounds of formula (C2) (that is compounds of formula (C)
in which LG and LG' are different) may be prepared from compounds
of formula (E) in which B represents a suitable precursor group to
LG' (reaction scheme 8).
##STR00015##
[0227] For example, a compound of formula (C2) in which LG' is a
sulphone may be prepared from a compound of formula (E1), which is
a compound of formula (E) in which B is a thioether group, by
reaction with a suitable oxidising agent, for example a peracid
such as meta-chloroperbenzoic acid) (reaction scheme 9).
##STR00016##
[0228] Compounds of formula (E) may be prepared from compounds of
formula (C1) by treatment with a reagent B--H or B.
[0229] For example, a compound of formula (E1) may be prepared from
a compound of formula (C1) by reaction with a thiol or thiolate
anion, optionally in the presence of a suitable base, in a suitable
solvent (see reaction scheme 10).
##STR00017##
[0230] Compounds of formula (D) may be prepared from compounds of
formula (F) by reaction with a suitable source of electropositive Y
(reaction scheme 11).
##STR00018##
[0231] For example a compound of formula (D) in which Y is an acyl
group may be prepared from a compound of formula (F) by reaction
with an acyl halide (for example acetyl chloride) in the presence
of a Lewis acid (for example aluminium trichloride) in a suitable
solvent (for example nitrobenzene).
[0232] Alternatively, compounds of formula (D) may be prepared from
compounds of formula (G) where D represents a suitable reactive
group (see reaction scheme 12 below). Examples of such a reactive
group are halogen atoms and sulphonates.
##STR00019##
[0233] For example, such a transformation may be carried out by
reaction with a metal or metalloid derivative of the group Y (for
example a boronic acid or boronate ester) in the presence of a base
(for example an inorganic base, such as potassium phosphate or
caesium fluoride, or an organic base, such as triethylamine), a
metal source (for example, a palladium source such as
Pd.sub.2(dba).sub.3) and, optionally, a ligand for the metal (for
example a phosphine ligand, such as X-Phos) in a suitable solvent
(for example a single solvent, such as acetonitrile, or a mixed
solvent system, such as a mixture of dimethoxyethane and water).
The metal catalyst and ligands may also be added as a single,
pre-formed, complex (for example a palladium/phosphine complex,
such as palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
[0234] Compounds of formula (G) may be prepared from compounds of
formula (F) by reaction with a suitable source of electropositive D
(reaction scheme 13).
##STR00020##
[0235] For example a compound of formula (G) in which D is a
halogen may be prepared from a compound of formula (F) by reaction
with an N-halosuccinimide (for example N-chlorosuccinimide) in a
suitable solvent (for example dimethylformamide).
[0236] Compounds of formula (F) are well known in the literature,
or can be made readily from compounds known in the literature by
standard methods known to the skilled man.
[0237] Compounds of formula (I) may also be prepared from compounds
of formula (H) where D represents a suitable reactive group (see
reaction scheme 14 below). Examples of such a reactive group are
halogen atoms and sulphonates.
##STR00021##
[0238] For example, such a transformation may be carried out by
reaction with a metal or metalloid derivative of the group Y (for
example a boronic acid or boronate ester) in the presence of a base
(for example an inorganic base, such as potassium phosphate or
caesium fluoride, or an organic base, such as triethylamine), a
metal source (for example, a palladium source such as
Pd.sub.2(dba).sub.3) and, optionally, a ligand for the metal (for
example a phosphine ligand, such as X-Phos) in a suitable solvent
(for example a single solvent, such as acetonitrile, or a mixed
solvent system, such as a mixture of dimethoxyethane and water).
The metal catalyst and ligands may also be added as a single,
pre-formed, complex (for example a palladium/phosphine complex,
such as palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
[0239] Compounds of formula (H) may be prepared from compounds of
formula (I) (reaction scheme 15), where LG represents a suitable
leaving group. Examples of such leaving groups are halogen atoms,
sulphonates and sulphones.
##STR00022##
[0240] For example, a compound of formula (H1), which is a compound
of formula (H) in which A is an alkylthio group, may be prepared by
reacting a compound of formula (I) with an alkanethiolate (for
example sodium methanethiolate) in a suitable solvent (for example
a polar solvent, such as methanol). See reaction scheme 16
below.
##STR00023##
[0241] In a further example, a compound of formula (H) may be
prepared by reacting a suitable metal or metalloid derivative A-M
(for example, a boronic acid or ester, a trialkyltin derivative, a
zinc derivative or a Grignard reagent) with a compound of formula
(i) in the presence of a suitable base (for example an inorganic
base, such as potassium phosphate or caesium fluoride, or an
organic base, such as triethylamine), a metal source (for example,
a palladium source such as Pd.sub.2(dba).sub.3) and, optionally, a
ligand for the metal (for example a phosphine ligand, such as
X-Phos) in a suitable solvent (for example a single solvent, such
as acetonitrile, or a mixed solvent system, such as a mixture of
dimethoxyethane and water). See reaction scheme 17 below. The metal
catalyst and ligands may also be added as a single, pre-formed,
complex (for example a palladium/phosphine complex, such as
palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
##STR00024##
[0242] As an additional example, a compound of formula (H) in which
A is an alkenyl group may be prepared using a Heck reaction in
which the group A component containing the double bond may be
reacted with a compound of formula (i) in the presence of a
suitable metal catalyst (for example a palladium derivative, such
as palladium acetate), optionally with a suitable ligand for the
metal, and a suitable base (for example an inorganic base, such as
potassium phosphate) in a suitable solvent (for example
N-methylpyrrolidone); see reaction scheme 18.
##STR00025##
[0243] Compounds of formula (i) may be prepared from compounds of
formula (J), where LG' is a second leaving group which may be the
same as or different to LG (reaction scheme 19).
##STR00026##
[0244] For example, a compound of formula (i) may be prepared from
a compound of formula (J) by reaction with a reagent X--H or
X.sup.- in a suitable solvent (for example an ether solvent, such
as tetrahydrofuran). The reagent X.sup.- may be generated in situ
by addition of a suitable base to X--H, or it may be prepared
separately and added as a suitable salt.
[0245] As a further example, a compound of formula (i) may be
prepared from a compound of formula (J) by treatment with a reagent
X--H in the presence of a suitable catalyst (for example a metal
catalyst, such as a palladium source) and optionally a suitable
ligand (for example a phosphine ligand, such as Josiphos) in a
suitable solvent.
[0246] Compounds of formula (J1), which are compounds of formula
(J) in which LG and LG' are the same and are, for example, a
halogen atom or a sulphonate, may be prepared from compounds of
formula (G) (see reaction scheme 20 below).
##STR00027##
[0247] For example, a compound of formula (J1) in which LG is a
halogen atom may be prepared from a compound of formula (G) by
treatment with a suitable reagent (for example a phosphoryl halide
such as phosphorous oxychloride) and optionally a suitable base
(for example an organic base, such as N,N-diethylaniline).
[0248] Compounds of formula (I) may be prepared from compounds of
formula (K) by reaction with a suitable source of electropositive Y
(reaction scheme 21).
##STR00028##
[0249] For example a compound of formula (I) in which Y is an acyl
group may be prepared from a compound of formula (K) by reaction
with an acyl halide (for example acetyl chloride) in the presence
of a Lewis acid (for example aluminium trichloride) in a suitable
solvent (for example nitrobenzene).
[0250] Compounds of formula (H) may also be prepared by reaction of
compounds of formula (K) with a suitable source of electrophilic D
(reaction scheme 22).
##STR00029##
[0251] For example a compound of formula (H) in which D is a
halogen may be prepared from a compound of formula (K) by reaction
with an N-halosuccinimide (for example N-chlorosuccinimide) in a
suitable solvent (for example dimethylformamide).
[0252] Compounds of formula (K) may be prepared from compounds of
formula (L) (shown in reaction scheme 23 below), in which LG
represents a leaving group.
##STR00030##
[0253] For example, a compound of formula (K) may be prepared from
a compound of formula (L) by reaction with a reagent X--H or
X.sup.- in a suitable solvent (for example an ether solvent, such
as tetrahydrofuran). The reagent X.sup.- may be generated in situ
by addition of a suitable base to X--H, or it may be prepared
separately and added as a suitable salt.
[0254] As an additional example a compound of formula (K) may be
prepared from a compound of formula (L) by treatment with a reagent
X--H in the presence of a suitable catalyst (for example a metal
catalyst, such as a palladium source) and optionally a suitable
ligand (for example a phosphine ligand, such as Josiphos) in a
suitable solvent.
[0255] Compounds of formula (L) may be prepared from compounds of
formula (M) (reaction scheme 24 below).
##STR00031##
[0256] For example, a compound of formula (L) in which LG is a
halogen atom may be prepared from a compound of formula M by
treatment with a suitable reagent (for example a phosphoryl halide
such as phosphorous oxychloride) and optionally a suitable base
(for example an organic base, such as N,N-diethylaniline).
[0257] Compounds of formula (M) may be prepared from amidines of
formula (N) by reaction with a suitable ketoester of formula (O)
(reaction scheme 25)
##STR00032##
[0258] For example, a compound of formula (M1), which is a compound
of formula (M) in which Z is a carboxylic acid or ester, may be
prepared by the reaction of an amidine of formula (N) with an
oxaloacetate diester of formula (O1), wherein (O1) is a compound of
formula (O) in which Z is CO.sub.2R, optionally in the presence of
a suitable base (for example an inorganic base, such as sodium
hydroxide), in a suitable solvent (for example water)--reaction
scheme 26. The diester (O1) may also be used in the form of a salt,
for example the sodium salt.
##STR00033##
[0259] In an additional example, shown schematically below in
reaction scheme 27, a compound of formula (M2) (i.e. a compound of
formula (M) in which Z is an acetal group) may be prepared by the
condensation of an amidine of formula (N) with a ketoester of
formula (O2) (i.e. a compound of formula (O) in which Z is
CH(OR).sub.2) in the presence of a base (e.g. an alkoxide base,
such as sodium methoxide) in a suitable solvent (e.g. an alcohol,
such as methanol).
##STR00034##
[0260] In general, amidines (N) and diesters (O) are either well
known in the literature or may be prepared using standard methods
with which the skilled man is familiar. Thus in a further aspect
the invention provides the use of an amidine of formula N as
defined above, as an intermediate in the preparation of a
herbicide, in particular in the preparation of a compound of
formula (I) as defined herein. However, we have found that novel
amidines of formula (II) as defined hereinafter, are particularly
useful as intermediates for use in the invention. The invention
also provides an amidine of formula (II)
##STR00035##
wherein R.sup.7 is methyl, Br, or Cl; R.sup.8 is H, F, Cl,
OR.sup.10, or N(R.sup.10).sub.2; R.sup.9 is H, F, or Cl; each
R.sup.10 is independently H or C.sub.1-4alkyl, provided that i)
R.sup.8 and R.sup.9 are not both hydrogen, (ii) when R.sup.7 is
methyl and R.sup.9 is hydrogen, then R.sup.8 is not F, Cl, or
NH.sub.2, (iii) when R.sup.7 is Cl and R.sup.8 is hydrogen, R.sup.9
is not Cl, (iv) when R.sup.7 is Cl and R.sup.8 is Cl, R.sup.9 is
not hydrogen, and (v) when R.sup.7 is Br, and R9 is hydrogen,
R.sup.8 is not F. Particularly preferred compounds of formula (II)
are those wherein R.sup.7 is methyl, Br, or Cl; R.sup.8 is F, Cl,
OR.sup.10, or N(R.sup.10).sub.2; R.sup.9 is F, or Cl; and each R10
is independently H or C.sub.1-4 alkyl. The skilled man will also
appreciate that in many cases amidines of formula (II) may be in
salt form, in particular in the form of the HCl salt. Such salts
may be obtained routinely by standard methods.
[0261] Compounds of formula (K1) (i.e. compounds of formula K in
which X is NH.sub.2) may be prepared by the reaction of amidines of
formula (N) with cyanoketones of formula (P) in the presence of a
base (e.g. an alkoxide base, such as sodium methoxide) in a
suitable solvent (e.g. an alcohol, such as ethanol)--see reaction
scheme 28 below.
##STR00036##
[0262] For example a compound of formula (K2), which is a compound
of formula (K1) in which Z is CO.sub.2R, may be prepared by the
reaction of an amidine of formula (N) with a cyanopyruvate ester of
formula (P1) (i.e. a compound of formula (P) in which Z is
CO.sub.2R). This is shown schematically in reaction scheme 29
below. In one example the compound of formula (P1) may be reacted
first with an alkylating agent (e.g. a methylating agent, such as
dimethyl sulphate) in the presence of a base (e.g. an inorganic
base, such as sodium bicarbonate) to form an enol ether, which is
then reacted with amidine (N) in the presence of a base (e.g. an
alkoxide base, such as sodium methoxide).
##STR00037##
[0263] Compounds of formula (P) are known or may be prepared using
routine, known methods.
[0264] Compounds of formula (H) may also be prepared from compounds
of formula (Q) (shown in reaction scheme 30 below), in which LG
represents a leaving group.
##STR00038##
[0265] For example, a compound of formula (H) may be prepared from
a compound of formula (Q) by reaction with a reagent X--H or
X.sup.- in a suitable solvent (for example an ether solvent, such
as tetrahydrofuran, or a polar aprotic solvent, such as
dimethylsulphoxide). The reagent X.sup.- may be generated in situ
by addition of a suitable base to X--H, or it may be prepared
separately and added as a suitable salt.
[0266] As an additional example a compound of formula (H) may be
prepared from a compound of formula (Q) by treatment with a reagent
X--H in the presence of a suitable catalyst (for example a metal
catalyst, such as a palladium source) and optionally a suitable
ligand (for example a phosphine ligand, such as Josiphos) in a
suitable solvent.
[0267] Compounds of formula (Q) may be prepared from compounds of
formula (R) (reaction scheme 31 below).
##STR00039##
[0268] For example, a compound of formula (Q) in which LG is a
halogen atom may be prepared from a compound of formula (R) by
treatment with a suitable reagent (for example a phosphoryl halide
such as phosphorous oxychloride) and optionally a suitable base
(for example an organic base, such as N,N-diethylaniline).
[0269] Compounds of formula (R) may be prepared from compounds of
formula (M) by reaction with a suitable source of electropositive D
(reaction scheme 32 below).
##STR00040##
[0270] For example a compound of formula (R) in which D is a
halogen may be prepared from a compound of formula (M) by reaction
with an N-halosuccinimide (e.g. N-chlorosuccinimide) in a suitable
solvent (e.g. dimethylformamide), or with a metal hypohalite (e.g.
sodium hypochlorite) in a suitable solvent (e.g. acidic water).
[0271] Compounds of formula (I) may also be prepared from compounds
of formula (S) (see reaction scheme 33), in which LG represents a
leaving group (e.g. a halogen or sulphonate).
##STR00041##
[0272] For example, a compound of formula (I) may be prepared from
a compound of formula (S) by reaction with a reagent X--H or
X.sup.- in a suitable solvent (e.g. methanol, dimethylsulphoxide or
water). The reagent X.sup.- may be generated in situ by addition of
a suitable base to X--H, or it may be prepared separately and added
as a suitable salt.
[0273] As a further example, a compound of formula (I) may be
prepared from a compound of formula (S) by treatment with a reagent
X--H in the presence of a suitable catalyst (e.g. a metal catalyst,
such as a palladium source) and optionally a suitable ligand (e.g.
a phosphine ligand, such as Josiphos) in a suitable solvent.
[0274] Compounds of formula (S) may be prepared from compounds of
formula (T) (reaction scheme 34).
##STR00042##
[0275] For example, a compound of formula (S) in which LG is a
halogen atom may be prepared from a compound of formula (T) by
treatment with a suitable reagent (e.g. a phosphoryl halide, such
as phosphorous oxychloride) and optionally a suitable base (e.g. an
organic base, such as N,N-diethylaniline).
[0276] Compounds of formula (T) may be prepared from amidines of
formula (N) by reaction with a suitable ketoester of formula (U)
(reaction scheme 35).
##STR00043##
[0277] For example, a compound of formula (T1), which is a compound
of formula (T) in which Z is a carboxylic acid or ester, may be
prepared by the reaction of an amidine of formula (N) with an
oxaloacetate diester of formula (U1) (i.e. a compound of formula
(U) in which Z is CO.sub.2R), optionally in the presence of a
suitable base (e.g. an inorganic base, such as sodium hydroxide),
in a suitable solvent (e.g. water). This is shown schematically
below (reaction scheme 36). The diester (U1) may also be used in
the form of a salt, for example the sodium salt.
##STR00044##
[0278] Compounds of formula (U) are known in the literature, or may
be prepared from compounds of formula (O) by methods well known in
the art (reaction scheme 37).
##STR00045##
[0279] Compounds of formula (T) may be prepared by the condensation
of amidines of formula (N) with substituted acetate esters of
formula (V) and esters of formula (W) in the presence of a base
(e.g. an alkoxide base, such as sodium ethoxide), in a suitable
solvent (e.g. an alcohol, such as ethanol) (reaction scheme
38).
##STR00046##
[0280] For example a compound of formula (T1) (as defined above)
may be prepared by the reaction of an amidine of formula (N) with
an acetate ester of formula (V) and a diethyl oxalate of formula
(W1) (i.e. a compound of formula (W) in which Z is a carboxylate
ester).
[0281] Compounds of formula (V) and (W) are readily available and
well known in the literature.
[0282] Alternatively, compounds of formula (T) may be prepared from
compounds of formula (M) by reaction with a suitable source of
electropositive Y (reaction scheme 39).
##STR00047##
[0283] For example a compound of formula (T) in which Y is an acyl
group may be prepared from a compound of formula (M) by reaction
with an acyl halide (e.g. acetyl chloride) in the presence of a
Lewis acid (e.g. aluminium trichloride) in a suitable solvent (e.g.
nitrobenzene).
[0284] Compounds of formula (T) may also be prepared from compounds
of formula (R) where D represents a suitable reactive group
(reaction scheme 40). Examples of such a reactive group are halogen
atoms and sulphonates.
##STR00048##
[0285] For example, such a transformation may be carried out by
reaction with a metal or metalloid derivative of the group Y (e.g.
a boronic acid or boronate ester) in the presence of a base (e.g.
an inorganic base, such as potassium phosphate or caesium fluoride,
or an organic base, such as triethylamine), a metal source (e.g. a
palladium source such as Pd.sub.2(dba).sub.3) and, optionally, a
ligand for the metal (e.g. a phosphine ligand, such as X-Phos) in a
suitable solvent (e.g. a single solvent, such as acetonitrile, or a
mixed solvent system, such as a mixture of dimethoxyethane and
water). The metal catalyst and ligands may also be added as a
single, pre-formed, complex (e.g. a palladium/phosphine complex,
such as palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
[0286] Alternatively, compounds of formula (T) may be prepared from
compounds of formula (X) (reaction scheme 41 below).
##STR00049##
[0287] For example, a compound of formula (T2), which is a compound
of formula (T) in which Z is O--(CHR.sup.w).sub.n--COR.sup.cb
(wherein R.sup.w, n and R.sup.cb are as defined hereinbefore), may
be prepared from a compound of formula (X) by reaction with a
compound of formula (Y) in the presence of a base e.g. sodium
hydride, in a suitable solvent e.g. an ether, such as
tetrahydrofuran (reaction scheme 42).
##STR00050##
[0288] Compounds of formula (X) may be prepared by the reaction of
amidines of formula (N) with malonyl diesters of formula (Z) in the
presence of a suitable base (e.g. an inorganic base, such as
potassium carbonate, or an alkoxide base, such as sodium methoxide)
in a suitable solvent (e.g. an ether, such as diglyme, or an
alcohol, such as ethanol) (reaction scheme 43).
##STR00051##
[0289] Diesters of formula (Z) are known in the literature or may
be prepared by methods well known in the literature.
[0290] Compounds of formula (X) may be prepared from compounds of
formula (AA) by reaction with a suitable source of electropositive
Y (reaction scheme 44).
##STR00052##
[0291] For example a compound of formula (X) in which Y is an acyl
group may be prepared from a compound of formula (AA) by reaction
with an acyl halide e.g. acetyl chloride, in the presence of a
Lewis acid e.g. aluminium trichloride, in a suitable solvent e.g.
nitrobenzene.
[0292] Alternatively, compounds of formula (X) may be prepared from
compounds of formula (AB) where D represents a suitable reactive
group (reaction scheme 45). Examples of such a reactive group are
halogen atoms and sulphonates.
##STR00053##
[0293] For example, such a transformation may be carried out by
reaction with a metal or metalloid derivative of the group Y (e.g.
a boronic acid or boronate ester), in the presence of a base (e.g.
an inorganic base, such as potassium phosphate or caesium fluoride,
or an organic base, such as triethylamine) a metal source (e.g. a
palladium source such as Pd.sub.2(dba).sub.3), and, optionally, a
ligand for the metal (e.g. a phosphine ligand, such as X-Phos), in
a suitable solvent (e.g. a single solvent, such as acetonitrile, or
a mixed solvent system, such as a mixture of dimethoxyethane and
water). The metal catalyst and ligands may also be added as a
single, pre-formed, complex (e.g a palladium/phosphine complex,
such as palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
[0294] Compounds of formula (AB) may be prepared by reaction of
compounds of formula (AA) with a suitable source of electropositive
D (reaction scheme 46).
##STR00054##
[0295] For example a compound of formula (AB) in which D is a
halogen may be prepared from a compound of formula (AA) by reaction
with a halogenating agent (e.g. an N-halosuccinimide such as
N-chlorosuccinimide, or an elemental halogen such as bromine).
[0296] Compounds of formula (AA) may be prepared from amidines of
formula (N) and malonyl diesters of formula (AC) (reaction scheme
47).
##STR00055##
[0297] Diesters of formula (AC) are well known in the
literature.
[0298] Compounds of formula (S) may be prepared from compounds of
formula (AD) in which B represents a suitable precursor group to LG
(reaction scheme 48).
##STR00056##
[0299] For example, a compound of formula (S) in which LG is a
sulphone may be prepared from a compound of formula (AD1), which is
a compound of formula (AD) in which B is a thioether group, by
reaction with a suitable oxidising agent, for example a peracid
such as meta-chloroperbenzoic acid) (reaction scheme 49).
##STR00057##
[0300] Compounds of formula (AD) may be prepared from compounds of
formula (AE) where D represents a suitable reactive group (reaction
scheme 50). Examples of such a reactive group are halogen atoms and
sulphonates.
##STR00058##
[0301] For example, such a transformation may be carried out by
reaction with a metal or metalloid derivative of the group Y (e.g.
a boronic acid or boronate ester) in the presence of a base (e.g.
an inorganic base, such as potassium phosphate or caesium fluoride,
or an organic base, such as triethylamine), a metal source (e.g. a
palladium source such as Pd.sub.2(dba).sub.3) and, optionally, a
ligand for the metal (e.g. a phosphine ligand, such as X-Phos) in a
suitable solvent (e.g. a single solvent, such as acetonitrile, or a
mixed solvent system, such as a mixture of dimethoxyethane and
water). The metal catalyst and ligands may also be added as a
single, pre-formed, complex (e.g. a palladium/phosphine complex,
such as palladium tetrakistriphenylphosphine,
bis(triphenylphosphine)palladium dichloride or
[1,1'-bis(diphenylphosphino)ferrocene] palladium dichloride).
[0302] Compounds of formula (AE) may be prepared from compounds of
formula (Q) by treatment with a reagent B--H or B.sup.-.
[0303] For example, a compound of formula (AE1), which is a
compound of formula (AE) in which B is a thioether, may be prepared
from a compound of formula (Q) by reaction with a thiol or thiolate
anion, optionally in the presence of a suitable base, in a suitable
solvent (see reaction scheme 51).
##STR00059##
[0304] Compounds of formula (S) may be prepared from compounds of
formula (AF), where LG and LG' (which may be the same or different)
are suitable leaving groups, such as halogen atoms or sulphonates
(reaction scheme 52).
##STR00060##
[0305] For example a compound of formula (S) in which Z is
CO.sub.2R may be prepared from a compound of formula (AF) by
reaction with an alcohol ROH and carbon monoxide in the presence of
a suitable metal catalyst (e.g. a palladium reagent, such as
bis(triphenylphosphine)palladium dichloride) and a suitable base
(e.g. an organic base, such as triethylamine). See reaction scheme
53 below. The reaction may conveniently be conducted in an
atmosphere of carbon monoxide gas at atmospheric or raised
pressure.
##STR00061##
[0306] Alternatively (see reaction scheme 54 below) a compound of
formula (S) in which Z is O--(CH.sup.w).sub.n--COR.sup.cb may be
prepared from a compound of formula (AF) by reaction with a
compound of formula (AG) in the presence of a base (e.g. sodium
hydride) in a suitable solvent (e.g. an ether, such as
tetrahydrofuran).
##STR00062##
[0307] Compounds of formula (AG) are known compounds or may be
prepared from known compounds using methods that are well known in
the literature.
[0308] Compounds of formula (AF1), which are compounds of formula
(AF) in which LG is the same as LG', may be prepared from compounds
of formula (X) by reaction with a suitable reagent, for example a
phosphoryl halide or sulphonyl anhydride (reaction scheme 55).
##STR00063##
[0309] For example, a compound of formula (AF1) in which LG and LG'
are halogen atoms may be prepared by reaction of a compound of
formula (X) with a halogenating agent (e.g. a phosphoryl halide
such as phosphorus oxychloride) in the presence of a suitable base
(e.g. an organic base, such as N,N-diethylaniline).
[0310] Compounds of formula (I) may be prepared from compounds of
formula (AH), where LG is a suitable leaving group, such as a
halogen atom or sulphonate (reaction scheme 56).
##STR00064##
[0311] For example a compound of formula (I) in which Z is
CO.sub.2R may be prepared from a compound of formula (AH) by
reaction with an alcohol ROH and carbon monoxide in the presence of
a suitable metal catalyst e.g. a palladium reagent, such as
bis(triphenylphosphine)palladium dichloride, and a suitable base
e.g. an organic base, such as triethylamine (see reaction scheme
57). The reaction may conveniently be conducted in an atmosphere of
carbon monoxide gas at atmospheric or raised pressure.
##STR00065##
[0312] Alternatively a compound of formula (I) in which Z is
O--(CHR.sup.w).sub.n--COR.sup.cb (as defined hereinbefore) may be
prepared from a compound of formula (AH) by reaction with a
compound of formula (AG) in the presence of a base e.g. sodium
hydride in a suitable solvent e.g. an ether, such as
tetrahydrofuran (reaction scheme 58).
##STR00066##
[0313] Compounds of formula (AH) may be prepared from compounds of
formula (AF) (reaction scheme 59).
##STR00067##
[0314] Compounds of formula (I) in which A is a ring may also be
prepared from compounds of formula (AI) wherein E represents a
suitable cyclisation precursor, by reactions in which ring A is
formed (reaction scheme 60). Examples of suitable cyclisation
precursors include groups containing carbon-carbon double or triple
bonds, such as alkenes and alkynes.
##STR00068##
[0315] For example, a compound of formula (I) in which A is an
unsaturated 6-membered ring may be prepared from a compound of
formula (AI1) i.e. a compound of formula (AI) in which E is an
alkyne, by reaction with a suitable diene (AJ) (reaction scheme 61
below).
##STR00069##
[0316] In a further example, a compound of formula (I) in which A
is a cyclopropane may be prepared from a compound of formula (AI2)
i.e. a compound of formula (I) in which A is an alkene, by reaction
with a suitable cyclopropanation reagent (e.g. a reagent
combination that generates a carbene, such as diiodomethane and
diethyl zinc) (reaction scheme 62).
##STR00070##
[0317] In an additional example a compound of formula (I) in which
A is a 4-membered ring may be prepared from a compound of formula
(AI2) by reaction with a suitable reagent (AK) containing a
carbon-carbon double bond, for example an alkene.
##STR00071##
[0318] In another example, a compound of formula (I) in which A is
a 5-membered ring may be formed from a compound of formula (AI2) by
reaction with a suitable 1,3-dipolar species (AL) such as a
trimethylenemethane species (reaction scheme 64).
##STR00072##
[0319] As a further example, a compound of formula (I) in which A
is an unsaturated 6-membered ring may be prepared from a compound
of formula (AI2) by reaction with a suitable diene (AJ) (reaction
scheme 65).
##STR00073##
[0320] Compounds of formulae (AJ), (AK) and (AL) are known in the
art, or can be made readily using methods that are well known in
the literature.
[0321] Compounds of formula (AI1) may be prepared from compounds of
formula (A) by a Sonogashira-type reaction with an alkyne (AM)
(reaction scheme 66).
##STR00074##
[0322] Compounds of formula (I) in which A is an alkene may be
prepared from compounds of formula (AI3), which are compounds of
formula (AI) in which E is an aldehyde or ketone group, by
olefination reactions that are well known in the literature, for
example the Wittig, Peterson, Tebbe and Petasis reactions (see
reaction scheme 67, below).
##STR00075##
[0323] Compounds of formula (AI3) may be prepared from compounds of
formula (AI2) by oxidative cleavage of the double bond (reaction
scheme 68), for example by treatment with ozone.
##STR00076##
[0324] Alternatively compounds of formula (AI3) may be prepared
from compounds of formula (AI4), which are compounds of formula
(AI) in which E is a 1,2-diol group, by treatment with a suitable
oxidising agent, for example sodium periodate (reaction scheme
69).
##STR00077##
[0325] Compounds of formula (AI4) may be prepared from compounds of
formula (AI2) by reaction with a suitable dihydroxylation reagent
(e.g. an osmium species such as osmium tetroxide) (reaction scheme
70 below).
##STR00078##
[0326] Compounds of formula (I) in which X is NH.sub.2 may be
prepared by the condensation of amidines of formula (N) with
substituted acetonitriles of formula (AN) and esters of formula (W)
(see reaction scheme 71 below). These reactions occur in the
presence of a base (e.g. an alkoxide base, such as sodium ethoxide)
in a suitable solvent (e.g. an alcohol, such as ethanol).
##STR00079##
[0327] For example, a compound of formula (I) in which Z is
CO.sub.2R may be prepared by the reaction of an amidine of formula
(N) with a substituted acetonitrile of formula (AN) and an oxalate
diester of formula (W1). Compounds of formula (AN) are known in the
literature.
[0328] Compounds of formula (I) in which m is 0 and n is 2 may be
prepared by the reaction of compounds of formula (AO) with a
reagent that can functionalise the double bond (reaction scheme
72).
##STR00080##
[0329] For example, a compound of formula (I) in which R' is
hydrogen may be prepared from a compound of formula (AO) by
reaction with a suitable reducing agent (e.g. hydrogen gas in the
presence of a metal catalyst, such as palladium supported on
carbon) (reaction scheme 73).
##STR00081##
[0330] As a further example, a compound of formula (I) in which R'
represents vicinal hydroxyl groups may be prepared from a compound
of formula (AO) by reaction with a dihydroxylation reagent (e.g.
osmium tetroxide) (see reaction scheme 74 below).
##STR00082##
[0331] Compounds of formula (AO) may be prepared by the Heck
reaction of compounds of formula (AH) with compounds of formula
(AP) in the presence of a suitable metal catalyst (e.g. a palladium
species, such as palladium acetate) and a base (e.g. an organic
base, such as triethylamine), in a suitable solvent (reaction
scheme 75).
##STR00083##
[0332] Compounds of formula (I) may be prepared from different
compounds of formula (I) by the conversion of any of the
substituents X, Y, Z or A into a different group X, Y, Z or A using
techniques that are known in the literature and with which the
skilled man will be familiar.
[0333] For example, a compound of formula (I) in which Y is an
alkyl group may be prepared from a compound of formula (I) in which
Y is an alkenyl or alkynyl group by reduction under suitable
conditions (see reaction schemes 76, 77). Examples of such
conditions include the use of hydrogen gas in the presence of a
suitable catalyst, e.g. a metal catalyst, such as for example,
palladium supported on carbon.
##STR00084##
##STR00085##
[0334] A compound of formula (I) in which Y is an alkenyl group may
be prepared from a compound of formula (I) in which Y is an alkynyl
group by reduction under suitable conditions (reaction scheme 78).
Such conditions include reduction using hydrogen gas in the
presence of an appropriate metal catalyst, for example a poisoned
palladium metal catalyst such as Lindlars catalyst.
##STR00086##
[0335] A compound of formula (I) in which Y is an acyl group may be
prepared from a compound of formula (I) in which Y is an enol ether
by hydrolysis (reaction scheme 79), for example using an aqueous
acid.
##STR00087##
[0336] In an additional example, a compound of formula (I) in which
Y is an alkene may be prepared from a compound of formula (I) in
which Y is an aldehyde or ketone by using a suitable olefination
reaction (reaction scheme 80), for example a Wittig, Horner-Emmons,
Peterson or Tebbe reaction.
##STR00088##
[0337] In a further example, a compound of formula (I) in which Y
is a cyclopropane may be prepared from a compound of formula (I) in
which Y is an alkene by reaction with a suitable cyclopropanation
reagent e.g. a reagent combination that generates a carbene, such
as diiodomethane and diethyl zinc (reaction scheme 81).
##STR00089##
[0338] A compound of formula (I) in which A is an aromatic or
heteroaromatic ring may be prepared from a compound of formula (I)
in which A is an alkylthio group (see reaction scheme 82
below).
##STR00090##
[0339] For example, such a transformation may be carried out by
reaction with a metal or metalloid derivative of the ring A (for
example a boronic acid or boronate ester) in the presence of a
metal source (for example, a palladium source such as
Pd.sub.2(dba).sub.3) and, optionally, a ligand for the metal (for
example a phosphine ligand, such as tri(2-furyl)phosphine), a
further metal source (for example a copper complex, such as copper
thiophene-2-carboxylate) in a suitable solvent (for example an
ether, such as tetrahydrofuran). The metal catalyst and ligands may
also be added as a single, pre-formed, complex (for example a
palladium/phosphine complex, such as palladium
tetrakistriphenylphosphine, bis(triphenylphosphine)palladium
dichloride or [1,1'-bis(diphenylphosphino)ferrocene] palladium
dichloride).
[0340] In a further example, an unsaturated group A (e.g. an alkene
or cycloalkene) may be reduced to form a saturated group (e.g. an
alkyl or cycloalkyl group). When A is an unsaturated ring it may be
oxidised to form an aromatic ring under standard conditions.
[0341] A compound of formula (I) in which R.sup.5 is not hydrogen
may be prepared from a compound of formula (I) in which R.sup.5 is
H by reaction with a suitable reagent R.sup.5-LG in which LG is a
leaving group such as a halogen atom. Examples of such reagents
R.sup.5-LG are alkyl halides and acid anhydrides. For example a
compound of formula (I) in which R.sup.5 is COR may be prepared
from a compound of formula (I) in which R.sup.5 is H by reaction
with an acylating agent such as an acyl chloride in the presence of
a base (see reactjon scheme 83 below).
##STR00091##
[0342] Alternatively a compound of formula (I) in which R.sup.5 is
not hydrogen may be prepared from a compound of formula (I) in
which R.sup.5 is H by reductive amination, involving first a
condensation with a carbonyl compound such as an aldehyde or ketone
and then reduction of the intermediate imine or iminium ion with a
suitable reducing agent such as a metal hydride (e.g. sodium
cyanoborohydride).
[0343] In an additional example a compound of formula (I) in which
R.sup.cb is OH may be prepared from a compound of formula (I) in
which R.sup.cb is OR, by hydrolysis under basic or acidic
conditions, for example by treatment with aqueous sodium hydroxide
(reaction scheme 84). Alternatively this transformation may be
achieved by treatment of the ester with a nucleophile, for example
an alkyl thiolate, in a suitable solvent.
##STR00092##
[0344] A compound of formula I in which R.sup.cb is OR may be
prepared directly from a compound of formula I in which R.sup.cb is
OH by esterification under standard conditions, for example by
treatment with an alcohol ROH and an acid catalyst (for example,
thionyl chloride). Alternatively, this transformation may be
achieved by first preparing an activated derivative of the acid
group, for example an acyl halide, followed by reaction with an
alcohol.
[0345] Other derivatives of the acid group in compounds of formula
(I) in which R.sup.cb is OH may be prepared by standard methods
found in the literature. For example a compound of formula (I) in
which R.sup.cb is NH.sub.2 may be prepared from a compound of
formula (I) in which R.sup.cb is OH by treatment with a suitable
coupling reagent (e.g. a carbodiimide, such as
dicyclohexylcarbodiimide) and ammonia, optionally with an additive
(e.g. dimethylaminopyridine), in a suitable solvent (e.g.
dimethylformamide)--see reaction scheme 85. Alternatively, this
transformation may be performed by first preparing an activated
derivative of the carboxylic acid group (e.g. an acyl halide such
as an acid chloride), and then treating the activated derivative
with ammonia.
##STR00093##
[0346] One skilled in the art will understand that transformations
of this type may equally well be conducted at different stages of
the synthetic route, for example converting one compound of formula
(T) into a different compound of formula (T).
[0347] The person skilled in the art will also understand that in
certain instances more than one transformation can be conducted at
a time, utilising the same reaction conditions. For example a
compound of formula (I) in which A and Y are the same may be
prepared from a compound of formula (i) by reaction with an excess
of a metal or metalloid derivative of A, such as a boronic acid, in
the presence of a metal catalyst (e.g. a palladium derivative such
as Pd.sub.2(dba).sub.3), a ligand (e.g. a phosphine ligand such as
X-Phos) and a base (such as, for example, potassium phosphate) in a
suitable solvent (reaction scheme 86).
##STR00094##
[0348] Another example is the preparation of a compound of formula
(I) in which R.sup.cb is NH.sub.2 from a compound of formula (S1)
(i.e. a compound of formula (S) in which R.sup.cb is OR) by
treatment with an excess of ammonia in a suitable solvent (see
reaction scheme 87 below).
##STR00095##
[0349] A further example is the preparation of a compound of
formula (R1) (i.e. a compound of formula (R) in which Z is
CO.sub.2R), from a compound of formula (M2) by oxidation using a
reagent that also provides a source of electropositive D (for
example, N-bromosuccinimide for the case in which D=Br; see
reaction scheme 88).
##STR00096##
[0350] The skilled man will appreciate that it is often possible to
alter the order in which the transformations above are conducted or
to combine them in alternative ways to prepare a wide range of
compounds of formula (I).
[0351] One skilled in the art will also realise that some reagents
will be incompatible with certain values or combinations of
substituents X, Y, Z and A. Accordingly additional steps, such as
protection and deprotection steps, will be necessary to achieve the
desired transformation, and the skilled man will immediately
recognise where this is the case.
[0352] Compounds of formula (I) may be used in unmodified form,
i.e. as obtainable from synthesis, but preferably are formulated in
any suitable manner using formulation adjuvants, such as carriers,
solvents and surface-active substances, for example, as described
hereinafter. The invention thus extends to herbicidal compositions
and/or formulations comprising a compound of the invention and at
least one agriculturally acceptable formulation adjuvant or
diluent.
[0353] The formulations can be in various physical forms, e.g. in
the form of dusting powders, gels, wettable powders,
water-dispersible granules, water-dispersible tablets, effervescent
pellets, emulsifiable concentrates, microemulsifiable concentrates,
oil-in-water emulsions, oil-flowables, aqueous dispersions, oily
dispersions, suspo-emulsions, capsule suspensions, emulsifiable
granules, soluble liquids, water-soluble concentrates (with water
or a water-miscible organic solvent as carrier), impregnated
polymer films or in other forms known e.g. from the Manual on
Development and Use of FAO Specifications for Plant Protection
Products, 5th Edition, 1999. The formulations can be in the form of
concentrates which are diluted prior to use, although ready-to-use
formulations can also be made. The dilutions can be made, for
example, with water, liquid fertilisers, micronutrients, biological
organisms, oil or solvents.
[0354] The formulations can be prepared e.g. by mixing the active
ingredient with the formulation adjuvants in order to obtain
compositions in the form of finely divided solids, granules,
solutions, dispersions or emulsions. The active ingredients can
also be formulated with other adjuvants, such as finely divided
solids, mineral oils, oils of vegetable or animal origin, modified
oils of vegetable or animal origin, organic solvents, water,
surface-active substances or combinations thereof. The active
ingredients can also be contained in very fine microcapsules
consisting of a polymer. Microcapsules usually have a diameter of
from 0.1 to 500 microns. Typically, they will contain active
ingredients in an amount of about from 25 to 95% by weight of the
capsule weight. The active ingredients can be in the form of a
monolithic solid, in the form of fine particles in solid or liquid
dispersion or in the form of a suitable solution. The encapsulating
membranes comprise, for example, natural or synthetic rubbers,
cellulose, styrene/butadiene copolymers, polyacrylonitrile,
polyacrylate, polyesters, polyamides, polyureas, polyurethane or
chemically modified polymers and starch xanthates or other known
polymers. Alternatively, very fine microcapsules can be formed in
which the active ingredient is contained in the form of finely
divided particles in a solid matrix of base substance, but the
microcapsules are not themselves encapsulated.
[0355] The formulation adjuvants that are suitable for the
preparation of compositions according to the invention are known
per se. As liquid carriers there may be used: water, toluene,
xylene, petroleum ether, vegetable oils, acetone, methyl ethyl
ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone,
amyl acetate, 2-butanone, butylene carbonate, chlorobenzene,
cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone
alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene,
diethylene glycol, diethylene glycol abietate, diethylene glycol
butyl ether, diethylene glycol ethyl ether, diethylene glycol
methyl ether, N,N-dimethylformamide, dimethyl sulfoxide,
1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether,
dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl
acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane,
2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene
glycol, ethylene glycol butyl ether, ethylene glycol methyl ether,
gamma-butyrolactone, glycerol, glycerol acetate, glycerol
diacetate, glycerol triacetate, hexadecane, hexylene glycol,
isoamyl acetate, isobornyl acetate, isooctane, isophorone,
isopropylbenzene, isopropyl myristate, lactic acid, laurylamine,
mesityl oxide, methoxypropanol, methyl isoamyl ketone, methyl
isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate,
methylene chloride, m-xylene, n-hexane, n-octylamine, octa-decanoic
acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol,
polyethylene glycol (PEG), propionic acid, propyl lactate,
propylene carbonate, propylene glycol, propylene glycol methyl
ether, p-xylene, toluene, triethyl phosphate, triethylene glycol,
xylenesulfonic acid, paraffin, mineral oil, trichloroethylene,
perchloroethylene, ethyl acetate, amyl acetate, butyl acetate,
propylene glycol methyl ether, diethylene glycol methyl ether,
methanol, ethanol, isopropanol, and alcohols of higher molecular
weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol,
octanol, ethylene glycol, propylene glycol, glycerol,
N-methyl-2-pyrrolidone and the like. Water is generally the carrier
of choice for diluting the concentrates. Suitable solid carriers
are, for example, talc, titanium dioxide, pyrophyllite clay,
silica, attapulgite clay, kieselguhr, limestone, calcium carbonate,
bentonite, calcium montmorillonite, cottonseed husks, wheat flour,
soybean flour, pumice, wood flour, ground walnut shells, lignin and
similar substances, as described, for example, in CFR 180.1001. (c)
& (d).
[0356] A large number of surface-active substances may
advantageously be used in the formulations, especially in those
formulations designed to be diluted with a carrier prior to use.
Surface-active substances may be anionic, cationic, non-ionic or
polymeric and they can be used as emulsifiers, wetting agents or
suspending agents or for other purposes. Typical surface-active
substances include, for example, salts of alkyl sulfates, such as
diethanolammonium lauryl sulfate; salts of alkylarylsulfonates,
such as calcium dodecylbenzenesulfonate; alkylphenol/alkylene oxide
addition products, such as nonylphenol ethoxylate; alcohol/alkylene
oxide addition products, such as tridecylalcohol ethoxylate; soaps,
such as sodium stearate; salts of alkylnaphthalenesulfonates, such
as sodium dibutylnaphthalenesulfonate; dialkyl esters of
sulfosuccinate salts, such as sodium
di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol
oleate; quaternary amines, such as lauryltrimethylammonium
chloride, polyethylene glycol esters of fatty acids, such as
polyethylene glycol stearate; block copolymers of ethylene oxide
and propylene oxide; and salts of mono- and di-alkylphosphate
esters; and also further substances described e.g. in "McCutcheon's
Detergents and Emulsifiers Annual" MC Publishing Corp., Ridgewood
N.J., 1981.
[0357] Further adjuvants that can usually be used in pesticidal
formulations include crystallisation inhibitors, viscosity
modifiers, suspending agents, dyes, anti-oxidants, foaming agents,
light absorbers, mixing auxiliaries, antifoams, complexing agents,
neutralising or pH-modifying substances and buffers, corrosion
inhibitors, fragrances, wetting agents, take-up enhancers,
micronutrients, plasticisers, glidants, lubricants, dispersants,
thickeners, antifreezes, microbicides, and also liquid and solid
fertilisers.
[0358] The compositions according to the invention can additionally
include an additive comprising an oil of vegetable or animal
origin, a mineral oil, alkyl esters of such oils or mixtures of
such oils and oil derivatives. The amount of oil additive in the
composition according to the invention is generally from 0.01 to
10%, based on the spray mixture. For example, the oil additive can
be added to the spray tank in the desired concentration after the
spray mixture has been prepared. Preferred oil additives comprise
mineral oils or an oil of vegetable origin, for example rapeseed
oil, olive oil or sunflower oil, emulsified vegetable oil, such as
AMIGO.RTM. (Rhone-Poulenc Canada Inc.), alkyl esters of oils of
vegetable origin, for example the methyl derivatives, or an oil of
animal origin, such as fish oil or beef tallow. A preferred
additive contains, for example, as active components essentially
80% by weight alkyl esters of fish oils and 15% by weight
methylated rapeseed oil, and also 5% by weight of customary
emulsifiers and pH modifiers. Especially preferred oil additives
comprise alkyl esters of C.sub.8-22 fatty acids, especially the
methyl derivatives of C.sub.12-18 fatty acids, for example the
methyl esters of lauric acid, palmitic acid and oleic acid, being
of importance. Those esters are known as methyl laurate
(CAS-111-82-0), methyl palmitate (CAS-112-39-0) and methyl oleate
(CAS-112-62-9). A preferred fatty acid methyl ester derivative is
Emery.RTM. 2230 and 2231 (Cognis GmbH). Those and other oil
derivatives are also known from the Compendium of Herbicide
Adjuvants, 5th Edition, Southern Illinois University, 2000. Another
preferred adjuvant is Adigor.RTM. (Syngenta AG) which is a
methylated rapeseed oil-based adjuvant.
[0359] The application and action of the oil additives can be
further improved by combination with surface-active substances,
such as non-ionic, anionic or cationic surfactants. Examples of
suitable anionic, non-ionic and cationic surfactants are listed on
pages 7 and 8 of WO97/34485. Preferred surface-active substances
are anionic surfactants of the dodecylbenzylsulfonate type,
especially the calcium salts thereof, and also non-ionic
surfactants of the fatty alcohol ethoxylate type. Special
preference is given to ethoxylated C.sub.12-22 fatty alcohols
having a degree of ethoxylation of from 5 to 40. Examples of
commercially available surfactants are the Genapol types (Clariant
AG). Also preferred are silicone surfactants, especially
polyalkyl-oxide-modified heptamethyltriloxanes which are
commercially available e.g. as Silwet L-77.RTM., and also
perfluorinated surfactants. The concentration of the surface-active
substances in relation to the total additive is generally from 1 to
30% by weight. Examples of oil additives consisting of mixtures of
oil or mineral oils or derivatives thereof with surfactants are
Edenor ME SU.RTM., Turbocharge.RTM. (Syngenta AG, CH) or ActipronC
(BP Oil UK Limited, GB).
[0360] If desired, it is also possible for the mentioned
surface-active substances to be used in the formulations on their
own, that is to say without oil additives.
[0361] Furthermore, the addition of an organic solvent to the oil
additive/surfactant mixture may contribute to an additional
enhancement of action. Suitable solvents are, for example,
Solvesso.RTM. (ESSO) or Aromatic Solvent.RTM. (Exxon Corporation).
The concentration of such solvents can be from 10 to 80% by weight
of the total weight. Oil additives that are present in admixture
with solvents are described, for example, in U.S. Pat. No.
4,834,908. A commercially available oil additive disclosed therein
is known by the name MERGE.RTM. (BASF Corporation). A further oil
additive that is preferred according to the invention is SCORE.RTM.
(Syngenta Crop Protection Canada).
[0362] In addition to the oil additives listed above, for the
purpose of enhancing the action of the compositions according to
the invention it is also possible for formulations of
alkylpyrrolidones (e.g. Agrimax.RTM.) to be added to the spray
mixture. Formulations of synthetic lattices, e.g. polyacrylamide,
polyvinyl compounds or poly-1-p-menthene (e.g. Bond.RTM.,
Courier.RTM. or Emerald.RTM.) may also be used. It is also possible
for solutions that contain propionic acid, for example Eurogkem
Pen-e-trate.RTM., to be added to the spray mixture as
action-enhancing agent.
[0363] Herbicidal compositions of the invention generally comprise
from 0.1 to 99% by weight, especially from 0.1 to 95% by weight,
compounds of formula (I) and from 1 to 99.9% by weight of a
formulation adjuvant which preferably includes from 0 to 25% by
weight of a surface-active substance. Whereas commercial products
will preferably be formulated as concentrates, the end user will
normally employ dilute formulations.
[0364] Examples of preferred formulation types and their typical
compositions are given below (% is percent by weight). Wettable
powders as described herein are one particularly preferred type of
formulation for use in the invention. In other preferred
embodiments, in particular where the
compound/composition/formulation of the invention is intended for
use on turf, granular (inert or fertiliser) formulations as
described herein are particularly suitable.
Emulsifiable Concentrates:
[0365] active ingredient: 1 to 95%, preferably 60 to 90%
surface-active agent: 1 to 30%, preferably 5 to 20% liquid carrier:
1 to 80%, preferably 1 to 35%
Dusts:
[0366] active ingredient: 0.1 to 10%, preferably 0.1 to 5% solid
carrier: 99.9 to 90%, preferably 99.9 to 99%
Suspension Concentrates:
[0367] active ingredient: 5 to 75%, preferably 10 to 50% water: 94
to 24%, preferably 88 to 30% surface-active agent: 1 to 40%,
preferably 2 to 30%
Wettable Powders:
[0368] active ingredient: 0.5 to 90%, preferably 1 to 80%
surface-active agent: 0.5 to 20%, preferably 1 to 15% solid
carrier: 5 to 95%, preferably 15 to 90%
Granules:
[0369] active ingredient: 0.1 to 30%, preferably 0.1 to 15% solid
carrier: 99.5 to 70%, preferably 97 to 85% The following Examples
further illustrate, but do not limit, the invention.
Formulation Examples for Herbicides of Formula (I) (%=% by
Weight)
TABLE-US-00002 [0370] F1. Emulsifiable concentrates a) b) c) d)
active ingredient 5% 10% 25% 50% calcium dodecylbenzenesulfonate 6%
8% 6% 8% castor oil polyglycol ether 4% -- 4% 4% (36 mol of
ethylene oxide) octylphenol polyglycol ether -- 4% -- 2% (7-8 mol
of ethylene oxide) NMP -- -- 10% 20% arom. hydrocarbon mixture 85%
78% 55% 16% (C.sub.9-C.sub.12)
[0371] Emulsions of any desired concentration can be obtained from
such concentrates by dilution with water.
TABLE-US-00003 F2. Solutions a) b) c) d) active ingredient 5% 10%
50% 90% 1-methoxy-3-(3-methoxy- -- 20% 20% -- propoxy)-propane
polyethylene glycol 20% 10% -- -- MW 400 NMP -- -- 30% 10% arom.
hydrocarbon mixture 75% 60% -- -- (C.sub.9-C.sub.12)
[0372] The solutions are suitable for use in the form of
microdrops.
TABLE-US-00004 F3. Wettable powders a) b) c) d) active ingredient
5% 25% 50% 80% sodium lignosulfonate 4% -- 3% -- sodium lauryl
sulphate 2% 3% -- 4% sodium -- 6% 5% 6% diisobutylnaphthalene-
sulfonate octylphenol polyglycol -- 1% 2% -- ether (7-8 mol of
ethylene oxide) highly dispersed silicic acid 1% 3% 5% 10% kaolin
88% 62% 35% --
[0373] The active ingredient is mixed thoroughly with the adjuvants
and the mixture is thoroughly ground in a suitable mill, affording
wettable powders which can be diluted with water to give
suspensions of any desired concentration.
TABLE-US-00005 F4. Coated granules a) b) c) active ingredient 0.1%
5% 15% highly dispersed silicic acid 0.9% 2% 2% inorganic carrier
99.0% 93% 83% (diameter 0.1-1 mm) e.g. CaCO.sub.3 or SiO.sub.2
[0374] The active ingredient is dissolved in methylene chloride and
applied to the carrier by spraying, and the solvent is then
evaporated off in vacuo.
TABLE-US-00006 F5. Coated granules a) b) c) active ingredient 0.1%
5% 15% polyethylene glycol MW 200 1.0% 2% 3% highly dispersed
silicic acid 0.9% 1% 2% inorganic carrier 98.0% 92% 80% (diameter
0.1-1 mm) e.g. CaCO.sub.3 or SiO.sub.2
[0375] The finely ground active ingredient is uniformly applied, in
a mixer, to the carrier moistened with polyethylene glycol.
Non-dusty coated granules are obtained in this manner.
TABLE-US-00007 F6. Extruder granules a) b) c) d) active ingredient
0.1% 3% 5% 15% sodium lignosulfonate 1.5% 2% 3% 4%
carboxymethylcellulose 1.4% 2% 2% 2% kaolin 97.0% 93% 90% 79%
[0376] The active ingredient is mixed and ground with the
adjuvants, and the mixture is moistened with water. The mixture is
extruded and then dried in a stream of air.
TABLE-US-00008 F7. Dusts a) b) c) active ingredient 0.1% 1% 5%
talcum 39.9% 49% 35% kaolin 60.0% 50% 60%
[0377] Ready-to-use dusts are obtained by mixing the active
ingredient with the carriers and grinding the mixture in a suitable
mill.
TABLE-US-00009 F8. Suspension concentrates a) b) c) d) active
ingredient 3% 10% 25% 50% ethylene glycol 5% 5% 5% 5% nonylphenol
polyglycol -- 1% 2% -- ether (15 mol of ethylene oxide) sodium
lignosulfonate 3% 3% 4% 5% carboxymethylcellulose 1% 1% 1% 1% 37%
aqueous formaldehyde 0.2% 0.2% 0.2% 0.2% solution silicone oil
emulsion 0.8% 0.8% 0.8% 0.8% water 87% 79% 62% 38%
[0378] The finely ground active ingredient is intimately mixed with
the adjuvants, giving a suspension concentrate from which
suspensions of any desired concentration can be obtained by
dilution with water.
[0379] Compounds of the invention (as well as mixtures and/or
compositions or formulations containing the same) find utility as
herbicides, and may thus be employed in methods of controlling
plant growth. Such methods involve applying to the plants or to the
locus thereof an herbicidally effective amount of said compound, or
composition comprising the same (or mixture as described
hereinafter). The invention thus also relates to a method of
inhibiting plant growth which comprises applying to the plants or
to the locus thereof a herbicidally effective amount of a compound
of formula (I), composition, or mixture of the invention. In
particular the invention provides a method of controlling weeds in
crops of useful plants, which comprising applying to said weeds or
the locus of said weeds, or to said crop of useful plants, a
compound of formula I or a composition or mixture containing the
same.
[0380] The term "locus" as used herein includes not only areas
where weeds may already be growing, but also areas where weeds have
yet to emerge, and also to areas under cultivation with respect to
crops of useful plants. Areas under cultivation include land on
which the crop plants are already growing and land intended for
cultivation with such crop plants.
[0381] A compound, composition, and/or mixture of the invention may
be used in a pre-emergence application and/or in a post-emergence
application in order to mediate its effect.
[0382] Crops of useful plants in which compounds of formula (I), as
well as formulations and/or mixtures containing the same, may be
used according to the invention include perennial crops, such as
citrus fruit, grapevines, nuts, oil palms, olives, pome fruit,
stone fruit and rubber, and annual arable crops, such as cereals,
for example barley and wheat, cotton, oilseed rape, maize, rice,
soy beans, sugar beet, sugar cane, sunflowers, ornamentals and
vegetables, especially cereals and maize.
[0383] Compounds of formula (I), formulations and/or mixtures
containing the same may also be used on turf, pasture, rangeland,
rights of way etc. In particular they may used on golf-courses,
lawns, parks, sports-fields, race-courses and the like.
[0384] Crops are to be understood as also including those crops
which have been rendered tolerant to herbicides or classes of
herbicides (e.g. ALS-, GS-, EPSPS-, PPO- and HPPD-inhibitors and
synthetic auxins) by conventional methods of breeding or by genetic
engineering. An example of a crop that has been rendered tolerant
to imidazolinones, e.g. imazamox, by conventional methods of
breeding is Clearfield.RTM. summer rape (canola). Examples of crops
that have been rendered tolerant to herbicides by genetic
engineering methods include e.g. glyphosate- and
glufosinate-resistant maize varieties commercially available under
the trade names RoundupReady.RTM. and LibertyLink.RTM., as well as
corn, soybean and cotton that have been engineered to be resistant
to Dicamba, phenoxypropionic acids, pyridyloxyacetic acids and/or
picolinate auxins.
[0385] Crops are also to be understood as being those which have
been rendered resistant to harmful insects by genetic engineering
methods, for example Bt maize (resistant to European corn borer),
Bt cotton (resistant to cotton boll weevil) and also Bt potatoes
(resistant to Colorado beetle). Examples of Bt maize are the Bt 176
maize hybrids of NK.RTM. (Syngenta Seeds). The Bt toxin is a
protein that is formed naturally by Bacillus thuringiensis soil
bacteria. Examples of toxins, or transgenic plants able to
synthesise such toxins, are described in EP-A-451 878, EP-A-374
753, WO 93/07278, WO 95/34656, WO 03/052073 and EP-A-427 529.
Examples of transgenic plants comprising one or more genes that
code for an insecticidal resistance and express one or more toxins
are KnockOut.RTM. (maize), Yield Gard.RTM. (maize), NuCOTIN33B.RTM.
(cotton), Bollgard.RTM. (cotton), NewLeaf.RTM. (potatoes),
NatureGard.RTM. and Protexcta.RTM.. Plant crops or seed material
thereof can be both resistant to herbicides and, at the same time,
resistant to insect feeding ("stacked" transgenic events). For
example, seed can have the ability to express an insecticidal Cry3
protein while at the same time being tolerant to glyphosate.
[0386] Crops are also to be understood as being those which are
obtained by conventional methods of breeding or genetic engineering
and contain so-called output traits (e.g. improved storage
stability, higher nutritional value and improved flavour).
[0387] The term "weeds" as used herein means any undesired plant,
and thus includes not only agronomically important weeds as
described below, but also volunteer crop plants.
[0388] Compounds of formula (I) may be used against a large number
of agronomically important weeds. The weeds that may be controlled
include both monocotyledonous and dicotyledonous weeds, such as,
for example, Alisma spp, Leptochloa chinensis, Stellaria,
Nasturtium, Agrostis, Digitaria, Avena, Setaria, Sinapis, Lolium,
Solanum, Echinochloa, Scirpus, Monochoria, Sagittaria, Bromus,
Alopecurus, Sorghum, Rottboellia, Cyperus, Abutilon, Sida,
Xanthium, Amaranthus, Ambrosia, Brachiaria, Bidens, Chenopodium,
Ipomoea, Chrysanthemum, Galium, Viola, Veronica, and Ischaemum
spp.
[0389] The rates of application of compounds of formula (I) may
vary within wide limits and depend on the nature of the soil, the
method of application (pre- or post-emergence; seed dressing;
application to the seed furrow; no tillage application etc.), the
crop plant, or weed to be controlled, the prevailing climatic
conditions, and other factors governed by the method of
application, the time of application and the target crop. The
compounds of formula I according to the invention are generally
applied at a rate of from 10 to 2000 g/ha, especially from 50 to
1000 g/ha.
[0390] Any method of application to weeds/crop of useful plant, or
locus thereof, which is routinely used in agriculture may be used,
for example application by spray or broadcast method typically
after suitable dilution of a compound of formula (I) (whether said
compound is formulated and/or in combination with one or more
further active ingredients and/or safeners, as described
herein).
[0391] The compounds of formula (I) according to the invention can
also be used in combination with other active ingredients, e.g.
other herbicides, and/or insecticides, and/or acaricides, and/or
nematocides, and/or molluscicides, and/or fungicides, and/or plant
growth regulators. Such mixtures, and the use of such mixtures to
control weeds and/or undesired plant growth form yet further
aspects of the invention. For the avoidance of doubt, mixtures of
invention also include mixtures of two or more different compounds
of formula (I).
Where a compound of formula (I) is combined with at least one
additional herbicide, the following mixtures of the compound of
formula (I) are particularly preferred. Compound of formula
(I)+acetochlor, compound of formula (I)+acifluorfen, compound of
formula (I)+acifluorfen-sodium, compound of formula (I)+aclonifen,
compound of formula (I)+acrolein, compound of formula (I)+alachlor,
compound of formula (I)+alloxydim, compound of formula (I)+allyl
alcohol, compound of formula (I)+ametryn, compound of formula
(I)+amicarbazone, compound of formula (I)+amidosulfuron, compound
of formula (I)+aminopyralid, compound of formula
(I)+aminocyclopyrachlor, compound of formula (I)+amitrole, compound
of formula (I)+ammonium sulfamate, compound of formula
(I)+anilofos, compound of formula (I)+asulam, compound of formula
(I)+atrazine, formula (I)+aviglycine, formula (I)+azafenidin,
compound of formula (I)+azimsulfuron, compound of formula (I)+BCPC,
compound of formula (I)+beflubutamid, compound of formula
(I)+benazolin, formula (I)+bencarbazone, compound of formula
(I)+benfluralin, compound of formula (I)+benfuresate, compound of
formula (I)+bensulfuron, compound of formula
(I)+bensulfuron-methyl, compound of formula (I)+bensulide, compound
of formula (I)+bentazone, compound of formula (I)+benzfendizone,
compound of formula (I)+benzobicyclon, compound of formula
(I)+benzofenap, compound of formula (I)+bifenox, compound of
formula (I)+bilanafos, compound of formula (I)+bispyribac, compound
of formula (I)+bispyribac-sodium, compound of formula (I)+borax,
compound of formula (I)+bromacil, compound of formula
(I)+bromobutide, formula (I)+bromophenoxim, compound of formula
(I)+bromoxynil, compound of formula (I)+butachlor, compound of
formula (I)+butafenacil, compound of formula (I)+butamifos,
compound of formula (I)+butralin, compound of formula
(I)+butroxydim, compound of formula (I)+butylate, compound of
formula (I)+cacodylic acid, compound of formula (I)+calcium
chlorate, compound of formula (I)+cafenstrole, compound of formula
(I)+carbetamide, compound of formula (I)+carfentrazone, compound of
formula (I)+carfentrazone-ethyl, compound of formula (I)+CDEA,
compound of formula (I)+CEPC, compound of formula
(I)+chlorflurenol, compound of formula (I)+chlorflurenol-methyl,
compound of formula (I)+chloridazon, compound of formula
(I)+chlorimuron, compound of formula (I)+chlorimuron-ethyl,
compound of formula (I)+chloroacetic acid, compound of formula
(I)+chlorotoluron, compound of formula (I)+chlorpropham, compound
of formula (I)+chlorsulfuron, compound of formula (I)+chlorthal,
compound of formula (I)+chlorthal-dimethyl, compound of formula
(I)+cinidon-ethyl, compound of formula (I)+cinmethylin, compound of
formula (I)+cinosulfuron, compound of formula (I)+cisanilide,
compound of formula (I)+clethodim, compound of formula
(I)+clodinafop, compound of formula (I)+clodinafop-propargyl,
compound of formula (I)+clomazone, compound of formula
(I)+clomeprop, compound of formula (I)+clopyralid, compound of
formula (I)+cloransulam, compound of formula
(I)+cloransulam-methyl, compound of formula (I)+CMA, compound of
formula (I)+4-CPB, compound of formula (I)+CPMF, compound of
formula (I)+4-CPP, compound of formula (I)+CPPC, compound of
formula (I)+cresol, compound of formula (I)+cumyluron, compound of
formula (I)+cyanamide, compound of formula (I)+cyanazine, compound
of formula (I)+cycloate, compound of formula (I)+cyclosulfamuron,
compound of formula (I)+cycloxydim, compound of formula
(I)+cyhalofop, compound of formula (I)+cyhalofop-butyl, compound of
formula (I)+2,4-D, compound of formula (I)+3,4-DA, compound of
formula (I)+daimuron, compound of formula (I)+dalapon, compound of
formula (I)+dazomet, compound of formula (I)+2,4-DB, compound of
formula (I)+3,4-DB, compound of formula (I)+2,4-DEB, compound of
formula (I)+desmedipham, formula (I)+desmetryn, compound of formula
(I)+dicamba, compound of formula (I)+dichlobenil, compound of
formula (I)+ortho-dichlorobenzene, compound of formula
(I)+para-dichlorobenzene, compound of formula (I)+dichlorprop,
compound of formula (I)+dichlorprop-P, compound of formula
(I)+diclofop, compound of formula (I)+diclofop-methyl, compound of
formula (I)+diclosulam, compound of formula (I)+difenzoquat,
compound of formula (I)+difenzoquat metilsulfate, compound of
formula (I)+diflufenican, compound of formula (I)+diflufenzopyr,
compound of formula (I)+dimefuron, compound of formula
(I)+dimepiperate, compound of formula (I)+dimethachlor, compound of
formula (I)+dimethametryn, compound of formula (I)+dimethenamid,
compound of formula (I)+dimethenamid-P, compound of formula
(I)+dimethipin, compound of formula (I)+dimethylarsinic acid,
compound of formula (I)+dinitramine, compound of formula
(I)+dinoterb, compound of formula (I)+diphenamid, formula
(I)+dipropetryn, compound of formula (I)+diquat, compound of
formula (I)+diquat dibromide, compound of formula (I)+dithiopyr,
compound of formula (I)+diuron, compound of formula (I)+DNOC,
compound of formula (I)+3,4-DP, compound of formula (I)+DSMA,
compound of formula (I)+EBEP, compound of formula (I)+endothal,
compound of formula (I)+EPTC, compound of formula (I)+esprocarb,
compound of formula (I)+ethalfluralin, compound of formula
(I)+ethametsulfuron, compound of formula
(I)+ethametsulfuron-methyl, formula (I)+ethephon, compound of
formula (I)+ethofumesate, compound of formula (I)+ethoxyfen,
compound of formula (I)+ethoxysulfuron, compound of formula
(I)+etobenzanid, compound of formula (I)+fenoxaprop, compound of
formula (I)+fenoxaprop-P, compound of formula (I)+fenoxaprop-ethyl,
compound of formula (I)+fenoxaprop-P-ethyl, compound of formula
(I)+fentrazamide, compound of formula (I)+ferrous sulfate, compound
of formula (I)+flamprop-M, compound of formula (I)+flazasulfuron,
compound of formula (I)+florasulam, compound of formula
(I)+fluazifop, compound of formula (I)+fluazifop-butyl, compound of
formula (I)+fluazifop-P, compound of formula (I)+fluazifop-P-butyl,
formula (I)+fluazolate, compound of formula (I)+flucarbazone,
compound of formula (I)+flucarbazone-sodium, compound of formula
(I)+flucetosulfuron, compound of formula (I)+fluchloralin, compound
of formula (I)+flufenacet, compound of formula (I)+flufenpyr,
compound of formula (I)+flufenpyr-ethyl, formula (I)+flumetralin,
compound of formula (I)+flumetsulam, compound of formula
(I)+flumiclorac, compound of formula (I)+flumiclorac-pentyl,
compound of formula (I)+flumioxazin, formula (I)+flumipropin,
compound of formula (I)+fluometuron, compound of formula
(I)+fluoroglycofen, compound of formula (I)+fluoroglycofen-ethyl,
formula (I)+fluoxaprop, formula (I)+flupoxam, formula
(I)+flupropacil, compound of formula (I)+flupropanate, compound of
formula (I)+flupyrsulfuron, compound of formula
(I)+flupyrsulfuron-methyl-sodium, compound of formula (I)+flurenol,
compound of formula (I)+fluridone, compound of formula
(I)+fluorochloridone, compound of formula (I)+fluoroxypyr, compound
of formula (I)+flurtamone, compound of formula (I)+fluthiacet,
compound of formula (I)+fluthiacet-methyl, compound of formula
(I)+fomesafen, compound of formula (I)+foramsulfuron, compound of
formula (I)+fosamine, compound of formula (I)+glufosinate, compound
of formula (I)+glufosinate-ammonium, compound of formula
(I)+glyphosate, compound of formula (I)+halosulfuron, compound of
formula (I)+halosulfuron-methyl, compound of formula (I)+haloxyfop,
compound of formula (I)+haloxyfop-P, compound of formula
(I)+HC-252, compound of formula (I)+hexazinone, compound of formula
(I)+imazamethabenz, compound of formula (I)+imazamethabenz-methyl,
compound of formula (I)+imazamox, compound of formula (I)+imazapic,
compound of formula (I)+imazapyr, compound of formula
(I)+imazaquin, compound of formula (I)+imazethapyr, compound of
formula (I)+imazosulfuron, compound of formula (I)+indanofan,
compound of formula (I)+iodomethane, compound of formula
(I)+iodosulfuron, compound of formula
(I)+iodosulfuron-methyl-sodium, compound of formula (I)+ioxynil,
compound of formula (I)+isoproturon, compound of formula
(I)+isouron, compound of formula (I)+isoxaben, compound of formula
(I)+isoxachlortole, compound of formula (I)+isoxaflutole, formula
(I)+isoxapyrifop, compound of formula (I)+karbutilate, compound of
formula (I)+lactofen, compound of formula (I)+lenacil, compound of
formula (I)+linuron, compound of formula (I)+MAA, compound of
formula (I)+MAMA, compound of formula (I)+MCPA, compound of formula
(I)+MCPA-thioethyl, compound of formula (I)+MCPB, compound of
formula (I)+mecoprop, compound of formula (I)+mecoprop-P, compound
of formula (I)+mefenacet, compound of formula (I)+mefluidide,
compound of formula (I)+mesosulfuron, compound of formula
(I)+mesosulfuron-methyl, compound of formula (I)+mesotrione,
compound of formula (I)+metam, compound of formula (I)+metamifop,
compound of formula (I)+metamitron, compound of formula
(I)+metazachlor, compound of formula (I)+methabenzthiazuron,
formula (I)+methazole, compound of formula (I)+methylarsonic acid,
compound of formula (I)+methyldymron, compound of formula
(I)+methyl isothiocyanate, compound of formula (I)+metobenzuron,
formula (I)+metobromuron, compound of formula (I)+metolachlor,
compound of formula (I)+S-metolachlor, compound of formula
(I)+metosulam, compound of formula (I)+metoxuron, compound of
formula (I)+metribuzin, compound of formula (I)+metsulfuron,
compound of formula (I)+metsulfuron-methyl, compound of formula
(I)+MK-616, compound of formula (I)+molinate, compound of formula
(I)+monolinuron, compound of formula (I)+MSMA, compound of formula
(I)+naproanilide, compound of formula (I)+napropamide, compound of
formula (I)+naptalam, formula (I)+NDA-402989, compound of formula
(I)+neburon, compound of formula (I)+nicosulfuron, formula
(I)+nipyraclofen, formula (I)+n-methyl glyphosate, compound of
formula (I)+nonanoic acid, compound of formula (I)+norflurazon,
compound of formula (I)+oleic acid (fatty acids), compound of
formula (I)+orbencarb, compound of formula (I)+orthosulfamuron,
compound of formula (I)+oryzalin, compound of formula
(I)+oxadiargyl, compound of formula (I)+oxadiazon, compound of
formula (I)+oxasulfuron, compound of formula (I)+oxaziclomefone,
compound of formula (I)+oxyfluorfen, compound of formula
(I)+paraquat, compound of formula (I)+paraquat dichloride, compound
of formula (I)+pebulate, compound of formula (I)+pendimethalin,
compound of formula (I)+penoxsulam, compound of formula
(I)+pentachlorophenol, compound of formula (I)+pentanochlor,
compound of formula (I)+pentoxazone, compound of formula
(I)+pethoxamid, compound of formula (I)+petrolium oils, compound of
formula (I)+phenmedipham, compound of formula
(I)+phenmedipham-ethyl, compound of formula (I)+picloram, compound
of formula (I)+picolinafen, compound of formula (I)+pinoxaden,
compound of formula (I)+piperophos, compound of formula
(I)+potassium arsenite, compound of formula (I)+potassium azide,
compound of formula (I)+pretilachlor, compound of formula
(I)+primisulfuron, compound of formula (I)+primisulfuron-methyl,
compound of formula (I)+prodiamine, compound of formula
(I)+profluazol, compound of formula (I)+profoxydim, formula
(I)+prohexadione-calcium, compound of formula (I)+prometon,
compound of formula (I)+prometryn, compound of formula
(I)+propachlor, compound of formula (I)+propanil, compound of
formula (I)+propaquizafop, compound of formula (I)+propazine,
compound of formula (I)+propham, compound of formula
(I)+propisochlor, compound of formula (I)+propoxycarbazone,
compound of formula (I)+propoxycarbazone-sodium, compound of
formula (I)+propyzamide, compound of formula (I)+prosulfocarb,
compound of formula (I)+prosulfuron, compound of formula
(I)+pyraclonil, compound of formula (I)+pyraflufen, compound of
formula (I)+pyraflufen-ethyl, formula (I)+pyrasulfotole, compound
of formula (I)+pyrazolynate, compound of formula
(I)+pyrazosulfuron, compound of formula (I)+pyrazosulfuron-ethyl,
compound of formula (I)+pyrazoxyfen, compound of formula
(I)+pyribenzoxim, compound of formula (I)+pyributicarb, compound of
formula (I)+pyridafol, compound of formula (I)+pyridate, compound
of formula (I)+pyriftalid, compound of formula (I)+pyriminobac,
compound of formula (I)+pyriminobac-methyl, compound of formula
(I)+pyrimisulfan, compound of formula (I)+pyrithiobac, compound of
formula (I)+pyrithiobac-sodium, formula (I)+pyroxasulfone, formula
(I)+pyroxulam, compound of formula (I)+quinclorac, compound of
formula (I)+quinmerac, compound of formula (I)+quinoclamine,
compound of formula (I)+quizalofop, compound of formula
(I)+quizalofop-P, compound of formula (I)+quizalofop-ethyl,
compound of formula (I)+quizalofop-P-ethyl, compound of formula
(I)+rimsulfuron, compound of formula (I)+sethoxydim, compound of
formula (I)+siduron, compound of formula (I)+simazine, compound of
formula (I)+simetryn, compound of formula (I)+SMA, compound of
formula (I)+sodium arsenite, compound of formula (I)+sodium azide,
compound of formula (I)+sodium chlorate, compound of formula
(I)+sulcotrione, compound of formula (I)+sulfentrazone, compound of
formula (I)+sulfometuron, compound of formula
(I)+sulfometuron-methyl, compound of formula (I)+sulfosate,
compound of formula (I)+sulfosulfuron, compound of formula
(I)+sulfuric acid, compound of formula (I)+tar oils, compound of
formula (I)+2,3,6-TBA, compound of formula (I)+TCA, compound of
formula (I)+TCA-sodium, formula (I)+tebutam, compound of formula
(I)+tebuthiuron, formula (I)+tefuryltrione, compound of formula
1+tembotrione, compound of formula (I)+tepraloxydim, compound of
formula (I)+terbacil, compound of formula (I)+terbumeton, compound
of formula (I)+terbuthylazine, compound of formula (I)+terbutryn,
compound of formula (I)+thenylchlor, compound of formula
(I)+thiazafluoron, compound of formula (I)+thiazopyr, compound of
formula (I)+thifensulfuron, compound of formula (I)+thiencarbazone,
compound of formula (I)+thifensulfuron-methyl, compound of formula
(I)+thiobencarb, compound of formula (I)+tiocarbazil, compound of
formula (I)+topramezone, compound of formula (I)+tralkoxydim,
compound of formula (I)+tri-allate, compound of formula
(I)+triasulfuron, compound of formula (I)+triaziflam, compound of
formula (I)+tribenuron, compound of formula (I)+tribenuron-methyl,
compound of formula (I)+tricamba, compound of formula
(I)+triclopyr, compound of formula (I)+trietazine, compound of
formula (I)+trifloxysulfuron, compound of formula
(I)+trifloxysulfuron-sodium, compound of formula (I)+trifluralin,
compound of formula (I)+triflusulfuron, compound of formula
(I)+triflusulfuron-methyl, compound of formula (I)+trifop, compound
of formula (I)+trifop-methyl, compound of formula
(I)+trihydroxytriazine, compound of formula (I)+trinexapac-ethyl,
compound of formula (I)+tritosulfuron, compound of formula
(I)+[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-
-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetic acid ethyl
ester (CAS RN 353292-31-6), compound of formula
(I)+4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyrid-
inyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one (CAS RN 352010-68-5),
and compound of formula
(I)+4-hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carb-
onyl]-bicyclo[3.2.1]oct-3-en-2-one.
[0393] Whilst two-way mixtures of a compound of formula (I) and
another herbicide are explicitly disclosed above, the skilled man
will appreciate that the invention extends to three-way, and
further multiple combinations comprising the above two-way
mixtures.
[0394] In preferred embodiments a compound of formula (I) is
combined with an acetolactate synthase inhibitor, (e.g. one or more
of florasulam, metsulfuron, thifensulfuron, tribenuron,
triasulfuron, flucarbazone, flupyrsulfuron, iodosulfuron,
mesosulfuron, propoxicarbazone, sulfosulfuron, pyroxsulam and
tritosulfuron, as well as salts or esters thereof), a synthetic
auxin herbicide (e.g. one or more of aminocyclopyrachlor,
aminopyralid, clopyralid, 2,4-D, 2,4-DB, dicamba, dichlorprop,
fluoroxypyr, MCPA, MCPB, mecopropand mecoprop-P), an
ACCase-inhibiting herbicide (e.g. one or more of phenylpyrazolin;
pinoxaden; an aryloxyphenoxypropionic herbicide such as clodinafop,
cyhalofop, diclofop, fenoxaprop, fluazifop, haloxyfop, quizalofop,
trifop and mixtures thereof, as well as the isomers thereof, for
example, fenoxaprop-P, fluazifop-P, haloxyfop-P, quizalofop-P; and
a cyclohexanedione herbicide such as alloxydim; butroxydim,
clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim and
tralkoxydim, as well as salts or esters thereof), and/or an auxin
transport inhibitor such as semicarbazone (e.g. diflufenzopyr, in
particular the sodium salt) or phthalamate compound (e.g.
naptalam).
[0395] Particularly preferred mixture partners for compounds of
formula (I) are: florasulam, iodosulfuron-methyl-sodium,
mesosulfuron-methyl, metsulfuron-methyl, thifensulfuron,
triasulfuron, tribenuron-methyl or pyroxsulam; dicamba,
fluoroxypyr, MCPA, mecoprop or mecoprop-P; clodinafop-propargyl,
cyhalofop-butyl, diclofop-methyl, fenoxaprop-ethyl,
fenoxaprop-P-ethyl, fluazifop-butyl, fluazifop-P-butyl,
haloxyfop-methyl, haloxyfop-P-methyl, pinoxaden, propaquizafop,
quizalofop-ethyl, quizalofop-P-ethyl, tralkoxydim, trifop-methyl,
diflufenzopyr-Na, and naptalam.
[0396] For the avoidance of doubt, even if not explicitly stated
above, the mixing partners of the compound of formula (I) may also
be in the form of any suitable agrochemically acceptable ester or
salt, as mentioned e.g. in The Pesticide Manual, Thirteenth
Edition, British Crop Protection Council, 2003.
[0397] The mixing ratio of the compound of formula (I) to the
mixing partner is preferably from 1:100 to 1000:1.
[0398] The mixtures can advantageously be used in the
above-mentioned formulations (in which case "active ingredient"
relates to the respective mixture of compound of formula (I) with
the mixing partner).
[0399] The compounds of formula (I) according to the invention can
also be used in combination with one or more safeners. Likewise,
mixtures of a compound of formula (I) according to the invention
with one or more further active ingredients, in particular with one
or more further herbicides, can also be used in combination with
one or more safeners. Suitable safeners for use in combination with
compounds of formula (I) include AD 67 (MON 4660), benoxacor,
cloquintocet-mexyl, cyometrinil and the corresponding (Z) isomer,
cyprosulfamide (CAS RN 221667-31-8), dichlormid,
fenchlorazole-ethyl, fenclorim, flurazole, fluxofenim, furilazole
and the corresponding R isomer, isoxadifen-ethyl, mefenpyr-diethyl,
oxabetrinil, naphthalic anhydride (CAS RN 81-84-5) and
N-isopropyl-4-(2-methoxy-benzoylsulfamoyl)-benzamide (CAS RN
221668-34-4). Particularly preferred safeners for use in the
invention are cloquintocet-mexyl, cyprosulfamide,
fenchlorazole-ethyl and mefenpyr-diethyl. The safeners of the
compound of formula (I) may also be in the form of esters or salts,
as mentioned e.g. in The Pesticide Manual, 13.sup.th Edition supra.
The reference to cloquintocet-mexyl also applies to a lithium,
sodium, potassium, calcium, magnesium, aluminium, iron, ammonium,
quaternary ammonium, sulfonium or phosphonium salt thereof as
disclosed in WO02/34048, and the reference to fenchlorazole-ethyl
also applies to fenchlorazole, etc.
[0400] Preferably the mixing ratio of compound of formula (I) to
safener is from 100:1 to 1:10, especially from 20:1 to 1:1.
[0401] The mixtures can advantageously be used in the
above-mentioned formulations (in which case "active ingredient"
relates to the respective mixture of compound of formula (I) with
the safener).
[0402] Preferred mixtures of a compound of formula (I) with further
herbicides and safeners include: a compound of formula
(I)+pinoxaden+cloquinctocet-mexyl, a compound of formula
(I)+clodinafop+cloquintocet-mexyl, and a compound of formula
(I)+clodinafop-propargyl+cloquintocet-mexyl.
[0403] Various aspects and embodiments of the present invention
will now be illustrated in more detail by way of example. It will
be appreciated that modification of detail may be made without
departing from the scope of the invention.
[0404] For the avoidance of doubt, where a literary reference,
patent application, or patent, is cited within the text of this
application, the entire text of said citation is herein
incorporated by reference.
EXAMPLES
Example 1
Synthesis of 2-cyclopropyl-4,5-dichloro-6-methoxycarbonyl
pyrimidine
1.1 Preparation of Cyclopropylcarboxamidine Hydrochloride Salt
##STR00097##
[0406] Hydrogen chloride gas was bubbled through a stirred solution
of cyclopropylcarbonitrile (10.0 g, 0.15 mol) and methanol (6 ml,
0.15 mol) in dry ether (60 ml) at 0.degree. C. for 2 hours. The
reaction mixture was evaporated under reduced pressure and the
residue dissolved in methanol (125 ml). The solution was added to
an ice-cold mixture of methanol (125 ml) and liquid ammonia (15 ml)
and the mixture stirred for 1 hour. The resulting clear solution
was evaporated to leave cyclopropylcarboxamidine hydrochloride salt
as a white solid (12.0 g, 67%).
[0407] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 8.75 (2H,
s), 8.64 (2H, s), 1.81 (1H, quintet), 1.11 (4H, s) ppm.
1.2 Preparation of 2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic
acid
##STR00098##
[0409] A solution of sodium hydroxide (2.85 g, 71.3 mmol) in water
(3 ml) was added to a stirred solution of diethyl oxaloacetate
sodium salt (8.7 g, 50 mmol) in water (50 ml) and the mixture
stirred for 20 minutes. Cyclopropylcarboxamidine hydrochloride salt
(5.0 g, 40 mmol) was added to the solution and the mixture was
heated at 70.degree. C. overnight, then cooled to ambient
temperature and acidified to pH1 by the cautious addition of
concentrated hydrochloric acid. The precipitate was isolated by
filtration and dried to yield
2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic acid (4.7 g,
63%).
[0410] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 13.30 (1H,
br s), 12.97 (1H, br s), 6.59 (1H, s), 1.94 (1H, quintet), 1.04
(4H, m) ppm.
1.3 Preparation of
5-chloro-2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic acid
##STR00099##
[0412] Aqueous sodium hypochlorite (470 ml) was added to a solution
of 2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic acid (68.7 g,
0.38 mol) in concentrated hydrochloric acid (280 ml) and water (412
ml), maintaining the temperature below 15.degree. C. during the
course of the addition. The reaction mixture was stirred for 12
hours at ambient temperature, then sodium metabisulphite (6.87 g)
and sodium hydroxide (50% aqueous solution; 29.0 g) were added,
maintaining the temperature below 15.degree. C. during the
addition. The precipitate was removed by filtration and dried to
provide 5-chloro-2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic
acid (54 g, 66%).
[0413] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 14.10 (1H,
br s), 13.43 (1H, br s), 1.95 (1H, m), 1.08 (2H, m), 1.04 (2H, m)
ppm.
1.4 Preparation of
2-cyclopropyl-4,5-dichloropyrimidine-6-carboxylic acid
##STR00100##
[0415] A mixture of
5-chloro-2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic acid (10.0
g, 40 mmol) and phosphorus oxychloride (21.5 ml) was heated at
reflux for 12 hours. The mixture was allowed to cool to ambient
temperature and then added carefully to iced water and the
resulting mixture extracted with ether. The combined ether layers
were washed successively with water and brine, dried over sodium
sulphate, filtered and the filtrate evaporated under reduced
pressure to provide
2-cyclopropyl-4,5-dichloropyrimidine-6-carboxylic acid as a brown
solid (7.0 g, 64%).
[0416] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 3.37 (1H,
br s), 2.24 (1H, m), 1.16 (2H, m), 1.08 (2H, m) ppm.
1.5 Preparation of
2-cyclopropyl-4,5-dichloro-6-methoxycarbonylpyrimidine
##STR00101##
[0418] An excess of freshly prepared diazomethane was added to a
solution of 2-cyclopropyl-4,5-dichloropyrimidine-6-carboxylic acid
(50.0 g, 0.21 mol) in ether (1.5 l) at 0.degree. C. After stirring
for 15 minutes the reaction mixture was concentrated under reduced
pressure to leave a brown oil. The residue was purified by column
chromatography on silica using 10% ethyl acetate in hexane as
eluent to provide
2-cyclopropyl-4,5-dichloro-6-methoxycarbonylpyrimidine (45.0 g,
85%) as a yellow oil, which solidified upon cooling. .sup.1H nmr
(400 MHz, d.sub.6-DMSO) .delta..sub.H 3.95 (3H, s), 2.25 (1H,
quintet), 1.17 (2H, m), 1.03 (2H, m) ppm.
[0419] Further examples, prepared using the general method of
Example 1, are given in Table 2 below.
TABLE-US-00010 TABLE 2 Compounds made according to the general
method described in Example 1 above. Characteristic data is .sup.1H
nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Name Structure
Characteristic data 2-(4-Chloro-2-fluoro-3-
methoxyphenyl)-4,5-dichloro-6- methoxycarbonylpyrimidine
##STR00102## 7.78 (1H, dd), 7.26 (1H, dd), 4.05 (3H, s), 4.01 (3H,
s)
Example 2
Synthesis of 4-amino-5-chloro-2-cyclopropyl-6-methoxycarbonyl
pyrimidine
##STR00103##
[0421] A mixture of
2-cyclopropyl-4,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in Example 1) (2.5 g, 10 mmol), ammonia (7M solution in
methanol; 6 ml, 42 mmol) and methanol (8.3 ml) was heated in a
microwave reactor at 120.degree. C. for 20 minutes, then allowed to
cool to ambient temperature. The solvent was evaporated under
reduced pressure and the residue recrystallised from methanol to
provide a white solid. The solid was dissolved in chloroform and
the resulting solution washed with water and brine, dried over
magnesium sulphate, filtered and the filtrate evaporated under
reduced pressure to provide
4-amino-5-chloro-2-cyclopropyl-6-methoxycarbonylpyrimidine as a
white solid (0.77 g, 38%).
[0422] .sup.1H nm r (400 MHz, CDCl.sub.3) .delta..sub.H 5.40 (2H,
br s), 4.00 (3H, s), 2.10 (1H, m), 1.10 (4H, m) ppm.
Example 3
Synthesis of
5-chloro-2-cyclopropyl-4-dimethylamino-6-methoxycarbonylpyrimidine
##STR00104##
[0424] A mixture of
2-cyclopropyl-4,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in example 1) (0.5 g, 2.0 mmol), dimethylamine
hydrochloride (325 mg, 4.0 mmol), triethylamine (0.55 ml, 4.0 mmol)
and dichloromethane (7 ml) was stirred at ambient temperature for 4
hours. Ethyl acetate was added and the solution washed with brine,
dried over magnesium sulphate, filtered and the filtrate evaporated
under reduced pressure to provide
5-chloro-2-cyclopropyl-4-dimethylamino-6-methoxycarbonyl-pyrimidine
as a white solid (0.46 g, 90%).
[0425] .sup.1H nm r (400 MHz, CDCl.sub.3) .delta..sub.H 4.00 (3H,
s), 3.20 (6H, s), 2.10 (1H, m), 1.00 (4H, m) ppm.
Example 4
synthesis of 4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine
4.1 Preparation of 2,4-dihydroxy-6-methoxycarbonylpyrimidine
(methyl orotate)
##STR00105##
[0427] Thionyl chloride (500 ml), pyridine (2.5 ml) and a few drops
of dimethylformamide were added to orotic acid monohydrate (78 g,
0.44 mol). The reaction mixture was stirred at RT for 5 days and
then heated under reflux for an additional 14 hours. After cooling
the solid material was allowed to settle and the supernatant
decanted. The solid residue was washed with hexane and dried.
Methanol (700 ml) was added dropwise with agitation to the solid.
Once the rate of the gas formation slowed, the mixture was heated
at reflux overnight and then cooled to 4-5.degree. C. The solid was
removed by filtration and washed with methanol and ether to provide
methyl orotate (73 g, 97%).
[0428] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 11.41 (1H,
s), 11.26 (1H, s), 6.04 (1H, s), 3.84 (3H, s) ppm.
4.2 Preparation of
5-chloro-2,4-dihydroxy-6-methoxycarbonylpyrimidine
##STR00106##
[0430] A catalytic quantity of ferric chloride was added to a
solution of methyl orotate (34 g, 0.20 mol) in acetic anhydride (5%
solution in glacial acetic acid, 500 ml). The mixture was heated to
90-95.degree. C. and sulphuryl chloride (54 g, 0.40 mol) was added
dropwise. After the addition was complete, the solution was slowly
brought to reflux with agitation and heating was continued
overnight. The solution was cooled to 18.degree. C. and the solid
was removed by filtration. The solid was washed with acetic acid
and then with water, and dried to give
5-chloro-2,4-dihydroxy-6-methoxycarbonylpyrimidine (36.0 g,
89%).
[0431] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 11.86 (1H,
s), 11.62 (1H, s), 3.88 (3H, s) ppm.
4.3 Preparation of 6-methoxycarbonyl-2,4,5-trichloropyrimidine
##STR00107##
[0433] Phosphorus oxychloride (993 ml) was added to
5-chloro-2,4-dihydroxy-6-methoxycarbonylpyrimidine (30.0 g, 0.146
mol) at 10.degree. C. and the resulting solution cooled to
0.degree. C. N,N-Diethyl aniline (30.9 ml, 0.193 mol) was added
dropwise to the stirred solution. After the addition was complete,
the reaction mixture was allowed to warm slowly to ambient
temperature and was then heated at reflux overnight. The resulting
solution was cooled and concentrated under reduced pressure. The
residue was poured onto crushed ice (600 g) and extracted with cold
ether. The ether extracts were washed with brine, dried over sodium
sulphate, filtered and evaporated under reduced pressure to give a
light brown solid. This was triturated with warm hexane to yield
6-methoxycarbonyl-2,4,5-trichloropyrimidine (28 g, 82%).
[0434] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.02 (3H, s)
ppm.
4.4 Preparation of
4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine
##STR00108##
[0436] Aqueous ammonia (30% solution; 8.0 ml, 0.42 mol) was added
dropwise to a stirred solution of
6-methoxycarbonyl-2,4,5-trichloropyrimidine (20.0 g, 0.083 mol) in
THF (1000 ml) at 0.degree. C. The reaction mixture was stirred at
0.degree. C. for 1 hour and then filtered. The filtrate was
evaporated under reduced pressure to give a white solid that was
washed with twice with hexane and dried under vacuum to provide
4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine (15.0 g, 82%).
[0437] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.H 8.57 (1H,
br s), 7.94 (1H, br s), 3.88 (3H, s) ppm.
Example 5
Synthesis of
4-amino-5-chloro-6-methoxycarbonyl-2-(4-trifluoro-methylphenyl)-pyrimidin-
e
##STR00109##
[0439] 4-Trifluoromethylphenyl boronic acid (190 mg, 1.0 mmol),
4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in example 4) (221 mg, 1.0 mmol), caesium fluoride (302
mg, 2.0 mmol) and [1,1'-bis(diphenylphosphino)-ferrocene]
dichloropalladium (II) complex with dichloromethane (1:1) (82 mg,
0.10 mmol) were placed in a vial. The vial was evacuated and
backfilled with nitrogen before adding dimethoxyethane (2 ml) and
water (2 ml). The reaction mixture was heated in a microwave
reactor at 140.degree. C. for 20 minutes, then allowed to cool and
filtered through a plug of silica, washing with ethyl acetate. The
filtrate was evaporated under reduced pressure and the crude
product purified by chromatography on silica using a gradient of
hexane/ethyl acetate (100:0 to 3:2) as eluent to provide
4-amino-5-chloro-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-pyrimidine
as a pale yellow solid (102 mg, 31%).
[0440] M.p. 204-205.degree. C.; .sup.1H nm r (400 MHz, CDCl.sub.3)
.delta..sub.H 8.50 (2H, d), 7.70 (2H, d), 5.60 (2H, br s), 4.00
(3H, s) ppm.
[0441] Further compounds, prepared using this general method, are
listed in Table 3 below.
TABLE-US-00011 TABLE 3 Compounds made according to the general
method described in Example 5 above. Characteristic data provided
is either melting point (.degree. C.) and/or 1H-nmr data (400 MHz,
CDCl.sub.3) .delta..sub.H ppm Characteristic Name Structure data
4-Amino-5- chloro-2-(4- chloro- phenyl)- 6-methoxy- carbonyl-
pyrimidine ##STR00110## 8.30 (2H, d), 7.4 (2H, d), 5.5 (2H, br s),
4.00 (3H, s) 4-Amino-5- chloro-2-(4- chloro-2- fluoro-3- methoxy-
phenyl)-6- methoxy- carbonyl- pyrimidine ##STR00111## 141-142
4-Amino-5- chloro-2-(4- chloro-3- dimethyl- amino-2- fluoro-
phenyl)- 6-methoxy- carbonyl- pyrimidine ##STR00112## 7.60 (1H,
dd), 7.20 (1H, dd), 5.70 (2H, br s), 4.00 (3H, s), 2.9 (6H, s)
Example 6
Synthesis of
4-amino-2-cyclopropyl-6-methoxycarbonyl-4-methylpyrimidine
(compound 2-41)
##STR00113##
[0443] A mixture of methyl boronic acid (45 mg, 0.75 mmol),
4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in example 4) (114 mg, 0.50 mmol), palladium acetate (11
mg, 0.05 mmol), sodium
2-(dicyclohexylphosphino)-2',6'-dimethoxybiphenyl-3'-sulphonate (38
mg, 0.075 mmol), potassium phosphate (212 mg, 1 mmol), toluene (2
ml) and water (0.4 ml) was heated in a microwave reactor at
110.degree. C. for 40 minutes. The reaction mixture was allowed to
cool and the solvent evaporated under reduced pressure. The residue
was purified by chromatography on silica with 40% ethyl acetate in
hexane as eluent to provide
4-amino-2-cyclopropyl-6-methoxycarbonyl-4-methylpyrimidine as an
orange solid (27 mg, 26%).
[0444] M.p. 152-153.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 4.92 (2H, br s), 3.95 (3H, s), 2.18 (3H, s), 2.07
(1H, m), 1.03 (2H, m), 0.95 (2H, m) ppm.
[0445] Further compounds, prepared using this general method, are
listed in Table 4 below.
TABLE-US-00012 TABLE 4 Compounds made according to the general
method described in Example 6 above. Characteristic data provided
is either melting point (.degree. C.) and/or 1H- nmr data (400 MHz,
CDCl.sub.3) .delta..sub.H ppm Compound Number Name Structure
Characteristic data 5-41 4-Amino-2-(4- chlorophenyl)-6-
methoxycarbonyl- 4- methylpyrimidine ##STR00114## 206-208 27-41
4-Amino-2-(4- chloro-2-fluoro-3- methoxyphenyl)- 6-
methoxycarbonyl- 4- methylpyrimidine ##STR00115## 7.60 (1H, t),
7.20 (1H, d), 5.10 (2H, br s), 4.00 (3H, s), 3.95 (3H, s), 2.30
(3H, s) 60-41 4-Amino-2-(2- fluoro-3-methoxy- 4-methylphenyl)- 6-
methoxycarbonyl- 4- methylpyrimidine ##STR00116## 7.50 (1H, t),
7.00 (1H, d), 5.10 (2H, br s), 3.95 (3H, s), 3.90 (3H, s), 2.30
(3H, s), 2.25 (3H, s) 33-41 4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-6- methoxycarbonyl- 4-
methylpyrimidine ##STR00117## 7.60 (1H, t), 7.20 (1H, dd), 5.20
(2H, br s), 3.90 (3H, s), 2.90 (6H, s), 2.30 (3H, s)
Example 7
Synthesis of
4-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-cyclopropyl-6-metho-
xycarbonylpyrimidine (compound 33-58)
##STR00118##
[0447] A mixture of
4-amino-5-chloro-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-6-methoxycar-
bonylpyrimidine (prepared as described in example 5) (500 mg, 1.4
mmol), cyclopropyl boronic acid (144 mg, 1.68 mmol), palladium
acetate (16 mg, 0.072 mmol), tricyclohexylphosphine
tetrafluoroborate (52 mg, 0.14 mmol), potassium phosphate (890 mg,
4.2 mmol), toluene (9 ml) and water (1 ml) was purged with
nitrogen, then heated in a microwave reactor at 160.degree. C. for
30 minutes. The reaction mixture was allowed to cool, water added
and the resulting mixture extracted with dichloromethane. The
organic phase was washed with brine, dried over magnesium sulphate,
filtered and evaporated under reduced pressure. The residue was
purified by chromatography on silica using hexane/ethyl acetate
(first 8:2, then 6:4) as eluent to provide
4-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-cyclopropyl-6-metho-
xycarbonylpyrimidine as an off-white solid (178 mg, 35%).
[0448] M.p. 156-158.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 7.60 (1H, t), 7.20 (1H, dd), 5.50 (2H, br s), 4.00
(3H, s), 2.90 (6H, s), 1.70 (1H, m), 1.00 (2H, m), 0.60 (2H, m)
ppm.
[0449] Further examples, prepared using this general method, are
listed in Table 5 below.
TABLE-US-00013 TABLE 5 Compounds made according to the general
method described in Example 7 above. Characteristic data is .sup.1H
nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Compound No. Name
Structure Characteristic data 27-58 4-Amino-2-(4-chloro-2-
fluoro-3- methoxyphenyl)-5- cyclopropyl-6- methoxycarbonyl-
pyrimidine ##STR00119## 7.60 (1H, t), 7.20 (1H, dd), 5.50 (2H, br
s), 4.00 (6H, s), 1.70 (1H, m), 1.00 (2H, m), 0.60 (2H, m)
Example 8
Synthesis of
5-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-6-ethenyl-6-methoxyca-
rbonylpyrimidine (compound 33-61)
##STR00120##
[0451] Vinyl boronic acid pinacol ester (86 .mu.l, 0.51 mmol),
4-amino-5-chloro-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-6-methoxycar-
bonyl-pyrimidine (prepared as described in example 5) (165 mg, 0.46
mmol), caesium fluoride (139 mg, 0.92 mmol) and
[1,1'-bis(diphenylphosphino)-ferrocene] dichloropalladium (II)
complex with dichloromethane (1:1) (38 mg, 46 .mu.mol) were placed
in a vial. The vial was evacuated and backfilled with nitrogen
before adding dimethoxyethane (2 ml) and water (2 ml). The reaction
mixture was heated in a microwave reactor at 140.degree. C. for 20
minutes, then allowed to cool and filtered through a plug of
silica, washing with ethyl acetate. The filtrate was evaporated
under reduced pressure and the crude product purified by
chromatography on silica using a gradient of hexane/ethyl acetate
(100:0 to 8:2) as eluent to provide
5-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-ethenyl-6-methoxyca-
rbonylpyrimidine as a solid (68 mg, 42%).
[0452] M.p. 136-137.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 7.60 (1H, t), 7.20 (1H, dd), 6.80 (1H, dd), 5.70 (2H,
m), 5.40 (2H, br s), 3.90 (3H, s), 2.90 (6H, s) ppm.
[0453] Further compounds, prepared using this general method, are
listed in Table 6 below.
TABLE-US-00014 TABLE 6 Compounds made according to the general
method described in Example 8 above. Characteristic data provided
is either melting point (.degree. C.) and/or 1H- nmr data (400 MHz,
CDCl.sub.3) .delta..sub.H ppm Compound No. Name Structure
Characteristic data 2-61 4-Amino-2- cyclopropyl-5- ethenyl-6-
methoxycarbonyl- pyrimidine ##STR00121## 6.74 (1H, dd), 5.60 (1H,
dd), 5.50 (1H, dd), 5.18 (2H, br s), 3.91 (3H, s), 2.10 (1H, m),
1.05 (2H, m), 0.97 (2H, m) 5-61 4-Amino-2-(4- chlorophenyl)-5-
ethenyl-6- methoxycarbonyl- pyrimidine ##STR00122## 165-167 2-64
4-Amino-2- cyclopropyl-6- methoxycarbonyl- 5-(prop-1-en-2-
yl)-pyrimidine ##STR00123## 140-142 2-65 4-Amino-2- cyclopropyl-6-
methoxycarbonyl- 5-(pent-1-enyl)- pyrimidine ##STR00124## 6.30 (1H,
d), 5.90 (1H, dd), 5.10 (2H, br s), 3.90 (3H, s), 2.20 (2H, m),
2.10 (1H, m), 1.50 (2H, m), 1.10 (2H, m), 0.90 (5H, m) 2-66
4-Amino-2- cyclopropyl-5-(2- cyclopropyl- ethenyl)-6-
methoxycarbonyl- pyrimidine ##STR00125## 156-157 2-62 (Z isomer)
(Z)-4-Amino-2- cyclopropyl-6- methoxycarbonyl- 5-(prop-1-enyl)-
pyrimidine ##STR00126## 120-121 2-62 (E isomer) (E)-4-Amino-2-
cyclopropyl-6- methoxycarbonyl- 5-(prop-1-enyl)- pyrimidine
##STR00127## 147-148 27-61 4-Amino-2-(4- chloro-2-fluoro-3-
methoxyphenyl)- 5-ethenyl-6- methoxycarbonyl- pyrimidine
##STR00128## 146-148 2-77 4-Amino-2- cyclopropyl-5-
(3,3-dimethylbut- 1-ynyl)-6- methoxycarbonyl- pyrimidine
##STR00129## 5.40 (2H, br s), 3.90 (3H, s), 2.10 (1H, m), 1.30 (9H,
s), 1.10 (2H, m), 0.90 (2H, m) 27-62 (E isomer) (E)-4-Amino-2-(4-
chloro-2-fluoro-3- methoxyphenyl)- 6- methoxycarbonyl-
5-(prop-1-enyl)- pyrimidine ##STR00130## 7.60 (1H, t), 7.20 (1H,
d), 6.60 (1H, dd), 6.10 (1H, m), 5.30 (2H, br s), 4.00 (3H, s),
3.90 (3H, s), 1.90 (3H, d) 31-61 4-Amino-5- ethenyl-6-
methoxycarbonyl- 2-(4- trifluoromethyl- phenyl)-pyrimidine
##STR00131## 137-139 33-62 (E isomer) (E)-4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-6- methoxycarbonyl- 5-(prop-1-enyl)-
pyrimidine ##STR00132## 136-137 27-62 (Z isomer) (Z)-4-Amino-2-(4-
chloro-2-fluoro-3- methoxyphenyl)- 6- methoxycarbonyl-
5-(prop-1-enyl)- pyrimidine ##STR00133## 7.70 (1H, t), 7.30 (1H,
dd), 6.40 (1H, dd), 6.10 (1H, m), 5.30 (2H, br s), 4.00 (3H, s),
3.90 (3H, s), 1.60 (3H, dd) 2-221 2-Cyclopropyl-4- dimethylamino-6-
methoxycarbonyl- 5- methylpyrimidine ##STR00134## 4.00 (3H, s),
3.00 (6H, s), 2.30 (3H, s), 2.10 (1H, m), 1.00 (4H, m) 2-225
2-Cyclopropyl-4- dimethylamino-5- ethenyl-6- methoxycarbonyl-
pyrimidine ##STR00135## 6.80 (1H, dd), 5.30 (2H, dd), 3.90 (3H, s),
3.10 (6H, s), 2.10 (1H, m), 1.00 (4H, m) 27-63 4-Amino-2-(4-
chloro-2-fluoro-3- methoxyphenyl)- 6- methoxycarbonyl-
5-(prop-1-en-2- yl)-pyrimidine ##STR00136## 7.60 (1H, t), 7.20 (1H,
dd), 5.40 (1H, s), 5.30 (2H, br s), 5.10 (1H, s), 4.00 (3H, s),
3.90 (3H, s), 2.10 (3H, s) 27-69 4-Amino-2-(4- chloro-2-fluoro-3-
methoxyphenyl)- 6- methoxycarbonyl- 5-(2-methylprop- 1-enyl)-
pyrimidine ##STR00137## 7.70 (1H, t), 7.20 (1H, dd), 6.10 (1H, s),
5.30 (2H, br s), 4.00 (3H, s), 3.90 (3H, s) 2.00 (3H, s), 1.60 (3H,
s) 2-69 4-Amino-2- cyclopropyl-6- methoxycarbonyl- 5-(2-methylprop-
1-enyl)- pyrimidine ##STR00138## 6.00 (1H, s), 5.00 (2H, br s),
3.90 (3H, s), 2.10 (1H, m), 1.9 (3H, s), 1.50 (3H, s), 1.10 (2H,
m), 0.90 (2H, m). 33-62 (Z isomer) (Z)-4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-6- methoxycarbonyl- 5-(prop-1-enyl)-
pyrimidine ##STR00139## 7.60 (1H, t), 7.20 (1H, d), 6.40 (1H, dd),
6.10 (1H, m), 5.40 (2H, m), 3.90 (3H, s), 2.90 (6H, s), 1.60 (3H,
dd) 33-64 4-Amino-2-(4- chloro-3- dimethylamino-2- fluorophenyl)-6-
methoxycarbonyl- 5-(prop-1-en-2- yl)-pyrimidine ##STR00140## 7.60
(1H, t), 7.20 (1H, dd), 5.40 (2H, br s), 5.40 (1H, m), 5.10 (1H,
s), 3.90 (3H, s), 2.90 (6H, s), 2.10 (3H, s)
Example 9
Synthesis of
4-amino-6-methoxycarbonyl-5-prop-1-enyl-2-(4-tri-fluoromethylphenyl)-pyri-
midine (compound 31-62)
##STR00141##
[0455] 4-Trifluoromethylphenyl boronic acid (190 mg, 1.0 mmol),
4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in example 4) (221 mg, 1.0 mmol), caesium fluoride (302
mg, 2.0 mmol) and [1,1'-bis(diphenylphosphino)-ferrocene]
dichloropalladium (II) complex with dichloromethane (1:1) (82 mg,
0.10 mmol) were placed in a vial. The vial was evacuated and
backfilled with nitrogen before adding dimethoxyethane (2 ml) and
water (2 ml). The reaction mixture was heated in a microwave
reactor at 140.degree. C. for 20 minutes, then allowed to cool and
filtered through a plug of silica, washing with ethyl acetate. The
filtrate was evaporated under reduced pressure and the residue
dissolved in dimethoxyethane (2.5 ml) and water (2.5 ml). To this
solution were added propenyl boronic acid (112 mg, 1.3 mmol),
caesium fluoride (302 mg, 2.0 mmol) and
[1,1'-bis(diphenylphosphino)-ferrocene] dichloropalladium (II)
complex with dichloromethane (1:1) (82 mg, 0.10 mmol). The
resulting mixture was heated in a microwave reactor at 140.degree.
C. for 20 minutes, then allowed to cool and filtered through a plug
of silica, washing with ethyl acetate. The filtrate was washed with
brine, dried over magnesium sulphate, filtered and evaporated under
reduced pressure. The crude product was purified by chromatography
on silica using a gradient of hexane/ethyl acetate (100:0 to 8:2)
as eluent to provide
4-amino-6-methoxycarbonyl-5-prop-1-enyl-2-(4-trifluoromethylphenyl)-pyrim-
idine as an off-white solid (145 mg, 43%).
[0456] M.p. 123-125.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 8.50 (2H, d), 7.70 (2H, d), 6.40 (1H, dd), 6.10 (1H,
dd), 5.30 (2H, br s), 3.90 (3H, s), 1.90 (3H, dd) ppm.
[0457] Further compounds, prepared using this general method, are
listed in Table 7 below.
TABLE-US-00015 TABLE 7 Compounds made according to the general
method described in Example 9 above. Characteristic data provided
is either melting point (.degree. C.) and/or 1H- nmr data (400 MHz,
CDCl.sub.3) .delta..sub.H ppm Compound No. Name Structure
Characteristic data 31-64 4-Amino-6- methoxycarbonyl-
5-(prop-1-en-2- yl)-2-(4- trifluoromethyl- phenyl)-pyrimidine
##STR00142## 83-85 31-63 4-Amino-6- methoxycarbonyl-
5-(prop-1-en-3- yl)-2-(4- trifluoromethyl- phenyl)-pyrimidine
##STR00143## 8.50 (2H, d), 7.70 (2H, d), 5.90 (1H, m), 5.20 (4H, m
+ br s), 4.00 (3H, s), 3.50 (2H, m) 27-61 4-Amino-2-(4-
chloro-2-fluoro-3- methoxyphenyl)- 5-ethenyl-6- methoxycarbonyl-
pyrimidine ##STR00144## 146-148
Example 10
Synthesis of
4-amino-5-ethenyl-6-methoxycarbonyl-2-methylthiopyrimidine
(compound 62-61)
10.1 Preparation of
4-amino-5-chloro-6-methoxycarbonyl-2-methylthiopyrimidine
##STR00145##
[0459] Sodium methanethiolate (3.0 g, 35 mmol) was added
portionwise to a stirred solution of
4-amino-2,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in example 4) (4.4. g, 20 mmol) in methanol (100 ml) to
give a pale yellow solution. The resulting mixture was stirred at
reflux for 2 hours then allowed to cool for 2 hours, filtered and
evaporated under reduced pressure. The residue was dissolved in
water and ethyl acetate, the phases separated and the aqueous
extracted with further ethyl acetate. The combined organic phases
were washed with water and brine, dried over magnesium sulphate,
filtered and evaporated under reduced pressure to provide
4-amino-5-chloro-6-methoxycarbonyl-2-methylthiopyrimidine as a
yellow solid (2.2 g), which was used without further
purification.
[0460] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 5.55 (2H, br
s), 3.95 (3H, s), 2.50 (3H, s) ppm.
10.2 Preparation of
4-amino-5-ethenyl-6-methoxycarbonyl-2-methylthiopyrimidine
(compound 62-61)
##STR00146##
[0462] Water (2 ml) was added with stirring to a solution of
4-amino-5-chloro-6-methoxycarbonyl-2-methylthiopyrimidine (233 mg,
1.0 mmol) in dimethoxyethane (3 ml). The mixture was heated in a
microwave reactor at 140.degree. C. for 2 hours, then allowed to
cool, diluted with ethyl acetate and washed with water and brine.
The organic phase was dried over magnesium sulphate, filtered and
evaporated under reduced pressure to provide a brown oil which was
purified by chromatography on silica using hexane/ethyl acetate
(4:1) as eluent to provide
4-amino-5-ethenyl-6-methoxycarbonyl-2-methylthiopyrimidine as a
beige solid (120 mg, 50%).
[0463] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 6.70 (1H,
dd), 5.75 (2H, dd), 5.30 (2H, br s), 3.90 (3H, s), 2.50 (3H, s)
ppm.
Example 11
Synthesis of
4-amino-5-ethenyl-6-methoxycarbonyl-2-(4-methylphenyl)-pyrimidine
(compound 36-61)
##STR00147##
[0465] A solution of
4-amino-5-ethenyl-6-methoxycarbonyl-2-methylthiopyrimidine
(prepared as described in example 10) (113 mg, 0.50 mmol),
4-methylphenylboronic acid (74 mg, 0.55 mmol), copper
thiophene-2-carboxylate (125 mg, 0.65 mmol)), tri(2-furyl)phosphine
(19 mg, 80 .mu.mol) and tris(dibenzylideneacetone)dipalladium
chloroform adduct (10 mg, 10 .mu.mol) in tetrahydrofuran (3 ml) was
heated in a microwave reactor at 100.degree. C. for 30 minutes,
then allowed to cool. Ether was added and the resulting solution
washed with concentrated aqueous ammonia and brine, dried over
magnesium sulphate, filtered and evaporated under reduced pressure
to provide a brown solid (0.13 g). The crude product was purified
by chromatography on silica using hexane/ethyl acetate (4:1) as
eluent to provide
4-amino-5-ethenyl-6-methoxycarbonyl-2-(4-methylphenyl)-pyrimidine
as a pale yellow solid (45 mg, 33%).
[0466] M.p. 122-123.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 8.24 (2H, d), 7.22 (2H, d), 6.80 (1H, dd), 5.60 (2H,
m), 5.35 (2H, br s), 3.93 (3H, s), 2.39 (3H, s) ppm.
[0467] Further compounds, prepared using this general method, are
listed in Table 8 below.
TABLE-US-00016 TABLE 8 Compounds made according to the general
method described in Example 11 above. Characteristic data provided
is either melting point (.degree. C.) and/or 1H-nmr data (400 MHz,
CDCl.sub.3) .delta..sub.H ppm Compound No. Name Structure
Characteristic data 19-61 4-Amino-2-(4- chloro-3- fluorophenyl)-5-
ethenyl-6- methoxycarbonyl- pyrimidine ##STR00148## 155-156 61-61
4-Amino-2-(3- chloro-5- fluorophenyl)-5- ethenyl-6-
methoxycarbonyl- pyrimidine ##STR00149## 158-159 15-61
4-Amino-2-(4- chloro-2- fluorophenyl)-5- ethenyl-6-
methoxycarbonyl- pyrimidine ##STR00150## 137-138 63-61 4-Amino-5-
ethenyl-6- methoxycarbonyl- 2-(3,4,5- trifluorophenyl)- pyrimidine
##STR00151## 188-190 9-61 4-Amino-2-(3,4- dichlorophenyl)-
5-ethenyl-6- methoxycarbonyl- pyrimidine ##STR00152## 8.49 (1H, d),
8.22 (1H, dd), 7.50 (1H, d), 6.79 (1H, dd), 5.78 (1H, m), 5.64 (1H,
dd), 5.40 (2H, br s), 3.98 (3H, s) 14-61 4-Amino-2-(4- chloro-3-
trifluoromethyl- phenyl)-5-ethenyl-6- methoxycarbonyl- pyrimidine
##STR00153## 8.72 (1H, d), 8.49 (1H, dd), 7.56 (1H, d), 6.78 (1H,
dd), 5.69 (1H, m), 5.65 (1H, dd), 5.42 (2H, br s), 3.97 (3H, s)
6-61 4-Amino-2-(4- bromophenyl)-5- ethenyl-6- methoxycarbonyl-
pyrimidine ##STR00154## 8.25 (2H, d), 7.56 (2H, d), 6.79 (1H, dd),
5.66 (1H, m), 5.63 (1H, dd), 5.38 (2H, br s), 3.96 (3H, s) 41-61
4-Amino-5- ethenyl-2-(4- fluorophenyl)-6- methoxycarbonyl-
pyrimidine ##STR00155## 8.37 (2H, d), 7.11 (2H, m), 6.80 (1H, dd),
5.65 (1H, m), 5.62 (1H, dd), 5.37 (2H, br s), 3.96 (3H, s) 44-61
4-Amino-2-(3- chloro-4- fluorophenyl)-5- ethenyl-6-
methoxycarbonyl- pyrimidine ##STR00156## 8.46 (1H, dd), 8.27 (1H,
m), 7.19 (1H, t), 6.79 (1H, dd), 5.67 (1H, m), 5.63 (1H, dd), 5.39
(2H, br s), 3.96 (3H, s) 43-61 4-Amino-5- ethenyl-2-(4- fluoro-3-
trifluoromethyl- phenyl)-6- methoxycarbonyl- pyrimidine
##STR00157## 8.67 (1H, dd), 8.59 (1H, m), 7.25 (1H, t), 6.80 (1H,
dd), 5.68 (1H, m), 5.64 (1H, dd), 5.41 (2H, br s), 3.97 (3H, s)
45-61 4-Amino-5- ethenyl-2-(4- fluoro-3- methylphenyl)-6-
methoxycarbonyl- pyrimidine ##STR00158## 8.22 (1H, m), 8.18 (1H,
m), 7.05 (1H, t), 6.79 (1H, dd), 5.66 (1H, m), 5.62 (1H, dd), 5.36
(2H, br s), 3.96 (3H, s), 2.34 (3H, s) 42-61 4-Amino-5-
ethenyl-2-(4- fluoro-3- methoxyphenyl)- 6- methoxycarbonyl-
pyrimidine ##STR00159## 8.02 (1H, dd), 7.97 (1H, m), 7.13 (1H, dd),
6.79 (1H, dd), 5.67 (1H, m), 5.63 (1H, d), 5.37 (2H, br s), 4.00
(3H, s), 3.96 (3H, s) 67-61 4-Amino-2-(3,4- difluorophenyl)-5-
ethenyl-6- methoxycarbonyl- pyrimidine ##STR00160## 8.22 (1H, m),
8.15 (1H, m), 7.21 (1H, q), 6.80 (1H, dd), 5.67 (1H, d), 5.64 (1H,
d), 5.38 (2H, br s), 3.97 (3H, s) 68-61 4-Amino-2-(4-
cyanophenyl)-5- ethenyl-6- methoxycarbonyl- pyrimidine ##STR00161##
8.49 (2H, d), 7.74 (2H, d), 6.82 (1H, dd), 5.70 (1H, m), 5.66 (1H,
dd), 5.41 (2H, br s), 3.97 (3H, s) 69-61 4-Amino-5- ethenyl-6-
methoxycarbonyl- 2-(4- methoxycarbonyl- phenyl)- pyrimidine
##STR00162## 165-166 47-61 4-Amino-5- ethenyl-6- methoxycarbonyl-
2-(4- trifluoromethoxy- phenyl)-pyrimidine ##STR00163## 8.40 (2H,
d), 7.27 (2H, d), 6.80 (1H, dd), 5.66 (1H, d), 5.63 (1H, d), 5.41
(2H, br s), 3.96 (3H, s) 71-61 4-Amino-5- ethenyl-2-(3,4-
ethylenedioxy- phenyl)-6- methoxycarbonyl- pyrimidine ##STR00164##
7.92 (1H, d), 7.88 (1H, dd), 6.90 (1H, d), 6.79 (1H, dd), 5.63 (1H,
s), 5.59 (1H, d), 5.36 (2H, br s), 4.30 (4H, m), 3.94 (3H, s) 30-61
4-Amino-2-(4- chloro-3,5- difluorophenyl)-5- ethenyl-6-
methoxycarbonyl- pyrimidine ##STR00165## 8.04 (2H, m), 6.79 (1H,
dd), 5.66 (2H, m), 5.40 (2H, br s), 3.95 (3H, s) 26-61
4-Amino-2-(4- chloro-3- methoxyphenyl)- 5-ethenyl-6-
methoxycarbonyl- pyrimidine ##STR00166## 7.97 (1H, d), 7.95 (1H,
dd), 7.42 (1H, d), 6.78 (1H, dd), 5.66 (1H, m), 5.63 (1H, dd), 5.39
(2H, br s), 4.03 (3H, s), 3.95 (3H, s) 70-61 4-Amino-5- ethenyl-6-
methoxycarbonyl- 2-(3,4- methylenedioxy- phenyl)-pyrimidine
##STR00167## 7.97 (1H, dd), 7.84 (1H, d), 6.88 (1H, d), 6.78 (1H,
dd), 6.03 (2H, s), 5.84 (2H, br s), 5.67 (1H, dd), 5.63 (1H, dd),
3.96 (3H, s) 72-61 4-Amino-5- ethenyl-6- methoxycarbonyl- 2-(4-
methylthiophenyl)- pyrimidine ##STR00168## 8.28 (2H, d), 7.27 (2H,
d), 6.78 (1H, dd), 5.64 (1H, s), 5.59 (1H, d), 5.44 (2H, br s),
3.95 (3H, s), 2.53 (3H, s) 73-61 4-Amino-5- ethenyl-6-
methoxycarbonyl- 2-(2-naphthyl)- pyrimidine ##STR00169## 8.91 (1H,
s), 8.47 (1H, d), 7.96 (1H, m), 7.88 (1H, d), 7.85 (1H, m), 7.49
(2H, m), 6.80 (1H, dd), 5.63 (2H, m), 5.45 (2H, br s), 3.98 (3H,
s)
Example 12
Synthesis of
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-ethenylpyrimidine-6-carbo-
xylic acid (compound 27-21)
##STR00170##
[0469] Sodium hydroxide (24 mg, 2 mmol) was added to a suspension
of
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-ethenyl-6-methoxycarbonyl-
pyrimidine (prepared as described in example 8) (100 mg, 0.30 mmol)
in tetrahydrofuran (10 ml) and water (6.5 ml) The reaction mixture
was stirred for 3 hours at ambient temperature then acidified to pH
1-2 and washed with ethyl acetate. The aqueous phase was
concentrated under reduced pressure to provide an off white solid
which was purified using a FractionLynx automated hplc system to
yield
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-ethenylpyrimidine-6-carbo-
xylic acid as a white solid (28 mg, 29%)
[0470] .sup.1H nm r (400 MHz, d.sub.6-DMSO) .delta..sub.H 7.50 (1H,
m), 7.30 (1H, d), 6.50 (1H, m), 5.80 (1H, d), 5.30 (1H, d), 3.80
(3H, s) (amine and acid protons not observed).
[0471] Further examples, prepared using this general method, are
listed in Table 9 below.
TABLE-US-00017 TABLE 9 Compounds made according to the general
method described in Example 12 above. Characteristic data is
.sup.1H nmr data (400 MHz, d.sub.6- DMSO) .delta..sub.H ppm
Compound No. Name Structure Characteristic data 33-21
4-Amino-2-(4-chloro-3- dimethylamino-2- fluorophenyl)-5-
ethenylpyrimidine-6- carboxylic acid ##STR00171## 7.50 (1H, t),
7.20 (1H, t), 6.50 (3H, br s and t), 5.70 (1H, d), 5.20 (1H, d),
2.40 (6h, d) (acid proton not observed)
Example 13
synthesis of
4-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-ethenyl-6-ethoxycar-
bonyl-pyrimidine (compound 33-101)
##STR00172##
[0473] A solution of
4-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-ethenyl-6-methoxyca-
rbonyl-pyrimidine (prepared by the method described in example 8)
(200 mg, 0.57 mmol), 1-hydroxy-3-isothionato-1,1,3,3-tetrabutyl
distannoxane (32 mg, 0.057 mmol), and ethanol (0.22 ml, 5.7 mmol)
in toluene (8 ml) was heated at reflux for 3 hours. The reaction
was allowed to cool and evaporated under reduced pressure and the
residue purified by chromatography on silica using a hexane/ethyl
acetate gradient (8:2 to 6:4) as eluent to provide
4-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-ethenyl-6-ethoxycar-
bonyl-pyrimidine as a white solid (193 mg, 93%).
[0474] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 7.60 (1H,
t), 7.20 (1H, dd), 6.80 (1H, dd), 5.70 (2H, dd), 5.50 (2H, br s),
4.40 (2H, q), 2.90 (6H, d), 1.40 (3H, t) ppm.
[0475] Further examples, prepared using this general method, are
listed in Table 10 below.
TABLE-US-00018 TABLE 10 Compounds made according to the general
method described in Example 13 above. Characteristic data is
.sup.1H nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Compound
Characteristic No. Name Structure data 33-306 4-Amino-2-(4-
chloro-3- dimethylamino-2- fluorophenyl)-5- ethenyl-6-
isopropoxycarbon- yl-pyrimidine ##STR00173## 7.62 (1H, t), 7.21
(1H, dd), 6.72 (1H, dd), 5.67 (1H, m), 5.64 (1H, m), 5.36 (2H, br
s), 5.28 (1H, septet), 2.90 (6H, d), 1.37 (6H, d) 33-316
4-Amino-2-(4- chloro-3- dimethylamino-2- fluorophenyl)-5-
ethenyl-6- .sup.npropoxycarbonyl- pyrimidine ##STR00174## 7.61 (1H,
t), 7.22 (1H, dd), 6.76 (1H, dd), 5.68 (1H, s), 5.64 (1H, d), 5.42
(2H, br s), 4.31 (2H, t), 2.91 (6H, d), 1.80 (2H, sextet), 1.03
(3H, t) 33-391 4-Amino-6- .sup.nbutoxycarbonyl-2- (4-chloro-3-
dimethylamino-2- fluorophenyl)-5- ethenyl-pyrimidine ##STR00175##
7.62 (1H, t), 7.22 (1H, dd), 6.77 (1H, dd), 5.68 (1H, s), 5.65 (1H,
d), 5.39 (2H, br s), 4.36 (2H, t), 2.90 (6H, d), 1.76 (2H, m), 1.46
(2H, m), 0.96 (3H, t) 33-326 4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-5- ethenyl-6-(2- methylpropoxy)
carbonyl-pyrimidine ##STR00176## 7.62 (1H, dd), 7.22 (1H, dd), 6.77
(1H, dd), 5.68 (1H, s), 5.64 (1H, d), 5.40 (2H, br s), 4.22 (1H,
dd), 4.13 (1H, dd), 2.90 (6H, d), 1.93 (1H, m), 1.00 (3H, d), 0.92
(3H, t) 33-392 4-Amino-2-(4- chloro-3- dimethylamino-2-
fluorophenyl)-5- ethenyl-6- .sup.noctyloxycarbonyl- pyrimidine
##STR00177## 7.61 (1H, dd), 7.22 (1H, dd), 6.77 (1H, dd), 5.78 (1H,
s), 5.64 (1H, d), 5.40 (2H, br s), 5.35 (2H, t), 2.90 (6H, d), 1.76
(2H, quintet), 1.43 (2H, m), 1.30 (8H, m), 0.88 (3H, m) 33-393
4-Amino-2-(4- chloro-3- dimethylamino-2- fluorophenyl)-5-
ethenyl-6-(2- ethylhexyloxy) carbonyl-pyrimidine ##STR00178## 7.63
(1H, t), 7.21 (1H, dd), 6.76 (1H, dd), 5.68 (1H, m), 5.64 (1H, m),
5.38 (2H, br s), 4.26 (2H, m), 2.90 (6H, d), 1.72 (1H, m), 1.37
(8H, m), 1.27 (3H, t), 0.92 (3H, m) 33-336 4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-5- ethenyl-6- phenylmethoxy-
carbonyl-pyrimidine ##STR00179## 7.61 (1H, dd), 7.45 (2H, m), 7.36
(3H, m), 7.21 (1H, dd), 6.70 (1H, dd), 5.60 (1H, d), 5.56 (1H, s),
5.39 (4H, br s), 2.91 (6H, d) 33-394 4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-5- ethenyl-6-(1- phenyl-
ethoxy)carbonyl- pyrimidine ##STR00180## 7.65 (1H, t), 7.45 (2H,
m), 7.35 (3H, m), 7.22 (1H, dd), 6.64 (1H, dd), 6.14(1H, q), 5.59
(1H, d), 5.53(1H, dd), 5.38 (2H, br s), 2.91 (6H, d), 1.69 (3H, d)
33-395 4-Amino-2-(4- chloro-3- dimethylamino-2- fluorophenyl)-5-
ethenyl-6-(prop-2- enyloxy)carbonyl- pyrimidine ##STR00181## 7.61
(1H, t), 7.22 (1H, dd), 6.78 (1H, dd), 6.02 (1H, m), 5.68 (1H, d),
5.65 (1H, dd), 5.47 (1H, m), 5.43 (2H, br s), 5.31 (1H, m), 4.85
(2H, m), 2.91 (6H, d) 33-396 4-Amino-2-(4- chloro-3-
dimethylamino-2- fluorophenyl)-5- ethenyl-6-(2- ethoxy-
ethoxy)carbonyl- pyrimidine ##STR00182## 7.60 (1H, t), 7.22 (1H,
dd), 6.79 (1H, dd), 5.69 (1H, d), 5.65 (1H, m), 5.41 (2H, br s),
4.50 (2H, m), 3.76 (2H, m), 3.58 (2H, q), 2.90 (6H, d), 1.25 (3H,
t) 33-397 4-Amino-6-(2- .sup.nbutoxy- ethoxy)carbonyl-2-
(4-chloro-3- dimethylamino-2- fluorophenyl)-5- ethenyl-pyrimidine
##STR00183## 7.52 (1H, t), 7.24 (1H, dd), 6.77 (1H, dd), 5.75 (2H,
m), 4.50 (2H, m), 3.75 (2H, m), 3.51 (2H, t), 3.29 (2H, br s), 2.91
(6H, d), 1.57 (2H, m), 1.38 (2H, m), 0.92 (3H, t)
Example 14
Synthesis of
4-amino-2-cyclopropyl-6-methoxycarbonyl-5-(trimethylsilylethynyl)-pyrimid-
ine (compound 2-78)
##STR00184##
[0477] Palladium tetrakis(triphenylphosphine) (231 mg, 0.20 mmol)
was added to a degassed solution of
4-amino-5-chloro-2-cyclopropyl-6-methoxycarbonylpyrimidine
(prepared as described in example 2) (227 mg, 1.0 mmol) and
trimethylsilylacetylene (0.28 ml, 2.0 mmol) in diisopropylamine (8
ml) and fluorobenzene (20 ml). The resulting solution was heated
under nitrogen at 80.degree. C. for 32 hours, then allowed to cool
and the solvent evaporated under reduced pressure. The residue was
dissolved in dichloromethane, washed with water and brine, dried
over magnesium sulphate, filtered and evaporated under reduced
pressure. The crude material was purified by high pressure liquid
chromatography to provide
4-amino-2-cyclopropyl-6-methoxycarbonyl-5-(trimethylsilylethynyl)-pyrimid-
ine as a white solid (15 mg, 5%).
[0478] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 5.50 (2H, br
s), 3.95 (3H, s), 2.10 (1H, m), 1.10 (2H, m), 1.00 (2H, m), 0.30
(9H, s) ppm.
Example 15
Synthesis of
4-amino-2-chloro-6-methoxycarbonyl-5-prop-1-ynyl-pyrimidine
(compound 1-74)
15.1 Preparation of
2,4-dichloro-5-iodo-6-methoxycarbonylpyrimidine
##STR00185##
[0480] A mixture of
2,4-dihydroxy-5-iodo-6-methoxycarbonylpyrimidine (1.0 g, 3.38
mmol), phosphorus oxychloride (6 ml) and dimethylformamide (0.1 ml)
was heated at reflux for 3 hours, then allowed to cool to room
temperature, concentrated under reduced pressure and poured into
iced water. The resulting mixture was extracted with
dichloromethane and the combined organic extracts washed with
brine, dried over magnesium sulphate, filtered and evaporated under
reduced pressure. The residue was purified by chromatography on
silica using a gradient of hexane/ethyl acetate (8:2 to 6:4) as
eluent to provide 2,4-dichloro-5-iodo-6-methoxycarbonylpyrimidine
as a brown solid (520 mg, 46%).
[0481] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.00 (3H, s)
ppm.
15.2 Preparation of
4-amino-2-chloro-5-iodo-6-methoxycarbonylpyrimidine
##STR00186##
[0483] A solution of
2,4-dichloro-5-iodo-6-methoxycarbonylpyrimidine (950 mg, 2.86 mmol)
and ammonia (7M in methanol; 1.6 ml, 11 mmol) in anhydrous dioxane
(10 ml) was stirred at ambient temperature for 30 minutes then
evaporated under reduced pressure. The residue was dissolved in
ethyl acetate, washed with water, dried over magnesium sulphate,
filtered and evaporated under reduced pressure. The residue was
purified by chromatography on silica using a gradient of
hexane/ethyl acetate (9:1 to 6:4) as eluent to provide
4-amino-2-chloro-5-iodo-6-methoxycarbonylpyrimidine as a white
solid (590 mg, 66%).
[0484] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 5.90 (2H, br
s), 4.00 (3H, s) ppm.
15.3 Preparation of
4-amino-2-chloro-6-methoxycarbonyl-5-prop-1-ynyl-pyrimidine
(compound 1-74)
##STR00187##
[0486] A solution of
4-amino-2-chloro-5-iodo-6-methoxycarbonylpyrimidine (210 mg, 0.67
mmol), 1-tributylstannyl-propyne (0.3 ml, 1 mmol) and
bis(triphenylphosphine)palladium dichloride (48 mg, 0.067 mmol) in
dimethylformamide (6 ml) was heated in a microwave reactor at
160.degree. C. for 20 minutes, then allowed to cool. Ethyl acetate
was added and the resulting solution washed with water and brine,
dried over magnesium sulphate, filtered and evaporated. The residue
was purified by chromatography using a gradient of hexane/ethyl
acetate (9:1 to 2:8) as eluent to provide
4-amino-2-chloro-6-methoxycarbonyl-5-prop-1-ynyl-pyrimidine as a
white solid (90 mg, 63%).
[0487] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.00 (3H,
s), 2.20 (3H, s) ppm (amine protons not observed).
Example 16
Synthesis of
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-6-methoxycarbonyl-5-prop-1--
ynyl-pyrimidine (compound 27-74)
##STR00188##
[0489] 4-Chloro-2-fluoro-3-methoxyphenyl boronic acid (232 mg, 1.13
mmol), 4-amino-2-chloro-6-methoxycarbonyl-5-prop-1-ynyl-pyrimidine
(prepared as described in example 15) (170 mg, 0.76 mmol), caesium
fluoride (228 mg, 1.5 mmol) and
[1,1'-bis(diphenylphosphino)-ferrocene] dichloropalladium (II)
complex with dichloromethane (1:1) (62 mg, 0.075 mmol) were placed
in a vial. The vial was evacuated and backfilled with nitrogen
before adding dimethoxyethane (5 ml) and water (5 ml). The reaction
mixture was heated in a microwave reactor at 140.degree. C. for 20
minutes, then allowed to cool. Dichloromethane was added and the
solution washed with water, dried over magnesium sulphate, filtered
and evaporated under reduced pressure. The crude product was
purified by chromatography on silica using a gradient of
hexane/ethyl acetate (9:1 to 3:2) as eluent to provide
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-6-methoxycarbonyl-5-
-prop-1-ynyl-pyrimidine as a white solid (30 mg, 11%).
[0490] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 7.70 (1H,
t), 7.20 (1H, dd), 5.80 (2H, br s), 4.00 (6H, s), 2.20 (3H, s)
ppm.
Example 17
Synthesis of
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-6-formyl-6-methoxycarbonyl--
pyrimidine (compound 27-52)
##STR00189##
[0492] Ozone was bubbled through a stirred solution of
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-ethenyl-6-methoxycarbonyl-
-pyrimidine (prepared by the method described in example 8) (125
mg, 0.0.37 mmol) in dichloromethane (40 ml) at -78.degree. C. until
a blue colour persisted. Oxygen was then bubbled through the
solution until it became colourless. Dimethyl sulphide (2 ml) was
added and the solution allowed to warm to ambient temperature over
2 hours. The reaction mixture was evaporated under reduced pressure
and the residue purified by chromatography on silica using a
gradient of hexane/ethyl acetate (100:0 to 60:40) to provide
4-amino-2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-formyl-6-methoxycarbonyl--
pyrimidine as an off-white solid (50 mg, 40%).
[0493] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 10.40 (1H,
s), 7.80 (1H, t), 7.20 (1H, m), 4.10 (3H, s), 4.00 (3H, s) ppm
(amine protons not observed).
Example 18
Synthesis of
4-amino-5-(1-ethoxyethenyl)-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-
-pyrimidine (compound 31-67)
##STR00190##
[0495] A solution of
4-amino-5-chloro-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-pyrimidine
(prepared as described in example 5) (662 mg, 2.0 mmol),
1-ethoxy-1-tributylstannyl-ethene (0.8 ml, 2.4 mmol) and palladium
tetrakis(triphenylphosphine) (462 mg, 0.40 mmol) in
dimethylsulphoxide (14 ml) was heated at 170.degree. C. in a
microwave reactor for 30 minutes. The reaction mixture was allowed
to cool, potassium fluoride (saturated solution in methanol; 30 ml)
added and the resulting mixture stirred for 17 hours at ambient
temperature. The mixture was filtered through Celite.RTM., the
solid washed with methanol and the filtrate concentrated under
reduced pressure. The residue was extracted with ether and ethyl
acetate and the combined organic extracts washed with brine, dried
over magnesium sulphate, filtered and evaporated under reduced
pressure. The crude material was purified column chromatography on
silica using hexane/ethyl acetate (4:1) as eluent to provide
4-amino-5-(1-ethoxyethenyl)-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-
-pyrimidine as a pale yellow solid (651 mg, 89%). .sup.1H nmr (400
MHz, CDCl.sub.3) .delta..sub.H 8.50 (2H, d), 7.80 (2H, d), 5.60
(2H, br s), 4.50 (2H, dd), 3.90 (2H, q), 3.90 (3H, s), 1.40 (3H, t)
ppm.
[0496] Further examples, prepared using this general method, are
listed in Table 11 below.
TABLE-US-00019 TABLE 11 Compounds made according to the general
method described in Example 18 above. Characteristic data is
.sup.1H nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Compound
Characteristic No. Name Structure data 33-67 4-Amino-2-(4-chloro-
3-dimethylamino-2- fluorophenyl)-5-(1- ethoxyethenyl)-6-
methoxycarbonyl- pyrimidine ##STR00191## 7.60 (1H, t), 7.20 (1H,
dd), 5.60 (2H, br s), 4.50 (2H, dd), 3.90 (3H, s), 3.90 (2H, q),
2.90 (6H, s), 1.40 (3H, t) 27-67 4-Amino-2-(4-chloro- 2-fluoro-3-
methoxyphenyl)-5- (1-ethoxyethenyl)-6- methoxycarbonyl- pyrimidine
##STR00192## 7.60 (1H, t), 7.20 (1H, dd), 5.60 (2H, br s), 4.50
(2H, dd), 4.00 (3H, d), 3.90 (3H, s), 3.90 (2H, q), 1.40 (3H,
t)
[0497] Also isolated from a reaction of this type was
4-amino-2-(4-[1-ethoxyethenyl]-2-fluoro-3-methoxy-phenyl)-6-methoxycarbon-
yl-5-methylcarbonyl-pyrimidine (compound 66-53).
[0498] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 7.60 (1H,
t), 7.50 (1H, dd), 5.70 (2H, br s), 4.50 (2H, dd), 4.00 (3H, d),
3.90 (3H, s), 3.90 (2H, q), 2.60 (3H, s), 1.40 (3H, t) ppm.
Example 19
Synthesis of
4-amino-6-methoxycarbonyl-5-methylcarbonyl-2-(4-trifluoromethylphenyl)-py-
rimidine (compound 31-53)
##STR00193##
[0500] A solution of
4-amino-5-(1-ethoxyethenyl)-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-
-pyrimidine (prepared as described in Example 18) (300 mg, 0.82
mmol) and hydrochloric acid (1M; 6 ml, 6 mmol) in tetrahydrofuran
(12 ml) was stirred at ambient temperature for 1 hour. The reaction
mixture was concentrated under reduced pressure, extracted with
ethyl acetate and the combined organic extracts washed with aqueous
sodium hydrogen carbonate and brine, dried over magnesium sulphate,
filtered and evaporated under reduced pressure. The crude product
was purified by column chromatography on silica using a gradient of
hexane/ethyl acetate (100:0 to 4:1) as eluent to provide
4-amino-6-methoxycarbonyl-5-methylcarbonyl-2-(4-trifluoromethylphenyl)-py-
rimidine as an off white solid (241 mg, 87%).
[0501] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 8.50 (2H,
d), 7.70 (2H, d), 4.00 (3H, s), 3.48 (2H, br s), 2.50 (3H, s)
ppm.
[0502] Further examples, prepared using this general method, are
listed in Table 12 below.
TABLE-US-00020 TABLE 12 Compounds made according to the general
method described in Example 19 above. Characteristic data is
.sup.1H nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Compound
Characteristic No. Name Structure data 33-53 4-Amino-2-(4-chloro-
3-dimethylamino-2- fluorophenyl)-6- methoxycarbonyl-5-
methylcarbonyl- pyrimidine ##STR00194## 7.70 (1H, t), 7.20 (1H,
dd), 4.00 (3H, s), 2.90 (6H, s), 2.50 (3H, s) (amine protons not
observed) 27-53 4-Amino-2-(4-chloro- 2-fluoro-3-methoxy- phenyl)-6-
methoxycarbonyl-5- methylcarbonyl- pyrimidine ##STR00195## 7.70
(1H, t), 7.20 (1H, dd), 4.10 (3H, s), 4.00 (3H, s), 2.50 (3H, s)
(amine protons not observed) 65-53 4-Amino-2-(2-fluoro-
3-methoxy-4- methylcarbonyl- phenyl)-6- methoxycarbonyl-5-
methylcarbonyl- pyrimidine ##STR00196## 7.70 (1H, t), 7.50 (1H,
dd), 4.10 (3H, s), 4.00 (3H, s), 2.70 (3H, s), 2.50 (3H, s) (amine
protons not observed)
Example 20
Synthesis of
4-amino-5-(1-hydroxyethyl)-6-hydroxymethyl-2-(4-trifluoromethylphenyl)-py-
rimidine (compound 31-372)
##STR00197##
[0504] Sodium borohydride (11 mg, 0.30 mmol) was added to a stirred
solution of
4-amino-6-methoxycarbonyl-5-methylcarbonyl-2-(4-trifluoromethylphenyl)-py-
rimidine (prepared as described in example 19) (51 mg, 0.15 mmol)
in methanol (2 ml). The reaction mixture was stirred at ambient
temperature for 1 hour, then 1N hydrochloric acid (1 ml) was added
and the mixture concentrated under reduced pressure and extracted
with ethyl acetate. The combined organic extracts were washed with
brine, dried over magnesium sulphate, filtered and evaporated under
reduced pressure. The residue was purified using a FractionLynx
automated hplc system to provide
4-amino-5-(1-hydroxyethyl)-6-hydroxymethyl-2-(4-trifluoromethylphenyl)-py-
rimidine as a colourless oil (13 mg, 28%).
[0505] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 8.40 (2H,
d), 7.70 (2H, d), 6.00 (2H, br s), 5.00 (1H, q), 4.80 (1H, br s),
4.60 (2H, q), 2.70 (1H, br s), 1.50 (3H, d) ppm.
Example 21
Synthesis of
4-amino-5-ethyl-6-methoxycarbonyl-2-(4-trifluoro-methylphenyl)-pyrimidine
(compound 31-42)
##STR00198##
[0507] A solution of
4-amino-5-ethenyl-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-pyrimidin-
e (prepared using the method described in example 8) (38 mg, 0.11
mmol) in methanol (10 ml) was reduced using a Thales H-cube reactor
fitted with a 30 mm palladium on carbon cartridge. The reaction was
performed at 30.degree. C. and 20 bar pressure at a flow rate of 1
ml/minute. The reaction solution was evaporated under reduced
pressure to provide
4-amino-5-ethyl-6-methoxycarbonyl-2-(4-trifluoromethylphenyl)-pyrimidine
(38 mg, 99%).
[0508] M.p. 123-124.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 8.50 (2H, d), 7.70 (2H, d), 5.30 (2H, br s), 4.00
(3H, s), 2.70 (2H, q), 1.30 (3H, t) ppm.
[0509] Further compounds, prepared using this general method, are
listed in Table 13 below.
TABLE-US-00021 TABLE 13 Compounds made according to the general
method described in Example 21 above. Characteristic data provided
is .sup.1H-nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm
Compound No. Name Structure Characteristic data 31-43 4-Amino-6-
methoxycarbonyl- 5-propyl-2-(4- trifluoromethyl- phenyl)-pyrimidine
##STR00199## 8.50 (2H, d), 7.70 (2H, d), 5.20 (2H, br s), 4.00 (3H,
s), 2.60 (2H, q), 1.70 (2H, septet), 1.10 (3H, t)
Example 22
Synthesis of
4-amino-2-(3-dimethylamino-4-ethenyl-2-fluorophenyl)-5-ethenyl-6-methoxyc-
arbonylpyrimidine (compound 64-61)
##STR00200##
[0511] A mixture of
4-amino-2-(4-chloro-3-dimethylamino-2-fluorophenyl)-5-ethenyl-6-methoxyca-
rbonylpyrimidine (prepared as described in example 8) (200 mg, 0.57
mmol), vinyl boronic acid pinacol ester (0.12 ml, 0.69 mmol),
palladium acetate (6 mg, 0.029 mmol), tricyclohexylphosphine
tetrafluoroborate (21 mg, 0.057 mmol), potassium phosphate (363 mg,
1.7 mmol), toluene (3.6 ml) and water (0.4 ml) was purged with
nitrogen, then heated in a microwave reactor at 180.degree. C. for
30 minutes. The reaction mixture was allowed to cool, water added
and the resulting mixture extracted with dichloromethane. The
organic phase was washed with brine, dried over magnesium sulphate,
filtered and evaporated under reduced pressure. The residue was
purified by chromatography on silica using hexane/ethyl acetate
(first 8:2, then 6:4) as eluent to provide
4-amino-2-(3-dimethylamino-4-ethenyl-2-fluorophenyl)-5-ethenyl-6-methoxyc-
arbonylpyrimidine as a yellow oil (95 mg, 49%).
[0512] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 7.60 (1H,
t), 7.35 (1H, d), 7.20 (1H, dd), 6.80 (1H, dd), 5.70 (3H, m), 5.40
(2H, br s), 5.30 (1H, d), 3.90 (3H, s), 2.80 (6H, s) ppm.
Example 23
Synthesis of 4-chloro-2-fluoro-3-methoxybenzamidine
23.1 Preparation of 3-bromo-6-chloro-2-fluorophenol
##STR00201##
[0514] n-Butyllithium (2.1M in hexane; 68 ml, 149 mmol) was added
dropwise to a stirred solution of diisopropylamine (15 g, 149 mmol)
in anhydrous tetrahydrofuran (700 ml) at -78.degree. C. under a
nitrogen atmosphere. Once the addition was complete the reaction
mixture was allowed to warm to 0.degree. C., cooled to -78.degree.
C. and a solution of 1-bromo-4-chloro-2-fluorobenzene (25 g, 119
mmol) in anhydrous tetrahydrofuran (60 ml) was added dropwise. The
mixture was allowed to warm to -20.degree. C., cooled to
-78.degree. C. and a solution of trimethylborate (15 g, 143 mmol)
in anhydrous tetrahydrofuran (30 ml) added dropwise. The reaction
mixture was allowed to warm to -20.degree. C. and stirred at that
temperature for 30 minutes, then cooled to -78.degree. C. and
peracetic acid (80 ml) added dropwise. The mixture was allowed to
warm to ambient temperature and stirred overnight under nitrogen.
Water (11) was added and the resulting mixture extracted with ethyl
acetate (3.times.500 ml). The combined organic extracts were washed
with water and brine, dried over sodium sulphate, filtered and
evaporated under reduced pressure. The residue was purified by
column chromatography on silica using 2% ethyl acetate in hexane as
eluent to provide 3-bromo-6-chloro-2-fluorophenol (13.8 g,
51%).
23.2 Preparation of 1-bromo-4-chloro-2-fluoro-3-methoxybenzene
##STR00202##
[0516] Anhydrous potassium carbonate (17 g, 122 mmol) was added to
a solution of 3-bromo-6-chloro-2-fluorophenol (13.8 g, 61 mmol) in
anhydrous acetonitrile (100 ml). at ambient temperature. Methyl
iodide (17 g, 122 mmol) was then added dropwise. The resulting
mixture was heated at reflux for 2 hours, then cooled to ambient
temperature and filtered through Celite.RTM., the solid being
washed with acetonitrile. The filtrate was evaporated under reduced
pressure, the residue dissolved in ethyl acetate (250 ml) and
washed with water (100 ml). The aqueous phase was extracted with
ethyl acetate (100 ml and the combined organic phases were washed
with brine, dried over sodium sulphate, filtered and evaporated
under reduced pressure. The crude product was purified by column
chromatography on silica using hexane as eluent to provide
1-bromo-4-chloro-2-fluoro-3-methoxybenzene as a colourless oil,
which solidified on storage at 5.degree. C. (11.4 g, 78%).
23.3 Preparation of 4-chloro-2-fluoro-3-methoxybenzonitrile
##STR00203##
[0518] Copper(I) cyanide (57 g, 0.64 mol) was added to a degassed
solution of 1-bromo-4-chloro-2-fluoro-3-methoxybenzene (76 g, 0.32
mol) in anhydrous dimethylformamide (760 ml). The resulting mixture
was again degassed and tetrakis(triphenylphosphine) palladium(0)
(1.2 g) added. The reaction mixture was heated at 110.degree. C.
under nitrogen for 24 hours, then allowed to cool to ambient
temperature and water (2.5 l) added. The resulting mixture was
stirred for 10 minutes, then filtered through Celite.RTM. and the
solid washed with ethyl acetate (500 ml). The filtrate was
separated into phases and the aqueous extracted with ethyl acetate
(3.times.500 ml). The combined organic phases were washed with
water and brine, dried over sodium sulphate, filtered and
evaporated under reduced pressure. The crude product which was
purified by column chromatography on silica using agradient of
ethyl acetate (2-5%) in hexane as eluent to provide
4-chloro-2-fluoro-3-methoxybenzonitrile as a colourless solid (38
g, 65%).
23.4 Preparation of 4-chloro-2-fluoro-3-methoxybenzamidine
##STR00204##
[0520] n-Butyllithium (2.2M in hexane; 196 ml, 0.43 mol) was added
dropwise to a solution of hexamethyldisilazane (72 g, 0.45 mol) in
anhydrous diethyl ether (800 ml) at -15.degree. C. under a nitrogen
atmosphere. The resulting solution was stirred at -15.degree. C.
for 1 hour, then a solution of
4-chloro-2-fluoro-3-methoxybenzonitrile (40 g, 0.22 mol) in
anhydrous diethyl ether (600 ml) was added dropwise. The reaction
mixture was stirred at -15.degree. C. for 30 minutes, then allowed
to warm to ambient temperature and stirring continued for 2 hours.
The mixture was cooled to -10.degree. C., hydrochloric acid (3M;
360 ml) added dropwise and the resulting mixture stirred at
0.degree. C. for 45 minutes. The phases were separated and the
aqueous layer washed with ethyl acetate (250 ml). The aqueous phase
was cooled to 0.degree. C., basified by the addition of aqueous
sodium hydroxide (3M) and extracted with ethyl acetate (3.times.300
ml). The combined organic extracts were dried over sodium sulphate,
filtered and evaporated under reduced to provide
4-chloro-2-fluoro-3-methoxybenzamidine as a yellow solid (33 g,
75%).
Example 24
Synthesis of
4-chloro-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidine
(compound 31-390)
24.1 Preparation of
6-ethoxycarbonyl-4-hydroxy-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidin-
e and
4,6-dihydroxy-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)--
3,4-dihydropyrimidine
##STR00205##
[0522] A suspension of sodium ethoxide (940 mg, 13.8 mmol) in
ethanol (4.5 ml) was added to a solution of
4-(trifluoromethyl)benzamidine hydrochloride dihydrate (2.79 g,
12.4 mmol) and diethyl oxalpropiolate (2.6 ml, 13.8 mmol) in
ethanol (30 ml) and the resulting mixture stirred at ambient
temperature for 18 hours. The reaction mixture was concentrated
under reduced pressure, then dichloromethane was added and the
solution dried over magnesium sulphate, filtered and evaporated
under reduced pressure. The crude product was purified by
chromatography on silica using hexane/ethyl acetate (3:2) as eluent
to provide a mixture of
6-ethoxycarbonyl-4-hydroxy-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidin-
e and
4,6-dihydroxy-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)--
3,4-dihydropyrimidine as a pale brown solid (2.21 g).
24.2 Preparation of
4-chloro-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidine
(compound 31-390)
##STR00206##
[0524] Phosphorus oxychloride (5 ml) was added to a mixture of
6-ethoxycarbonyl-4-hydroxy-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidin-
e and
4,6-dihydroxy-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)--
3,4-dihydropyrimidine (640 mg, 1.9 mmol) in a sealed vial. The
resulting mixture was heated at 105.degree. C. for 3 hours, then
cooled to ambient temperature and allowed to stand for 18 hours.
The mixture was poured onto ice and solid sodium hydrogen carbonate
added to bring the pH to 7. The resulting mixture was extracted
with ethyl acetate and the combined organic extracts washed with
brine, dried over magnesium sulphate, filtered and evaporated under
reduced pressure to provide
4-chloro-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidine
as a brown oil (142 mg).
[0525] MH.sup.+ 345, 347.
Example 25
Synthesis of
4-dimethylamino-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)-pyr-
imidine (compound 31-301)
##STR00207##
[0527] A solution of
4-chloro-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)-pyrimidine
(prepared as described in example 24) (100 mg, 0.29 mmol),
dimethylamine hydrochloride (47 mg, 0.58 mmol) and triethylamine
(0.08 ml, 0.58 mmol) in dichloromethane (2 ml) was stirred at
ambient temperature for 2.5 hours. Ethyl acetate was added and the
resulting solution washed with brine, dried over magnesium
sulphate, filtered and evaporated under reduced pressure. A
sub-sample of the residue was purified using a FractionLynx
automated hplc system to provide
4-dimethylamino-6-ethoxycarbonyl-5-methyl-2-(4-trifluoromethylphenyl)-pyr-
imidine as a yellow oil (7 mg)
[0528] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 8.50 (2H,
d), 7.70 (2H, d), 4.50 (2H, q), 3.20 (6H, s), 2.40 (3H, s), 1.50
(3H, t) ppm.
Example 26
Synthesis of
5-chloro-2-cyclopropyl-4-methoxy-6-methoxycarbonyl-pyrimidine
##STR00208##
[0530] Triethylamine (1 ml, 2.5 mmol) was added to a stirred
solution of 2-cyclopropyl-4,5-dichloro-6-methoxycarbonylpyrimidine
(prepared as described in example 1) (500 mg, 2.0 mmol) in methanol
(10 ml). The mixture was heated at 45.degree. C. for 14 hours,
allowed to stand at ambient temperature for 72 hours, and then
evaporated under reduced pressure. The residue was dissolved in
ethyl acetate and the resulting solution washed with water and
brine, dried over magnesium sulphate, filtered and evaporated under
reduced pressure to provide
5-chloro-2-cyclopropyl-4-methoxy-6-methoxycarbonyl-pyrimidine as a
white solid (400 mg, 81%).
[0531] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.03 (3H,
s), 4.00 (3H, s), 2.20 (1H, m), 1.12 (2H, m), 1.08 (2H, m) ppm.
[0532] Further examples, prepared using this general method, are
listed in Table 14 below.
TABLE-US-00022 TABLE 14 Compounds made according to the general
method described in Example 26 above. Melting point Name Structure
(.degree. C.) 5-Chloro-2-(4- chloro-2-fluoro- 3-methoxy- phenyl)-4-
methoxy-6- methoxy- carbonyl- pyrimidine ##STR00209## 143-145
Example 27
Synthesis of
2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-ethenyl-4-methoxy-6-methoxycarbon-
yl-pyrimidine (compound 27-398)
##STR00210##
[0534] A mixture of vinyl boronic acid pinacol ester (0.1 ml, 0.58
mmol),
5-chloro-2-(4-chloro-2-fluoro-3-methoxyphenyl)-4-methoxy-6-methoxycarbony-
lpyrimidine (prepared as described in example 26) (200 mg, 0.55
mmol), caesium fluoride (168 mg, 1.1 mmol),
[1,1'-bis(diphenylphosphino)-ferrocene] dichloropalladium (II)
complex with dichloromethane (1:1) (46 mg, 0.056 mmol),
dimethoxyethane (2 ml) and water (2 ml) was heated in a microwave
reactor at 150.degree. C. for 20 minutes, then allowed to cool.
Ethyl acetate was added and the solution washed with brine, dried
over magnesium sulphate, filtered and evaporated under reduced
pressure to leave a brown gum, which was purified by chromatography
on silica using hexane/ethyl acetate (9:1 then 4:1) as eluent to
provide
2-(4-chloro-2-fluoro-3-methoxyphenyl)-5-ethenyl-4-methoxy-6-methoxycarbon-
yl-pyrimidine as a white solid (115 mg, 59%).
[0535] M.p. 107-108.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 7.82 (1H, t), 7.24 (1H, d), 6.82 (1H, q), 6.06 (1H,
d), 5.63 (1H, d), 4.17 (3H, s), 4.04 (6H, s), 3.97 (3H, s) ppm.
[0536] Further examples, prepared using this general method, are
listed in Table 15 below.
TABLE-US-00023 TABLE 15 Compounds made according to the general
method described in Example27 above. Characteristic data is .sup.1H
nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Com- pound
Characteristic No. Name Structure data 2-398 2-Cyclopropyl-
5-ethenyl-4- methoxy-6- methoxy- carbonyl- pyrimidine ##STR00211##
6.71 (1H, dd), 5.89 (1H, d), 5.50 (1H, d), 4.00 (3H, s), 3.95 (3H,
s), 2.20 (1H, m), 1.14 (2H, m), 1.03 (2H, m)
Example 28
Synthesis of
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylthio-pyrimidine
(compound 2-400)
28.1 Preparation of
5-chloro-2-cyclopropyl-6-methoxycarbonyl-4-methylthio-pyrimidine
##STR00212##
[0538] Sodium methanethiolate (1.0 g, 14 mmol) was added
portionwise to a stirred solution of
2-cyclopropyl-4,5-dichloro-6-methoxycarbonylpyrimidine (prepared as
described in example 1) (2.46 g, 10 mmol) in methanol (50 ml). The
resulting mixture was stirred at ambient temperature for 1.5 hours,
then evaporated under reduced pressure. The residue was partitioned
between ethyl acetate and water and the organic phase washed with
water and brine, dried over magnesium sulphate, filtered and
evaporated to provide
5-chloro-2-cyclopropyl-6-methoxycarbonyl-4-methylthio-pyrimidine as
a white solid (2.1 g, 80%).
[0539] M.p. 74-75.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 4.00 (3H, s), 2.50 (3H, s), 2.24 (1H, m), 1.17 (2H,
m), 1.10 (2H, m) ppm.
28.2 Preparation of
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylthio-pyrimidine
(compound 2-400)
##STR00213##
[0541] A mixture of vinyl boronic acid pinacol ester (0.4 ml, 2
mmol),
5-chloro-2-cyclopropyl-6-methoxycarbonyl-4-methylthio-pyrimidine
(258 mg, 1.0 mmol), caesium fluoride (0.6 g, 4 mmol),
[1,1'-bis(diphenylphosphino)-ferrocene] dichloropalladium (II)
complex with dichloromethane (1:1) (200 mg, 0.25 mmol),
dimethoxyethane (3 ml) and water (2 ml) was heated in a microwave
reactor at 140.degree. C. for 1 hour, then allowed to cool. Ethyl
acetate was added and the solution washed with water and brine,
dried over magnesium sulphate, filtered and evaporated under
reduced pressure to leave a brown oil, which was purified by
chromatography on silica using hexane/ethyl acetate (4:1) as eluent
to provide
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylthio-pyrimidine
as a colourless gum (150 mg, 60%).
[0542] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 6.68 (1H,
m), 5.55 (2H, m), 3.90 (3H, s), 2.50 (3H, s), 2.23 (1H, m), 1.20
(2H, m), 1.08 (2H, m) ppm.
Example 29
Synthesis of (i)
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylsulphinyl-pyrimidine
(compound 2-401) and (ii)
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylsulphonyl-pyrimidine
(compound 2-402)
##STR00214##
[0544] Peracetic acid (32% solution in dilute acetic acid; 0.25 ml,
1.1 mmol) was added dropwise to a stirred solution of
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylthio-pyrimidine
(prepared as described in example 28) (125 mg, 0.5 mmol) in
dichloromethane (5 ml) at 0.degree. C. The reaction mixture was
stirred at ambient temperature for 1 hour, then further
dichloromethane added and the resulting solution washed with water
and brine, dried over magnesium sulphate, filtered and evaporated
under reduced pressure to leave a yellow gum. This was purified by
chromatography on silica using hexane/ethyl acetate (4:1) as eluent
to provide
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylsulphinyl-pyrimidine
as a white solid (40 mg, 30%).
[0545] M.p. 74-75.degree. C.; .sup.1H nmr (400 MHz, CDCl.sub.3)
.delta..sub.H 7.02 (1H, dd), 5.67 (1H, d), 5.50 (1H, d), 3.95 (3H,
s), 2.88 (3H, s), 2.42 (1H, m), 1.27 (2H, m), 1.10 (2H, m) ppm.
[0546] Also isolated, as a yellow solid, was
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylsulphonyl-pyrimidine
(10 mg, 7%).
[0547] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 7.18 (1H,
dd), 5.65 (1H, d), 5.58 (1H, d), 3.94 (3H, s), 3.33 (3H, s), 2.38
(1H, m), 1.20 (4H, m) ppm.
Example 30
Synthesis of
4-azido-2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-pyrimidine
(compound 2-399)
##STR00215##
[0549] m-Chloroperbenzoic acid (516 mg, 3.0 mmol) was added
portionwise to a stirred solution of
2-cyclopropyl-5-ethenyl-6-methoxycarbonyl-4-methylthio-pyrimidine
(prepared as described in example 28) (250 mg, 1.0 mmol) in
dichloromethane (10 ml) at 0.degree. C. The reaction mixture was
allowed to stand at ambient temperature for 16 hours, then further
dichloromethane added and the resulting solution washed with water
and brine, dried over magnesium sulphate, filtered and evaporated
under reduced pressure to leave a gum. This was dissolved in
methanol (10 ml) and sodium azide (500 mg, 7.7 mmol) added
portionwise. The reaction mixture was then allowed to stand at
ambient temperature for 64 hours, filtered and the filtrate
evaporated under reduced pressure. The residue was purified by
chromatography on silica using hexane/ethyl acetate (4:1) as eluent
to provide
4-azido-2-cyclopropyl-5-ethenyl-6-methoxycarbonylpyrimidine as a
white solid (65 mg, 27%).
[0550] M.p. 120-130.degree. C. (decomp.); .sup.1H nmr (400 MHz,
CDCl.sub.3) .delta..sub.H 7.18 (1H, dd), 5.65 (1H, d), 5.58 (1H,
d), 3.94 (3H, s), 2.38 (1H, m), 1.60 (2H, m), 1.46 (2H, m) ppm.
Example 31
Synthesis of (i)
2-cyclopropyl-4-hydroxy-6-methoxycarbonyl-methoxy-5-methylpyrimidine
and (ii)
4,6-bis(methoxycarbonyl-methoxy)-2-cyclopropyl-5-methylpyrimidine
(compound 2-384)
##STR00216##
[0552] A mixture of 2-cyclopropyl-4,6-dihydroxy-5-methylpyrimidine
(1.6 g, 9.6 mmol), methyl bromoacetate (1.5 g, 9.8 mmol), potassium
carbonate (1.4 g, 10 mmol) and dimethylformamide (7.5 ml) was
heated at 90.degree. C. for 6 hours, then allowed to cool and stood
at ambient temperature for 65 hours. Water was added and the
resulting precipitate washed with ether and dried to provide a
white solid. This was washed with ethyl acetate to provide
2-cyclopropyl-4-hydroxy-6-methoxycarbonylmethoxy-5-methylpyrimidi-
ne as a white solid (450 mg, 19%).
[0553] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 13.80 (1H,
br s), 4.70 (2H, s), 3.70 (3H, s), 1.90 (4H, m), 1.05 (4H, m)
ppm.
[0554] The combined ethyl acetate washings were evaporated under
reduced pressure and the residue purified by column chromatography
on silica using ethyl acetate as eluent to provide
4,6-bis(methoxycarbonylmethoxy) 2-cyclopropyl-5-methylpyrimidine as
a solid (450 mg, 15%).
[0555] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.80 (4H, br
s), 3.75 (6H, s), 2.10 (3H, s), 1.95 (1H, m), 0.90 (4H, m) ppm.
[0556] Further compounds, prepared using this general method, are
listed in Table 16 below.
TABLE-US-00024 TABLE 16 Compounds made according to the general
method described in Example 31 above. Characteristic data provided
is .sup.1H-nmr data (400 MHz, CDCl.sub.3) .delta..sub.H ppm Com-
Character- pound istic No. Name Structure data 2-389 4,6-bis(t-
butoxy- carbonyl- methoxy)- 2-cyclo- propyl- 5-methyl- pyrimidine
##STR00217## 4.85 (2H, s), 4.60 (2H, s), 1.90 (3H, s), 1.65 (1H,
m), 1.45 (18H, s), 1.10 (2H, m), 0.90 (2H, m)
Example 32
Synthesis of
4-chloro-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(compound 2-376)
##STR00218##
[0558] A stirred suspension of
2-cyclopropyl-4-hydroxy-6-methoxycarbonylmethoxy-5-methylpyrimidine
(prepared as described in example 31) (450 mg, 1.9 mmol) in
phosphorus oxychloride (3 ml) was heated at 120.degree. C. for 5
hours. The reaction mixture was allowed to cool and evaporated
under reduced pressure. The residue was dissolved in
dichloromethane and the solution washed with saturated aqueous
sodium bicarbonate, dried over magnesium sulphate, filtered and
evaporated under reduced pressure. The residue was purified by
column chromatography on silica using diethyl ether as eluent to
provide
4-chloro-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidin-
e as a solid (350 mg, 70%).
[0559] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.85 (2H,
s), 3.75 (3H, s), 2.20 (3H, s), 2.10 (1H, m), 1.00 (4H, m) ppm.
Example 33
Synthesis of
4-amino-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(compound 2-362)
33.1 Preparation of
4-azido-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(compound 2-388)
##STR00219##
[0561] A stirred solution of
4-chloro-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(prepared as described in example 32) (256 mg, 1.0 mmol) and sodium
azide (100 mg, 1.5 mmol) in dimethylformamide (10 ml) was heated at
90.degree. C. for 3 hours. The reaction mixture was allowed to cool
and added to water. Ether was added, the mixture stirred for 30
minutes, then the phases separated. The organic phase was dried
over magnesium sulphate, filtered and evaporated under reduced
pressure to provide
4-azido-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
as an oil (200 mg, 76%).
[0562] MH.sup.+: 264.
33.2 Preparation of
4-amino-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(compound 2-362)
##STR00220##
[0564] A mixture of
4-azido-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(200 mg, 0.76 mmol) and palladium (5% on carbon; catalytic) in
methanol (20 ml) was stirred under an atmosphere of hydrogen (4
bar) for 5 minutes. The reaction mixture was allowed to cool and
added to water. Ether was added, the mixture stirred for 30
minutes, then the phases separated. The organic phase was dried
over magnesium sulphate, filtered and evaporated under reduced
pressure to provide
4-amino-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine.
[0565] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 4.85 (2H,
s), 3.75 (3H, s), 2.20 (3H, s), 2.10 (1H, m), 1.00 (4H, m) ppm
(amino protons not observed).
Example 34
Synthesis of
(4-chloro-2-cyclopropyl-5-methyl-pyrimidin-6-yloxy)-acetic acid
(compound 2-375)
##STR00221##
[0567] A solution of
4-chloro-2-cyclopropyl-6-methoxycarbonylmethoxy-5-methylpyrimidine
(prepared as described in example 32) (256 mg, 1.0 mmol) and
ammonia (7M in methanol; 0.6 ml, 4 mmol) in methanol (2.5 ml) was
heated in a microwave reactor at 120.degree. C. for 20 minutes,
then cooled and evaporated under reduced pressure. The residue was
triturated with diethyl ether to provide
(4-chloro-2-cyclopropyl-5-methyl-pyrimidin-6-yloxy)-acetic acid as
a white solid (220 mg, 91%).
[0568] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 12.0 (1H, br
s), 4.81 (2H, s), 2.20 (3H, s), 2.10 (1H, m), 1.10 (4H, m) ppm.
Example 35
synthesis of
4-amino-5-ethenyl-6-methoxycarbonylmethoxy-2-methylthio-pyrimidine
(compound 2-366)
35.1 Preparation of
4-chloro-6-hydroxy-5-iodo-2-methylthio-pyrimidine
##STR00222##
[0570] N-Iodosuccinimide (8.1 g, 36 mmol) was added to a stirred
solution of 2-chloro-6-hydroxy-2-methylthiopyrimidine (5.28 g, 30
mmol) in methanol (100 ml) and the resulting mixture stirred at
ambient temperature for 1 hour. The reaction mixture was filtered
and the solid washed with diethyl ether to provide
4-chloro-6-hydroxy-5-iodo-2-methylthiopyrimidine as a white solid
(8.0 g, 88%).
[0571] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 2.50 (3H, s)
ppm (hydroxy proton not observed).
35.2 Preparation of 4,6-dichloro-5-iodo-2-methylthio-pyrimidine
##STR00223##
[0573] A suspension of
4-chloro-6-hydroxy-5-iodo-2-methylthiopyrimidine (906 mg, 3.0 mmol)
in phosphorus oxychloride (6 ml, 60 mmol) was heated at reflux for
3 hours, then allowed to cool and poured into iced water. The
mixture was filtered and the solid purified by chromatography on
silica using hexane/ethyl acetate (19:1) as eluent to provide
4,6-dichloro-5-iodo-2-methylthio-pyrimidine as a white solid (700
mg, 73%).
[0574] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 2.50 (3H, s)
ppm.
35.3 Preparation of
4-amino-6-chloro-5-iodo-2-methylthio-pyrimidine
##STR00224##
[0576] A solution of 4,6-dichloro-5-iodo-2-methylthio-pyrimidine
(320 mg, 1.0 mmol) and ammonia (7M in methanol; 0.15 ml, 1.1 mmol)
in methanol (2.5 ml) was heated in a microwave reactor at
120.degree. C. for 20 minutes, then cooled to 0.degree. C. The
solid was filtered and washed with hexane to provide
4-amino-6-chloro-5-iodo-2-methylthio-pyrimidine as a white solid
(210 mg, 70%).
[0577] .sup.1H nmr (400 MHz, d.sub.6-DMSO) .delta..sub.F, 7.20 (2H,
br s), 2.50 (3H, s) ppm.
35.4 Preparation of
4-amino-5-iodo-6-methoxycarbonylmethoxy-2-methylthio-pyrimidine
##STR00225##
[0579] Sodium hydride (50% in mineral oil; 72 mg, 1.5 mmol) was
added to a stirred solution of methyl glycolate (99 mg, 1.1 mmol)
in tetrahydrofuran (2 ml). After stirring for 10 minutes, a
solution of 4-amino-6-chloro-5-iodo-2-methylthio-pyrimidine (301
mg, 1.0 mmol) in tetrahydrofuran was added and the reaction mixture
heated at reflux for 2 hours. After cooling, saturated aqueous
ammonium chloride was added and the resulting mixture extracted
with ethyl acetate. The combined organic extracts were washed with
brine, dried over magnesium sulphate, filtered and evaporated under
reduced pressure. The residue was purified by chromatography on
silica, using a gradient of ethyl acetate in hexane (0-20%) as
eluent to provide
4-amino-5-iodo-6-methoxycarbonylmethoxy-2-methylthio-pyrimidine as
a yellow solid (130 mg, 36%).
[0580] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 5.30 (2H, br
s), 4.88 (2H, s), 3.75 (3H, s), 2.50 (3H, s) ppm.
35.5 Preparation of
4-amino-5-ethenyl-6-methoxycarbonylmethoxy-2-methylthio-pyrimidine
(compound 2-366)
##STR00226##
[0582] A mixture of vinyl boronic acid pinacol ester (0.067 ml,
0.375 mmol),
4-amino-5-iodo-6-methoxycarbonylmethoxy-2-methylthio-pyrimidine (89
mg, 0.25 mmol), caesium fluoride (76 mg, 0.50 mmol),
[1,1'-bis(diphenylphosphino)-ferrocene] dichloropalladium (II)
complex with dichloromethane (1:1) (20 mg, 0.025 mmol),
dimethoxyethane (1.5 ml) and water (1.5 ml) was heated in a
microwave reactor at 150.degree. C. for 20 minutes, then allowed to
cool. Dichloromethane was added and the solution washed with brine,
dried over magnesium sulphate, filtered and evaporated under
reduced pressure. The residue was purified by chromatography on
silica using hexane/ethyl acetate (4:1) as eluent to provide
4-amino-5-ethenyl-6-methoxycarbonylmethoxy-2-methylthio-pyrimidin-
e as a brown solid (43 mg, 67%).
[0583] .sup.1H nmr (400 MHz, CDCl.sub.3) .delta..sub.H 6.60 (1H,
m), 5.65 (1H, d), 5.50 (1H, d), 5.10 (2H, br s), 4.82 (2H, s), 3.72
(3H, s), 2.40 (3H, s) ppm.
Example 36
Pre-Emergence Biological Efficacy
[0584] Seeds of Alopecurus myosuroides (ALOMY), Setaria faberi
(SETFA), Echinochloa crus-galli (ECHCG), Solanum nigrum (SOLNI),
Amaranthus retoflexus (AMARE) and Ipomea hederaceae (IPOHE) were
sown in standard soil in pots. After cultivation for one day under
controlled conditions in a glasshouse (at 24/16.degree. C.,
day/night; 14 hours light; 65% humidity), the plants were sprayed
with an aqueous spray solution derived from the formulation of the
technical active ingredient in acetone/water (50:50) solution
containing 0.5% Tween 20 (polyoxyethylene sorbitan monolaurate, CAS
RN 9005-64-5) to give a final dose of 250 or 1000 g/ha of test
compound.
[0585] The test plants were then grown under controlled conditions
in the glasshouse (at 24/16.degree. C., day/night; 14 hours light;
65% humidity) and watered twice daily. After 13 days the test was
evaluated (100=total damage to plant; 0=no damage to plant).
Results are shown below in Table B1.
TABLE-US-00025 TABLE B1 Percentage damage caused to weed species by
compounds of the invention when applied pre-emergence. Compound
Species Number Dose (g/ha) SOLNI AMARE IPOHE SETFA ALOMY ECHCG 2-41
1,000 50 70 60 30 20 20 2-61 1,000 100 100 100 20 40 80 2-62 (E)
1,000 70 40 30 0 10 10 2-62 (Z) 1,000 100 90 100 20 20 10 2-64
1,000 80 100 100 20 20 0 2-65 250 0 0 0 0 0 0 2-66 1,000 0 -- 0 0 0
0 2-69 1,000 90 100 70 0 10 0 2-77 250 0 0 0 0 0 0 2-78 1,000 90 90
100 10 20 30 2-221 1,000 60 60 70 0 30 0 2-225 1,000 0 40 20 0 0 0
2-362 1,000 10 40 30 40 40 10 2-366 1,000 0 0 0 0 0 0 2-375 1,000 0
0 20 0 0 0 2-376 1,000 0 30 0 0 0 0 2-389 1,000 0 20 0 0 0 0 2-398
1,000 90 90 100 0 0 0 2-399 1,000 0 0 0 0 0 0 2-400 1,000 100 90 60
0 0 0 2-401 1,000 10 70 70 0 0 0 2-402 1,000 0 0 0 0 0 0 5-41 1,000
30 100 10 30 20 30 5-61 1,000 90 100 90 60 60 60 6-61 1,000 90 100
80 30 70 50 9-61 1,000 70 90 10 0 0 30 14-61 1,000 40 60 10 10 10
20 15-61 1,000 100 100 100 70 80 70 19-61 1,000 100 100 100 30 50
70 26-61 1,000 80 100 20 0 0 0 27-21 1,000 100 100 100 100 90 100
27-41 1,000 80 50 90 10 30 20 27-53 1,000 100 90 100 10 20 20 27-58
1,000 0 -- 10 0 0 0 27-61 1,000 100 100 90 90 90 90 27-62 (E) 1,000
80 50 90 80 90 90 27-62 (Z) 1,000 100 100 100 80 80 90 27-63 1,000
100 100 100 50 50 80 27-67 1,000 100 30 40 10 20 20 27-69 1,000 100
100 30 60 40 30 27-398 1,000 0 0 0 0 0 0 30-61 1,000 20 0 0 0 0 0
31-372 1,000 0 0 0 0 0 0 31-42 1,000 0 0 0 0 0 0 31-53 1,000 100
100 90 90 80 90 31-61 1,000 0 10 0 0 0 0 31-62 1,000 0 20 0 0 0 0
31-63 1,000 0 0 0 0 0 0 31-64 1,000 0 0 0 0 0 0 31-67 1,000 0 0 0 0
0 0 33-21 1,000 100 100 80 100 90 100 33-41 1,000 30 20 0 30 10 10
33-53 1,000 0 0 0 0 0 0 33-58 1,000 0 0 0 0 0 0 33-61 1,000 30 50
40 10 0 0 33-62 (E) 1,000 80 100 0 80 70 90 33-62 (Z) 1,000 60 70
20 30 30 30 33-64 1,000 0 0 0 0 0 0 33-67 1,000 0 0 10 0 0 0 33-101
1,000 90 100 30 90 60 90 33-306 1,000 80 40 0 20 20 20 33-316 1,000
80 90 10 70 60 90 33-326 1,000 60 60 10 20 20 40 33-336 1,000 80
100 20 80 70 90 33-391 1,000 100 100 20 90 70 100 33-392 1,000 80
100 0 90 70 100 33-393 1,000 20 20 0 0 0 0 33-394 1,000 40 40 0 30
20 30 33-395 1,000 100 100 30 80 60 90 33-396 1,000 90 100 50 80 70
90 33-397 1,000 100 100 50 90 80 100 36-61 1,000 100 100 100 80 70
90 41-61 1,000 0 100 40 10 20 10 42-61 1,000 20 60 0 20 10 10 43-61
1,000 70 60 10 50 30 70 44-61 1,000 40 50 10 30 20 40 45-61 1,000
40 100 0 50 50 40 47-61 1,000 0 0 0 0 0 0 60-41 1,000 40 0 10 10 20
10 61-61 1,000 30 0 0 0 0 0 62-61 1,000 100 100 100 0 0 0 63-61
1,000 0 0 0 0 0 0 64-61 1,000 10 30 0 10 10 10 65-53 1,000 0 0 20 0
0 0 66-53 1,000 20 10 30 0 0 0 67-61 1,000 70 100 50 30 30 30 68-61
250 30 10 0 0 0 0 69-61 1,000 0 0 0 0 0 0 70-61 1,000 100 100 80 70
80 90 71-61 1,000 40 0 0 0 10 20 72-61 1,000 50 60 70 0 0 0 73-61
1,000 0 0 0 0 0 0
Example 37
Post-Emergence Biological Efficacy
[0586] Seeds of Alopecurus myosuroides (ALOMY), Setaria faberi
(SETFA), Echinochloa crus-galli (ECHCG), Solanum nigrum (SOLNI),
Amaranthus retoflexus (AMARE) and Ipomea hederaceae (IPOHE) were
sown in standard soil in pots. After cultivation for 8 days under
controlled conditions in a glasshouse (at 24/16.degree. C.,
day/night; 14 hours light; 65% humidity), the plants were sprayed
with an aqueous spray solution derived from the formulation of the
technical active ingredient in acetone/water (50:50) solution
containing 0.5% Tween 20 (polyoxyethylene sorbitan monolaurate, CAS
RN 9005-64-5) to give a final dose of 250 or 1000 g/ha of test
compound.
[0587] The test plants were then grown on under controlled
conditions in a glasshouse (at 24/16.degree. C., day/night; 14
hours light; 65% humidity) and watered twice daily. After 13 days
the test was evaluated (100=total damage to plant; 0=no damage to
plant). Results are shown below in Table B2.
TABLE-US-00026 TABLE B2 Percentage damage caused to weed species by
compounds of the invention when applied post-emergence Compound
Species Number Dose (g/ha) SOLNI AMARE IPOHE SETFA ALOMY ECHCG 2-41
1,000 90 100 100 80 40 60 2-61 1,000 100 100 100 80 40 60 2-62 (E)
1,000 70 40 50 20 10 10 2-62 (Z) 1,000 70 70 100 30 10 10 2-64
1,000 80 60 70 30 10 40 2-65 250 40 20 40 0 0 0 2-66 1,000 60 50 40
10 0 0 2-69 1,000 80 20 70 10 10 0 2-77 250 40 30 70 0 0 0 2-78
1,000 100 100 100 60 30 60 2-221 1,000 80 100 80 60 20 70 2-225
1,000 50 40 30 0 0 0 2-362 1,000 80 80 80 70 40 60 2-366 1,000 20 0
0 0 0 0 2-375 1,000 10 10 20 0 0 0 2-376 1,000 30 20 50 20 0 0
2-389 1,000 30 0 20 0 0 0 2-398 1,000 80 90 90 0 0 0 2-399 1,000 20
20 20 0 0 0 2-400 1,000 100 80 60 0 0 0 2-401 1,000 80 70 70 0 0 0
2-402 1,000 20 0 50 0 0 0 5-41 1,000 70 100 40 30 30 20 5-61 1,000
100 100 100 100 80 90 6-61 1,000 90 100 70 30 60 50 9-61 1,000 90
100 70 0 20 20 14-61 1,000 80 10 40 0 0 0 15-61 1,000 100 100 80 70
90 70 19-61 1,000 100 100 100 40 40 60 26-61 1,000 80 100 70 0 50
60 27-21 1,000 90 100 90 100 90 90 27-41 1,000 80 100 60 80 30 50
27-53 1,000 90 100 60 40 30 30 27-58 1,000 80 90 60 40 10 20 27-61
1,000 80 100 80 100 90 90 27-62 (E) 1,000 100 100 90 100 90 100
27-62 (Z) 1,000 80 100 100 90 70 80 27-63 1,000 90 100 90 90 60 70
27-67 1,000 80 40 60 10 0 10 27-69 1,000 80 90 40 40 40 10 27-398
1,000 20 0 40 0 0 0 30-61 1,000 80 10 10 0 0 0 31-42 1,000 10 0 0 0
0 0 31-53 1,000 100 100 90 100 90 100 31-61 1,000 70 70 10 0 20 0
31-62 1,000 50 30 50 10 0 0 31-63 1,000 50 40 40 0 0 0 31-64 1,000
60 40 60 20 0 0 31-67 1,000 80 50 80 0 0 0 31-372 1,000 30 20 30 30
10 10 33-21 1,000 90 100 70 100 90 100 33-41 1,000 70 100 10 70 30
50 33-53 1,000 50 100 40 20 10 20 33-58 1,000 10 10 0 60 10 10
33-61 1,000 80 70 90 30 20 20 33-62 (Z) 1,000 80 100 40 80 80 80
33-62 (Z) 1,000 80 100 30 70 60 70 33-64 1,000 20 10 10 0 0 0 33-67
1,000 40 10 20 0 0 0 33-101 1,000 90 100 60 80 80 90 33-306 1,000
100 100 30 70 40 70 33-316 1,000 90 100 40 90 70 100 33-326 1,000
90 100 50 40 20 80 33-336 1,000 90 100 40 90 90 90 33-391 1,000 80
100 80 90 70 90 33-392 1,000 90 100 80 60 70 80 33-393 1,000 70 70
70 0 0 20 33-394 1,000 80 100 30 50 30 60 33-395 1,000 100 100 30
100 70 100 33-396 1,000 90 100 60 90 70 100 33-397 1,000 90 100 80
90 80 90 36-61 1,000 80 100 90 80 70 90 41-61 1,000 90 100 60 10 20
10 42-61 1,000 30 100 10 40 30 30 43-61 1,000 70 20 10 20 30 30
44-61 1,000 90 100 30 60 40 50 45-61 1,000 70 100 30 50 50 40 47-61
1,000 70 100 10 10 10 10 60-41 1,000 100 100 40 10 40 30 61-61
1,000 20 10 0 0 0 0 62-61 1,000 90 100 90 10 0 0 63-61 1,000 20 0
20 0 0 0 64-61 1,000 60 100 10 30 10 10 65-53 1,000 70 20 50 10 0
10 66-53 1,000 60 20 30 10 0 0 67-61 1,000 90 100 60 10 20 40 68-61
250 80 30 40 0 0 0 69-61 1,000 20 0 30 0 0 0 70-61 1,000 90 100 80
40 100 100 71-61 1,000 60 20 40 0 0 30 72-61 1,000 60 10 50 0 10 0
73-61 1,000 30 20 0 0 0 0
* * * * *